10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________

FORM 10-Q

_______________________________

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

or

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to _______________________

Commission file number 1-4347

_______________________________

ROGERS CORPORATION

 (Exact name of Registrant as specified in its charter)

_______________________________

Massachusetts	06-0513860
(State or other jurisdiction of	(I. R. S. Employer Identification No.)
incorporation or organization)
P.O. Box 188, One Technology Drive, Rogers, Connecticut	06263-0188
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code: (860) 774-9605

_______________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes X   No___

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes X   No___

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer     X                        Accelerated filer  ____

Non-accelerated filer  ____(Do not check if a smaller reporting company)           Smaller reporting company ____

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes__ No  X

The number of shares outstanding of the registrant's common stock as of July 23, 2012 was 16,431,245.

ROGERS CORPORATION

FORM 10-Q

June 30, 2012

TABLE OF CONTENTS
Part I – Financial Information
Item 1.		Condensed Consolidated Financial Statements (Unaudited):
		Condensed Consolidated Statements of Comprehensive Income (Loss)	3
		Condensed Consolidated Statements of Financial Position	4
		Condensed Consolidated Statements of Shareholders Equity	5
		Condensed Consolidated Statements of Cash Flows	6
		Notes to Condensed Consolidated Financial Statements	7
Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.		Quantitative and Qualitative Disclosures About Market Risk	40
Item 4.		Controls and Procedures	40
Part II – Other Information
Item 1.		Legal Proceedings	40
Item 6.		Exhibits	41
Signatures			42
Exhibits:
	Exhibit 10.3	General Release and Settlement Agreement with Michael D. Bessette
	Exhibit 23.1	Consent of National Economic Research Associates, Inc.
	Exhibit 23.2	Consent of Marsh U.S.A., Inc.
	Exhibit 31.1	Certification of President and CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	Exhibit 31.2	Certification of Vice President, Finance and CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	Exhibit 32	Certification of President and CEO and Vice President, Finance and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
	Exhibit 101.INS	XBRL Instance Document
	Exhibit 101.SCH	XBRL Schema Document
	Exhibit 101.CAL	XBRL Calculation Linkbase Document
	Exhibit 101.LAB	XBRL Labels Linkbase Document
	Exhibit 101.PRE	XBRL Presentation Linkbase Document
	Exhibit 101.DEF	XBRL Definition Linkbase Document

Forward Looking Statements

This Quarterly Report on Form 10-Q contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  See "Forward Looking Statements" under Part I- Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations of this Quarterly Report on Form 10Q.

2

Part I – Financial Information

Item 1.  Financial Statements

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(Dollars in thousands, except per share amounts)

	Three Months Ended						Six Months Ended
	June 30, 2012			June 30, 2011			June 30, 2012			June 30, 2011
Net sales	$	126,671		$	143,501		$	248,044		$	279,429
Cost of sales		89,799			94,930			174,731			188,316
Gross margin		36,872			48,571			73,313			91,113
Selling and administrative expenses		22,468			26,436			46,862			50,537
Research and development expenses		4,498			5,628			9,847			10,837
Restructuring and impairment charges		830			-			8,214			-
Operating income (loss)		9,076			16,507			8,390			29,739
Equity income in unconsolidated joint ventures		1,305			1,323			1,962			2,751
Other income (expense), net		261			280			122			1,629
Realized investment gain (loss):
Increase (decrease) in fair value of investments		-			602			(522	)		699
Less: Portion reclassified to/from other comprehensive income		-			573			2,723			667
Net realized gain (loss)		-			29			(3,245	)		32
Interest income (expense), net		(1,072	)		(1,265	)		(2,262	)		(2,843	)
Income (loss) before income tax expense (benefit)		9,570			16,874			4,967			31,308
Income tax expense (benefit)		3,115			3,442			213			6,811
Income (loss) from continuing operations		6,455			13,432			4,754			24,497
Income (loss) from discontinued operations, net of income taxes		-			(1,304	)		(108	)		(2,934	)
Net income (loss)	$	6,455		$	12,128		$	4,646		$	21,563
Basic net income (loss) per share:
Income (loss) from continuing operations	$	0.40		$	0.84		$	0.29		$	1.54
Income (loss) from discontinued operations		-			(0.08	)		(0.01	)		(0.18	)
Net income (loss)	$	0.40		$	0.76		$	0.28		$	1.36
Diluted net income (loss) per share:
Income (loss) from continuing operations	$	0.38		$	0.81		$	0.28		$	1.48
Income (loss) from discontinued operations		-			(0.08	)		(0.01	)		(0.18	)
Net income (loss)	$	0.38		$	0.73		$	0.27		$	1.30
Comprehensive income (loss)	$	(4,445	)	$	18,846		$	1,140		$	43,326
Shares used in computing:
Basic		16,309,053			15,944,483			16,270,955			15,918,978
Diluted		16,864,166			16,678,377			16,842,768			16,603,543

The accompanying notes are an integral part of the condensed consolidated financial statements.

3

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Unaudited)

(Dollars in thousands)

	June 30, 2012			December 31, 2011
Assets
Current assets
Cash and cash equivalents	$	95,786		$	79,728
Accounts receivable, less allowance for doubtful accounts of  $1,315 and  $1,040		81,767			77,682
Accounts receivable from joint ventures		2,418			1,640
Accounts receivable, other		3,325			3,819
Taxes receivable		1,719			2,713
Inventories		74,678			78,320
Prepaid income taxes		4,934			4,315
Deferred income taxes		1,893			2,146
Asbestos-related insurance receivables		6,471			6,459
Other current assets		9,989			7,360
Assets held for sale		-			1,400
Assets of discontinued operations		-			50
Total current assets		282,980			265,632
Property, plant and equipment, net of accumulated depreciation of $206,509 and $198,075		146,472			148,182
Investments in unconsolidated joint ventures		22,774			23,868
Deferred income taxes		20,650			20,117
Goodwill and other intangibles		153,835			158,627
Asbestos-related insurance receivables		21,262			21,943
Investments, other		5,000			5,000
Other long-term assets		8,189			8,299
Long-term marketable securities		-			25,960
Total assets	$	661,162		$	677,628
Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable	$	15,561		$	15,787
Accrued employee benefits and compensation		33,315			30,135
Accrued income taxes payable		31			1,799
Current portion of lease obligation		1,560			1,596
Current portion of long term debt		27,500			7,500
Asbestos-related liabilities		6,471			6,459
Other accrued liabilities		10,376			15,368
Liabilities of discontinued operations		-			153
Total current liabilities		94,814			78,797
Long term debt		92,500			115,000
Long term lease obligation		6,955			7,610
Pension liability		52,862			68,871
Retiree health care and life insurance benefits		9,486			9,486
Asbestos-related liabilities		21,468			22,326
Non-current income tax		18,628			17,588
Deferred income taxes		18,489			19,259
Other long-term liabilities		617			435
Shareholders’ Equity
Capital Stock - $1 par value; 50,000,000 authorized shares; 16,395,739 and
16,220,648 shares outstanding		16,396			16,221
Additional paid-in capital		58,510			52,738
Retained earnings		336,745			332,099
Accumulated other comprehensive income (loss)		(66,308	)		(62,802	)
Total shareholders' equity		345,343			338,256
Total liabilities and shareholders' equity	$	661,162		$	677,628

The accompanying notes are an integral part of the condensed consolidated financial statements.

4

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY

(Unaudited)

(Dollars in thousands)

(Dollars in thousands)	Capital Stock		Additional Paid-In Capital			Retained Earnings		Accumulated Other Comprehensive Income (Loss)			Total Shareholders’ Equity
Balance at December 31, 2011	$	16,221	$	52,738		$	332,099	$	(62,802	)	$	338,256
Comprehensive income (loss):
Net income (loss):		-		-			4,646		-			4,646
Other comprehensive income (loss):
Foreign currency translation, net of tax		-		-			-		(4,886	)		(4,886	)
Unrealized loss on marketable securities, net of tax		-		-			-		1,168			1,168
Unrealized loss on derivative instruments, net of tax		-		-			-		212			212
Total comprehensive income (loss)		-		-			4,646		(3,506	)		1,140
Stock options exercised		115		3,312			-		-			3,427
Stock issued to directors		15		(15	)		-		-			-
Shares issued for employees stock purchase plan		15		398			-		-			413
Shares issued for restricted stock		30		(601	)							(571	)
Stock-based compensation expense		-		2,678			-		-			2,678
Balance at June 30, 2012	$	16,396	$	58,510		$	336,745	$	(66,308	)	$	345,343

The accompanying notes are an integral part of the condensed consolidated financial statements

5

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Dollars in thousands)

	Six Months Ended
	June 30, 2012			June 30, 2011
Operating Activities:
Net income (loss)	$	4,646		$	21,563
Loss (earnings) from discontinued operations		108			2,934
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization		13,561			13,149
Stock-based compensation expense		2,678			3,610
Loss from long-term investments		3,245			-
Deferred income taxes		(1,050	)		2,148
Equity in undistributed income of unconsolidated joint ventures, net		(1,962	)		(2,751	)
Dividends received from unconsolidated joint ventures		2,929			2,762
Pension and postretirement benefits		6,718			2,970
Gain from the sale of property, plant and equipment		(579	)		(1,900	)
Impairment of assets		539			-
Amortization of inventory fair value		-			1,805
Changes in operating assets and liabilities excluding effects of
acquisition and disposition of businesses:
Accounts receivable		(3,340	)		(12,114	)
Accounts receivable, joint ventures		(778	)		(917	)
Inventories		3,018			(12,107	)
Pension contribution		(16,000	)		-
Other current assets		(3,331	)		(3,203	)
Accounts payable and other accrued expenses		(7,433	)		(22,097	)
Other, net		1,332			767
Net cash provided by (used in) operating activities of continuing operations		4,301			(3,381	)
Net cash provided by (used in) operating activites of discontinued operations		-			(2,979	)
Net cash provided by (used in) operating activites		4,301			(6,360	)
Investing Activities:
Capital expenditures		(10,767	)		(8,006	)
Proceeds from short-term investments		25,438			4,000
Proceeds from the sale of property, plant and equipment, net		1,979			5,900
Deferred purchase price for previous acquisition of business		(3,100	)		-
Acquisition of business, net of cash received		-			(139,825	)
Net cash provided by (used in) investing activities of continuing operations		13,550			(137,931	)
Financing Activities:
Proceeds from long term borrowings		-			145,000
Repayment of debt principal and long term lease obligation		(2,992	)		(10,000	)
Payment of long term borrowings acquired through acquisition		-			(7,452	)
Proceeds from sale of capital stock, net		3,427			5,464
Issuance of restricted stock shares		(571	)		-
Proceeds from issuance of shares to employee stock purchase plan		413			396
Net cash provided by (used in) financing activities of continuing operations		277			133,408
Effect of exchange rate fluctuations on cash		(2,070	)		2,395
Net increase (decrease) in cash and cash equivalents		16,058			(8,488	)
Cash and cash equivalents at beginning of year		79,728			80,135
Cash and cash equivalents at end of quarter	$	95,786		$	71,647
Supplemental disclosure of noncash investing and financing activities
Capital lease obligation acquired through acquisition	$	-		$	10,831

The accompanying notes are an integral part of the condensed consolidated financial statements.

6

ROGERS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 - Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.  In our opinion, the accompanying statements of financial position and related interim statements of comprehensive income (loss), statements of shareholders equity, and statements of cash flows include all normal recurring adjustments necessary for their fair presentation in accordance with U.S. generally accepted accounting principles.  All significant intercompany transactions have been eliminated.

For all periods and amounts presented, reclassifications have been made for discontinued operations. On December 31, 2011 the Thermal Management Solutions business, which had been a separate operating segment, was discontinued.  See Note 17-Discontinued Operations for further discussion.

Interim results are not necessarily indicative of results for a full year.  For further information regarding our accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in our Form 10-K for the fiscal year ended December 31, 2011.

Note 2 –Fair Value Measurements

The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

● Level 1 – Quoted prices in active markets for identical assets or liabilities.

● Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

● Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

From time to time we enter into various instruments that require fair value measurement, including foreign currency option contracts and copper derivative contracts.

(Dollars in thousands)	Carrying amount as of June 30, 2012			Level 1		Level 2			Level 3
Foreign currency option contracts	$	-		$	-	$	-		$	-
Copper derivative contracts		(82	)		-		(82	)		-

Auction Rate Securities

During the first quarter of 2012, we liquidated our auction rate security portfolio, receiving net proceeds of $25.4 million on a stated par value of $29.5 million.  As a result of this liquidation, we recognized a loss on the discount of the securities of $3.2 million (the remaining difference between the liquidation and par value of $0.9 million had previously been recognized as an impairment loss) in our condensed consolidated statements of comprehensive income (loss). Since the markets for these securities failed in the first quarter of 2008, we had redeemed $24.9 million of these securities, mostly at par prior to the liquidation in the first quarter of 2012.  Since par value redemptions had slowed in recent quarters with no clear path for full redemption over the next several years and the rate of return on these securities was very low, management determined that a discounted redemption in the first quarter of 2012 was in the best interests of the Company as the cash could be better utilized for other purposes going forward.

Prior to the first quarter of 2012, we had recognized an Other–than-temporary impairment (OTTI) on these securities. An OTTI is recognized in earnings for a security in an unrealized loss position when an entity either (a) has the intent to sell the security or (b) more likely than not will be required to sell the security before its anticipated recovery.  

7

When an OTTI of a security occurs, the amount of the OTTI recognized in earnings depends on whether the security holder intended to sell the security or it is more likely than not that the holder would be required to sell the security before recovery of its cost basis. If the holder does not intend to sell the security and it is not more likely than not that the holder would be required to sell the security before the recovery of its cost basis, the other-than-temporary loss would be separated into (i) the amount representing the credit loss and (ii) the amount related to all other factors.  The amount representing the credit loss would be recognized in earnings, and, the remaining amount would be recorded in other comprehensive income. This is the approach we used to recognize the OTTI taken prior to liquidation in the first quarter of 2012.  The amount representing the credit loss would have been recognized in earnings, and as long as the factors above were not met, the remaining amount would have been recorded in other comprehensive income.

8

Prior to the first quarter of 2008, our available-for-sale auction rate securities were recorded at fair value as determined in the active market at the time.  However, due to events in the credit markets, the auctions failed during the first quarter of 2008 for the auction rate securities that we held at the end of the first quarter of 2008, and all of our auction rate securities had been in a loss position since that time until we redeemed them in the first quarter of 2012. Given the lack of unobservable inputs in the auction markets since the first quarter of 2008, such securities were considered Level 3 securities.

Due to our belief that it would have taken more than twelve months for the auction rate securities market to recover, these securities were classified as long-term assets, except for those that were scheduled to be redeemed within a twelve month period, which were classified as short-term investments.

The reconciliation of our assets measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:

(Dollars in thousands)	Auction Rate Securities
Balance at December 31, 2011	$	25,960
Cash received for redemptions at par		-
Cash received for redemptions below par		(25,438	)
Reclassified from other comprehensive income		2,723
Reported in earnings		(3,245	)
Balance at June 30, 2012	$	-

There were no credit losses recognized for the six months ended June 30, 2012.  Below is a roll forward of credit losses recognized in earnings for the six months ended June 30, 2011.

(Dollars in thousands)
	Credit Losses
Balance at December 31, 2010	$	917
Credit losses recorded		39
Reduction in credit losses due to redemptions		(71	)
Balance at June 30, 2011	$	885

Derivatives Contracts

As of June 30, 2012, the carrying value of our derivative instruments was approximately $0.1 million.  As further explained below in Note 3, “Hedging Transactions and Derivative Financial Instruments”, we are exposed to certain risks relating to our ongoing business operations.  The primary risks being managed through the use of derivative instruments are foreign currency exchange rate risk and commodity pricing risk, particularly related to copper pricing.  The fair value of any foreign currency option derivatives is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics.  As of June 30, 2012, we did not have any outstanding foreign currency derivative contracts.

The fair value of the copper derivatives is computed using a combination of intrinsic and time value valuation models.  The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end.  The time value valuation model incorporates the constant changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative's strike price and the remaining time to the underlying copper derivative instrument's expiration date from the period end date.  Overall, fair value is a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate, and volatility.  We do not use derivative financial instruments for trading or speculation purposes.

9

Note 3 – Hedging Transactions and Derivative Financial Instruments

The guidance for the accounting and disclosure of derivatives and hedging transactions requires companies to recognize all of their derivative instruments as either assets or liabilities at fair value in the condensed consolidated statements of financial position.  The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies for special hedge accounting treatment as defined under the applicable accounting guidance.  For derivative instruments that are designated and qualify for hedge accounting treatment (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss).  This gain or loss is reclassified into earnings in the same line item of the condensed consolidated statements of comprehensive (loss) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings.  The remaining gain or loss on the derivative instrument in excess of the cumulative change in the present value of the future cash flows of the hedged item (i.e., the ineffective portion) if any, is recognized in the condensed consolidated statements of comprehensive income (loss) during the current period. 

As of the end of the second quarter of 2012, we have two contracts in place to hedge our exposure related to the purchase of copper at our German subsidiary, Curamik.  These contracts are held with financial institutions and minimize our risk associated with a potential rise in copper prices.  These two contracts cover our 2012 monthly copper exposure and qualify for hedge accounting treatment; therefore, any mark-to-market adjustments on these contracts are recorded in accumulated other comprehensive income (loss) in the equity section of our condensed consolidated statements of financial position. At June 30, 2012, the term loan debt represents $95.0 million of our outstanding facility.  The interest rate swap results in the variable portion of the interest rate for this portion of the debt being fixed at 0.075% for the period from July 2013 to June 2016. (At June 30, 2012, the rate charged on this debt is 0.25% on the variable portion of the rate plus a spread of 2.25%.)

In July 2012, we entered into an interest rate swap derivative instrument to hedge the variable portion of the interest rate on 65% of the term loan debt, effective July 2013. This transaction has been designated as a cash flow hedge.  

Notional Value of Copper Derivatives
Copper	70 metric tons per month

(Dollars in thousands)	The Effect of Current Derivative Instruments on the Financial Statements for the six-month period ended June 30, 2012				Fair Values of Derivative Instruments as of June 30, 2012
Foreign Exchange Option Contracts	Location of gain (loss)	Amount of gain (loss)			Other Assets (Liabilities)
Contracts not designated as hedging instruments	Other income, net	$	81		$	-
Copper Derivative Instruments
Contracts designated as hedging instruments	Other comprehensive income (loss)		(82	)		(82	)

Concentration of Credit Risk

By using derivative instruments, we are subject to credit and market risk.  If a counterparty fails to fulfill its performance obligations under a derivative contract, our credit risk will equal the fair value of the derivative instrument. Generally, when the fair value of a derivative contract is positive, the counterparty owes the Company, thus creating a receivable risk for the Company. We minimize counterparty credit (or repayment) risk by entering into derivative transactions with major financial institutions of investment grade credit rating.

10

Note 4 – Acquisition of Business

Curamik Electronics GmbH

On January 4, 2011, we acquired Curamik Electronics GmbH (Curamik), a manufacturer of power electronic substrate products headquartered in Eschenbach, Germany.  The aggregate purchase price was $151.1 million, which reflects post-closing adjustments.

Curamik, founded in 1983, is the worldwide leader for the development and production of direct bonded copper ceramic substrate products which are used primarily in the design of intelligent power management devices, such as IGBT (insulated gate bipolar transistor) modules, that enable a wide range of products, including high efficiency industrial motor drives, wind and solar energy converters and electrical systems in automobiles.  Most of Curamik’s products are manufactured using state of the art automated processes in its facility located in Eschenbach.

The acquisition has been accounted for in accordance with applicable purchase accounting guidance.  The following table represents the fair market value assigned to the acquired assets and liabilities in the transaction.

(Dollars in thousands)
Assets:
Cash	$	11,256
Accounts receivable		11,876
Other current assets		1,386
Inventory		12,259
Property, plant & equipment		32,312
Other non-current assets		2,276
Intangible assets		52,354
Goodwill		79,837
Total assets		203,556
Liabilities
Accounts payable		6,053
Other current liabilities		20,427
Deferred tax liability		9,329
Other long-term liabilities		16,666
Total liabilities		52,475
Fair value of net assets acquired	$	151,081

Total costs incurred related to the acquisition were approximately $3.4 million, of which $1.3 million were incurred in the first quarter of 2011 and $2.1 million in the fourth quarter of 2010.  They are included in “Selling and administrative expenses” on our condensed consolidated statements of comprehensive income (loss).

Note 5 - Inventories

Inventories were as follows:

	June 30,		December 31,
(Dollars in thousands)	2012		2011
Raw materials	$	30,517	$	30,655
Work-in-process		15,982		14,919
Finished goods		28,179		32,746
	$	74,678	$	78,320

11

Note 6 - Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Loss)

Comprehensive income (loss) for the periods ended June 30, 2012 and 2011 were as follows:

	Three Months Ended					Six Months Ended
(Dollars in thousands)	June 30,			June 30,		June 30,			June 30,
	2012			2011		2012			2011
Net income (loss)	$	6,455		$	12,128	$	4,646		$	21,563
Foreign currency translation adjustments		(10,857	)		6,298		(4,886	)		21,262
Unrealized gain (loss) on marketable securities, net of tax		-			420		1,168			501
Unrealized gain (loss) on derivative instruments, net of tax		(43	)		-		212			-
Comprehensive income (loss)	$	(4,445	)	$	18,846	$	1,140		$	43,326

The components of accumulated other comprehensive income (loss) at June 30, 2012 and December 31, 2011 were as follows:

	June 30,			December 31,
(Dollars in thousands)	2012			2011
Foreign currency translation adjustments	$	989		$	5,875
Funded status of pension plans and other postretirement benefits, net of tax		(67,239	)		(67,239	)
Unrealized gain (loss) on derivative instruments, net of tax		(58	)		(270	)
Unrealized gain (loss) on marketable securities, net of tax		-			(1,168	)
Accumulated other comprehensive income (loss)	$	(66,308	)	$	(62,802	)

Note 7- Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:

(In thousands, except per share amounts)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Numerator:
Income (loss)	$	6,455	$	13,432	$	4,754	$	24,497
Denominator:
Denominator for basic earnings per share -
Weighted-average shares		16,309		15,945		16,271		15,919
Effect of dilutive stock options		555		733		572		685
Denominator for diluted earnings per share - Adjusted
weighted-average shares and assumed conversions		16,864		16,678		16,843		16,604
Basic income (loss) per share:	$	0.40	$	0.84	$	0.29	$	1.54
Diluted income (loss) per share:		0.38		0.81		0.28		1.48

Certain potential ordinary shares were excluded from the calculation of diluted weighted-average shares outstanding because they would have an anti-dilutive effect on net income per share (see table below).

	Three Months Ended
	June 30, 2012		June 30, 2011
Anti-dilutive shares excluded		932,104		722,903

12

Note 8 – Stock-Based Compensation

Equity Compensation Awards

Stock Options

Stock options have been granted under various equity compensation plans.  While we may grant options to employees that become exercisable at different times or within different periods, we have generally granted options to employees that vest and become exercisable in one-third increments on the 2nd, 3rd and 4th anniversaries, of the grant dates.  The maximum contractual term for all options is normally ten years.

We use the Black-Scholes option-pricing model to calculate the grant-date fair value of an option.  The fair value of options granted during the three and six month periods ended June 30, 2012 and 2011 were calculated using the following weighted-average assumptions:

	Three Months Ended					Six Months Ended
	June 30, 2012		June 30, 2011			June 30, 2012			June 30, 2011
Options granted		-		58,550			46,950			58,550
Weighted average exercise price	$	-	$	47.89		$	41.27		$	47.89
Weighted-average grant date fair value		-		22.30			19.08			22.30
Assumptions:
Expected volatility		-		45.15	%		47.70	%		45.15	%
Expected term (in years)		-		6.0			5.9			6.0
Risk-free interest rate		-		2.64	%		1.43	%		2.64	%
Expected dividend yield		-		-			-			-

Expected volatility – In determining expected volatility, we have considered a number of factors, including historical volatility and implied volatility.

Expected term – We use historical employee exercise data to estimate the expected term assumption for the Black-Scholes valuation.

Risk-free interest rate – We use the yield on zero-coupon U.S. Treasury securities for a period commensurate with the expected term assumption as its risk-free interest rate.

Expected dividend yield – We do not currently pay dividends on our common stock; therefore, a dividend yield of 0% was used in the Black-Scholes model.

In most cases, we recognize expense using the straight-line attribution method for stock option grants.  The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest.  Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.  The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered option.  We currently expect, based on an analysis of our historical forfeitures, an annual forfeiture rate of approximately 3% and applied that rate to the grants issued.  This assumption will be reviewed periodically and the rate will be adjusted as necessary based on these reviews.  Ultimately, the actual expense recognized over the vesting period will only be for those options that vest.

During the three and six month periods ended June 30, 2012, we recognized approximately $0.6 million and $1.3 million of stock option compensation expense, respectively. During the three and six month periods ended June 30, 2011, we recognized approximately $0.8 million and $1.3 million of stock option compensation expense, respectively.

13

A summary of the activity under our stock option plans as of June 30, 2012 and changes during the three and six month periods then ended, is presented below:

	Options Outstanding			Weighted- Average  Exercise Price Per Share		Weighted-Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options outstanding at March 31, 2012		2,440,999		$	37.59		4.9	$	14,667,018
Options granted		-			-
Options exercised		(112,531	)		29.74
Options cancelled		(28,999	)		46.78
Options outstanding at June 30, 2012		2,299,469			38.07		4.8		14,513,131
Options exercisable at June 30, 2012		1,594,269			41.39		3.7		7,279,532
Options vested or expected to vest at June 30, 2012*		2,273,222			38.19		4.7		14,247,752

* In addition to the vested options, we expect a portion of the unvested options to vest at some point in the future.  Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options.

	Options Outstanding			Weighted- Average Exercise Price Per Share
Options outstanding at December 31, 2011		2,401,809		$	37.54
Options granted		46,950			41.27
Options exercised		(116,491	)		29.72
Options cancelled		(32,799	)		44.06
Options outstanding at June 30, 2012		2,299,469

During the six month period ended June 30, 2012, the total intrinsic value of options exercised (i.e., the difference between the market price at time of exercise and the price paid by the individual to exercise the options) was $1.1 million, and the total amount of cash received from the exercise of these options was $3.5 million.

Performance-Based Restricted Stock

In 2006, we began granting performance-based restricted stock grants to certain key executives.  These grants cliff vest at the end of the three-year measurement period, except for grants to those individuals who are retirement eligible during the grant period as such awards are subject to accelerated vesting as the grant is earned over the course of the vesting period (i.e. a pro-rata payout occurs based on the retirement date).  Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures. Compensation expense is recognized ratably over the vesting period, unless the employee has an accelerated vesting schedule.  Additionally, compensation expense is increased or decreased based on changes in the estimated pay out percentages each quarter. The 2009 grant, which vested as of December 31, 2011, met the performance criteria and was paid out at 97.4% of target.

	Performance Based Restricted Stock Awards
Non-vested awards outstanding at December 31, 2011		101,730
Awards granted		22,120
Stock issued		(43,750	)
Awards forfeited		(6,642	)
Non-vested awards outstanding at  June 30, 2012		73,458

During the three and six month periods ended June 30, 2012, due to reductions in the estimated payout percentages of outstanding grants, we recognized income for performance-based restricted stock awards of approximately $0.5 million and $0.4 million, respectively.  During the three and six month periods ended June 30, 2011, we recognized expense for performance-based restricted stock awards of approximately $0.9 million and $1.1 million, respectively.

14

Time-Based Restricted Stock

In 2011, we began granting time-based restricted stock awards to certain key executives and other key members of the Company’s management team.  Time-based restricted stock grants typically cliff vest at the end of the three-year vesting period, and we recognize compensation expense on these awards ratably over the vesting period.  The fair value of the award is determined based on the market value of the underlying stock price at the grant date.

	Time-Based Restricted Stock Awards
Non-vested awards outstanding at December 31, 2011		86,707
Awards granted		46,180
Stock issued		(980	)
Awards forfeited		(3,782	)
Non-vested awards outstanding at  June 30, 2012		128,125

During the three and six month periods ended June 30, 2012, we recognized compensation expense for time-based restricted stock awards of approximately $0.4 million and $0.9 million, respectively.  During the three and six month periods ended June 30, 2011, we recognized expense for time-based restricted stock awards of approximately $0.2 million of during each period.

Deferred Stock Units

We grant deferred stock units to non-management directors.  These awards are fully vested on the date of grant and the related shares are generally issued on the 13th month anniversary of the grant date unless the individual elects to defer the receipt of these shares.  Each deferred stock unit results in the issuance of one share of Rogers’ stock.  The grant of deferred stock units is typically done annually in the second quarter of each year.

	Deferred Stock Units
Non-vested awards outstanding at December 31, 2011		27,350
Awards granted		17,600
Stock issued		(14,800	)
Awards forfeited		-
Non-vested awards outstanding at  June 30, 2012		30,150

For each of the three and six month periods ended June 30, 2012 and 2011, we recognized compensation expense of $0.7 million related to deferred stock units.  There was no expense associated with these grants in the first quarter of either year.

Employee Stock Purchase Plan

We have an employee stock purchase plan (ESPP) that allows eligible employees to purchase, through payroll deductions, shares of our common stock at a discount to fair market value.  The ESPP has two six month offering periods each year, the first beginning in January and ending in June and the second beginning in July and ending in December.  The ESPP contains a look-back feature that allows the employee to acquire stock at a 15% discount from the underlying market price at the beginning or end of the applicable period, whichever is lower.  We recognize compensation expense on this plan ratably over the offering period based on the fair value of the anticipated number of shares that will be issued at the end of each offering period.  Compensation expense is adjusted at the end of each offering period for the actual number of shares issued.  Fair value is determined based on two factors: (i) the 15% discount amount on the underlying stock’s market value on the first day of the applicable offering period, and (ii) the fair value of the look-back feature determined by using the Black-Scholes model.  We recognized approximately $0.1 million of compensation expense associated with the plan for each of the three month periods ended June 30, 2012 and, 2011, and approximately $0.2 million of compensation expense associated with the six month periods ended June 30, 2012 and 2011.

15

Note 9 – Pension Benefit and Other Postretirement Benefit Plans

Components of Net Periodic Benefit Cost

The components of net periodic benefit cost for the periods indicated are:

(Dollars in thousands)

(Dollars in thousands)
	Pension Benefits												Retirement Health and Life Insurance Benefits
	Three Months Ended						Six Months Ended						Three Months Ended						Six Months Ended
Change in benefit obligation:	June 30,			June 30,			June 30,			June 30,			June 30,			June 30,			June 30,			June 30,
	2012			2011			2012			2011			2012			2011			2012			2011
Service cost	$	1,108		$	1,060		$	2,297		$	2,120		$	149		$	176		$	331		$	352
Interest cost		2,124			2,116			4,242			4,232			92			97			180			194
Expected return on plan assets		(2,495	)		(2,591	)		(4,903	)		(5,182	)		-			-			-			-
Amortization of prior service cost		116			150			232			300			(113	)		(157	)		(226	)		(314	)
Amortization of net loss		1,442			553			2,791			1,106			66			81			181			162
Special termination benefit		-			-			-			-			-			-			2,300			-
Adjustment to termination benefit		-			-			-			-			(707	)		-			(707	)		-
Net periodic benefit cost	$	2,295		$	1,288		$	4,659		$	2,576		$	(513	)	$	197		$	2,059		$	394

As a result of the early retirement program that we offered in the first quarter of 2012, we incurred $1.6 million in charges related to a special termination benefit associated with our retirement health and life insurance benefits program, as we extended eligibility in the benefits to certain individuals who participated in the early retirement program.

Early in the third quarter of 2012, we made a one-time cash payment to our former President and Chief Executive Officer of approximately $6.0 million in accordance with the provisions of his retirement contract as part of his Pension Restoration Plan.  We expect that this payment will result in a settlement charge of approximately $2.1 million, which will be recognized in the third quarter of 2012.

Employer Contributions

We made $6.0 million in voluntary contributions to our qualified defined benefit pension plans during the second quarter of 2012 and $10.0 million in the first quarter of 2012.  For the first six months of 2011, we did not make any voluntary contributions.

We made no payments under our non-qualified defined benefit pension plan in the first half of 2012 and only de minimis payments were made in the first half of 2011.

Note 10 – Segment Information

Our reporting structure is comprised of the following operating segments: High Performance Foams, Printed Circuit Materials, Curamik Electronics Solutions and Power Distribution Systems and the Other reportable segment.

Segment Structure
Core Strategic
	High Performance Foams
	Printed Circuit Materials
	Power Electronics Solutions
		Curamik Electronics Solutions
		Power Distribution Systems
Other

16

The “Power Electronics Solutions” core strategic category is comprised of  two operating segments – Curamik Electronics Solutions and Power Distribution Systems.

The following table sets forth the information about our reportable segments for the periods indicated:

(Dollars in thousands)	Three Months Ended						Six Months Ended
	June 30, 2012			June 30, 2011			June 30, 2012			June 30, 2011
Net sales
Core Strategic
High Performance Foams	$	43,329		$	44,021		$	83,763		$	83,156
Printed Circuit Materials		40,533			43,375			79,914			86,228
Power Electronics Solutions
Curamik Electronics Solutions		23,908			34,613			48,200			67,510
Power Distribution Systems		11,573			13,978			22,089			26,413
Other		7,328			7,514			14,078			16,122
Net sales		126,671			143,501			248,044			279,429
Operating income (loss)
Core Strategic
High Performance Foams		5,708			6,658			7,153			11,293
Printed Circuit Materials		3,123			4,405			2,777			9,234
Power Electronics Solutions
Curamik Electronics Solutions		(1,205	)		2,855			(2,978	)		3,157
Power Distribution Systems		135			1,644			(515	)		3,909
Other		1,315			945			1,953			2,146
Operating income (loss)		9,076			16,507			8,390			29,739
Equity income in unconsolidated joint ventures		1,305			1,323			1,962			2,751
Other income (expense), net		261			280			122			1,629
Net realized investment gain (loss)		-			29			(3,245	)		32
Interest income (expense), net		(1,072	)		(1,265	)		(2,262	)		(2,843	)
Income (loss) before income tax expense (benefit)	$	9,570		$	16,874		$	4,967		$	31,308

Inter-segment sales have been eliminated from the sales data in the preceding table.

Note 11 – Joint Ventures

As of June 30, 2012, we had two joint ventures, each 50% owned, which are accounted for under the equity method of accounting.

Joint Venture	Location	Reportable Segment	Fiscal Year-End
Rogers INOAC Corporation (RIC)	Japan	High Performance Foams	October 31
Rogers INOAC Suzhou Corporation (RIS)	China	High Performance Foams	December 31

Equity income of $1.3 million and $2.0 million for the three and six month periods ended June 30, 2012 and equity income of $1.3 million and $2.8 million for the three and six month periods ended June 30, 2011, respectively, is included in the condensed consolidated statements of comprehensive income (loss) related to the joint ventures.

17

The summarized financial information for the joint ventures for the periods indicated is as follows:

(Dollars in thousands)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net sales	$	15,880	$	16,783	$	28,685	$	34,863
Gross profit (loss)		2,608		3,211		4,433		7,535
Net income (loss)		2,610		2,646		3,924		5,502

The effect of transactions between us and our unconsolidated joint ventures was accounted for on a consolidated basis.  Receivables from and payables to joint ventures arise during the normal course of business from transactions between us and the joint ventures, typically from the joint venture purchasing raw materials from us to produce end products, which are sold to third parties, or from us purchasing finished goods from our joint ventures, which are then sold to third parties.

Note 12 - Debt

On July 13, 2011, we entered into an amended and restated $265 million secured five year credit agreement.  This credit agreement (“Amended Credit Agreement”) is with (i) JPMorgan Chase Bank, N.A., as administrative agent; (ii) HSBC Bank USA, National Association; (iii) RBS Citizens, National Association; (iv) Fifth Third Bank; and (v) Citibank, N.A.  JPMorgan Securities LLC and HSBC Bank USA, National Association acted as joint bookrunners and joint lead arrangers; HSBC Bank USA, National Association and RBS Citizens, National Association acted as co-syndication agents; and Fifth Third Bank and Citibank, N.A. acted as co-documentation agents.  The Amended Credit Agreement amends and restates the credit agreement signed between the Company and the same banks on November 23, 2010 and increased our borrowing capacity from $165.0 million under the original agreement to $265.0 million under the Amended Credit Agreement.

Key features of the Amended Credit Agreement, as compared to the November 23, 2010 credit agreement, include (1) an increase in credit from $165.0 million to $265.0 million with the addition of a $100.0 million term loan; (2) the extension of maturity from November 23, 2014 to July 13, 2016; (3) a 25 basis point reduction in  interest costs; (4) an increase in the size of permitted acquisitions from $25.0 million to $100.0 million; and (5) an increase in permitted additional indebtedness from $20.0 million to $120.0 million.

The Amended Credit Agreement provided for the extension of credit in the form of (1) a $100.0 million term loan (which refinances outstanding borrowings in the amount of $100.0 million from the existing revolving credit line), as further described below; and (2) up to $165.0 million of revolving loans, in multiple currencies, at any time and from time to time until the maturity of the Amended Credit Agreement, on July 13, 2016.  We may borrow, pre-pay and re-borrow amounts under the $165.0 million revolving portion of the Amended Credit Agreement; however, with respect to the $100.0 million term loan portion, any principal amounts re-paid may not be re-borrowed.  Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Amended Credit Agreement).  

Borrowings under the Amended Credit Agreement bear interest based on one of two options.  Alternate base rate loans bear interest that includes a base reference rate plus a spread of 75 - 150 basis points, depending on our leverage ratio.  The base reference rate is the greater of the (1) prime rate; (2) federal funds effective rate plus 50 basis points; and (3) adjusted 1-month London interbank offered (“LIBO”) rate plus 100 basis points.  Eurocurrency loans bear interest based on the adjusted LIBO rate plus a spread of 175 - 250 basis points, depending on our leverage ratio.

In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Amended Credit Agreement, the Company is required to pay a quarterly fee of 0.20% to 0.35% (based upon its leverage ratio) of the unused amount of the lenders’ commitments under the Amended Credit Agreement.  

In connection with the Amended Credit Agreement, we transferred borrowings in the amount of $100.0 million from the revolving credit line under the November 23, 2010 credit agreement to the term loan under the Amended Credit Agreement.  The Amended Credit Agreement requires the mandatory quarterly repayment of principal of amounts borrowed under such term loan.  Payments commenced on September 30, 2011, and are scheduled to be completed on June 30, 2016.  The aggregate payments due are as follows:

2011	$2.5 million
2012	$7.5 million
2013	$12.5 million
2014	$17.5 million
2015	$35.0 million
2016	$25.0 million

18

The Amended Credit Agreement is secured by many of the assets of Rogers and our World Properties, Inc, subsidiary, including but not limited to, receivables, equipment, intellectual property, inventory, stock in certain subsidiaries and real property.

As part of the Amended Credit Agreement, we are restricted in our ability to perform certain actions, including, but not limited to, our ability to pay dividends, incur additional debt, sell certain assets, and make capital expenditures, with certain exceptions.  Further, we are required to maintain certain financial covenant ratios, including a leverage ratio of no more than 3.0 to 1 and a minimum fixed charge coverage ratio (FCRR).  In the first quarter of 2012, through an amendment to the Amended Credit Agreement, the FCRR was modified from 2.5X to 1.25X of Adjusted EBITDA.  This ratio measures the Company’s ability to cover its fixed charge obligations.  The key components of fixed charges are capital expenditures, scheduled debt payments, capital lease payments, rent and interest expenses. Several factors contributed to the need for an amendment to this covenant.  The 2.5X ratio was based on a more robust set of financial projections, and these have moderated somewhat with the recent events in the marketplace and the overall global economy, particularly the situations in Europe and China.  Additionally, there were no mandatory term loan payments when the original ratio was determined. These would further stress the ratio.  Finally, an increase in planned capital investment added pressure to the ratio as well.

Relevant Fixed Charge metrics are detailed in the table below.

Periods	Q4 2011	Q1 2012	Q2 2012
Covenant Limit	2.5x	1.25x	1.25x
Actual FCCR	2.60	2.27	2.09

As of June 30, 2012, we were in compliance with all of our covenants, as we achieved actual ratios of approximately 1.6 on the leverage ratio and 2.09 on the fixed charge coverage ratio.

If an event of default occurs, the lenders may, among other things, terminate their commitments and declare all outstanding borrowings to be immediately due and payable together with accrued interest and fees.  We are in compliance with all financial and other covenants as of June 30, 2012.

In connection with the establishment of the initial credit in 2010, we capitalized approximately $2.3 million of debt issuance costs and, in connection to the Amended Credit Agreement, we capitalized an additional $0.1 million of debt issuance costs in 2012. These costs will be amortized over the life of the Amended Credit Agreement, as amended, which will terminate in June 2016.  We incurred amortization expense of $0.1 million in the second quarters of 2012 and 2011, respectively, and expenses of $0.2 million in the first six months of 2012 and 2011, respectively.  At June 30, 2012, we have approximately $2.0 million of credit facility costs remaining to be amortized.

In the first quarter of 2011, we made an initial draw on the line of credit of $145.0 million to fund the acquisition of Curamik.  During the first six months of 2012, we made principal payments of $2.5 million on the debt. We made $22.5 million of principal payments in fiscal 2011.  We are obligated to pay $10.0 million on this debt obligation within the next 12 months but anticipate paying down $27.5 million.  As of June 30, 2012, our outstanding debt related to the Amended Credit Agreement, as amended, consists of $95.0 million of term loan debt and $25.0 million on the revolving line of credit.  We have the option to pay part of or the entire amount at any time over the remaining life of the Amended Credit Agreement, as amended, with any balance due and payable at the agreement's expiration.

In addition, at June 30, 2012 we had the following standby letter of credit (LOC) and guarantee that were backed by the Amended Credit Agreement, as amended:

● $1.1 million letter of credit to guarantee Rogers workers compensation plan;

● $0.6 million letter guarantee to guarantee a payable obligation for a Chinese subsidiary (Rogers Suzhou).

No amounts were owed on the LOC or guarantee as of June 30, 2012 or December 31, 2011.

Capital Lease

During the first quarter of 2011, we recorded a capital lease obligation related to the acquisition of Curamik for its primary manufacturing facility in Eschenbach, Germany. We have an option to purchase the property in either 2013 or upon the expiration of the lease 2021 at a price which is the greater of (i) the then-current market value; and (ii) the fiscal residual book value of the land including the buildings and installations thereon. The total obligation recorded for the lease as of June 30, 2012 is $8.5 million.  Amortization expense related to the capital lease was $0.1 million in each of the three month periods ending June 30, 2012 and 2011, and $.2 million in each of the six month periods ending June, 30 2012 and 2011.  These expenses are included as depreciation expense in Cost of Sales on our condensed consolidated statements of other comprehensive income (loss).  Interest expense related to the debt recorded on the capital lease is included in interest expense on the condensed consolidated statements of other comprehensive income (loss).  (See “Interest” section below for further discussion.)

19

Interest

We incurred interest expense on our outstanding debt of $0.7 million and $1.5 million in the three and six month periods ended June 30, 2012, respectively, and $1.0 million and $2.1 million in the three and six months ended June 30, 2011, respectively.  We incurred an unused commitment fee of approximately $0.1 million and $0.2 million in the three and six month periods ended June 30, 2012, respectively, and of approximately $0.2 million and $0.4 million in the three and six month periods ended June 30, 2011.  In July 2012, we entered into an interest rate swap to hedge the variable interest rate on 65% of the term loan debt, effective July 2013.  At June 30, 2012, the term loan debt amounted to $95.0 million.  This interest rate swap results in the interest rate for this portion of the debt being set at 0.75% and is for the period from July 2013 to June 2016.

We also incurred interest expense on the capital lease of $0.4 million and $0.8 million in the three and six month periods ended June 30, 2012, respectively, and of $0.3 million and $0.7 million in the three and six month periods ended June 30, 2011, respectively.

Restriction on Payment of Dividends

Pursuant to the Amended Credit Agreement, as amended, we cannot make a cash dividend payment if a default or event of default has occurred and is continuing or shall result from the cash dividend payment.

Note 13 – Goodwill and Intangible Assets

Definite Lived Intangible Assets

(Dollars in thousands)	June 30, 2012						December 31, 2011
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trademarks and patents	$	1,006	$	177	$	829	$	879	$	140	$	739
Technology		35,095		6,335	$	28,760		35,769		4,655		31,114
Covenant-not-to-compete		968		235	$	733		956		135		821
Customer relationships		19,544		1,625	$	17,919		19,851		1,315		18,536
Total other intangible assets	$	56,613	$	8,372	$	48,241	$	57,455	$	6,245	$	51,210

Gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.

Amortization expense for the three and six month periods ended June 30, 2012 was approximately $1.0 million and $2.2 million, respectively. Amortization expense for the three and six month periods ending June 30, 2011 was approximately $1.4 million and $2.9 million, respectively. The estimated annual future amortization expense is $2.2 million, $5.7 million, $5.7 million, $5.5 million and $5.1 million for the remainder of 2012, 2013, 2014, 2015 and 2016, respectively.  These amounts could vary based on changes in foreign currency exchange rates.

The weighted average amortization period as of June 30, 2012, by intangible asset class, is presented in the table below:

Intangible Asset Class	Weighted Average Amortization Period
Trademarks and patents	9.1
Technology	6.1
Covenant not-to-compete	3.7
Customer relationships	9.3
Total other intangible assets	7.3

On January 4, 2011 we acquired Curamik, which contributed $52.4 million of intangible assets and $79.8 million of goodwill.  The intangible assets are comprised of trademarks, technology, and customer relationships and include $5.3 million of indefinite-lived intangible assets comprised of trademarks, which are assessed for impairment annually.  The definite-lived intangibles are amortized using a fair value methodology that is based on the projected economic use of the related underlying asset.

20

Goodwill

The changes in the carrying amount of goodwill for the period ending June 30, 2012, by reportable segment, are as follows:

(Dollars in thousands)	High Performance Foams		Printed Circuit Materials		Curamik Electronics Solutions			Power Distribution Systems		Other		Total
December 31, 2011	$	22,597	$	-	$	77,357		$	-	$	2,224	$	102,178
Foreign currency translation adjustment
		195		-		(1,779	)		-		-		(1,584	)
June 30, 2012	$	22,792	$	-	$	75,578		$	-	$	2,224	$	100,594

Note 14 – Commitments and Contingencies

We are currently engaged in the following environmental and legal proceedings:

Superfund Sites

We are currently involved as a potentially responsible party (PRP) in one active case involving a waste disposal site.

Chatham Superfund Site - Currently, this proceeding is at a stage where it is not possible to estimate the ultimate cost of remediation, or the timing and extent of remedial action that may be required by governmental authorities.  It is also not possible to estimate the amount of our liability, if any, alone or in relation to that of any other PRPs.  The costs incurred since inception for this claim have been immaterial and have been primarily covered by insurance policies, for both legal and remediation costs.  In this matter we have been assessed a cost sharing percentage of approximately 2% in relation to the range for estimated total cleanup costs of $17.0 million to $24.0 million.  We believe we have sufficient insurance coverage to fully cover this liability and have recorded a liability and related insurance receivable of approximately $0.3 million as of June 30, 2012, which approximates our share of the low end of the range.  We believe we are a de minimis participant and, as such, have been allocated an insignificant percentage of the total PRP cost sharing responsibility.  Based on facts presently known to us, we believe that the potential for the final results of this case having a material adverse effect on our results of operations, financial position or cash flows is remote.  This case has been ongoing for many years and we believe that it will continue on for the indefinite future.  No time frame for completion can be estimated at the present time.

Omega Chemical Superfund Site - In the fourth quarter of 2011, the United States Environmental Protection Agency (EPA) notified us that we were a PRP for the cleanup of the Omega Chemical Corporation Superfund Site in Los Angeles County, California.  In the first quarter of 2012, we were notified that we are no longer a PRP related to this superfund site.

PCB Contamination

We have been working with the Connecticut Department of Energy and Environmental Protection (CT DEEP) and the EPA, Region I, in connection with certain polychlorinated biphenyl (PCB) contamination in the soil beneath a section of cement flooring at our Woodstock, Connecticut facility.  In 2000, the majority of the clean-up efforts were completed, and a small amount of residual soil contamination remained.  In 2011, after several discussions and proposals with the CT DEEP, we agreed to install a pump and treat system to alleviate further contamination of the ground water.  Since inception, we have spent approximately $2.5 million in remediation and monitoring costs related to the PCB soil contamination at this site.  We anticipate future costs related to the ground water contamination issue to be de minimis and related to the continued use and maintenance of the pump and treat system now in place at the site.

In addition, during the first quarter of 2010, we discovered PCB contamination in the building at our Woodstock, Connecticut facility, due to it having contained the equipment that was the source of the original PCB soil contamination.  Remediation of the contamination within the facility is currently projected to cost between $1.0 million and $2.6 million; therefore, we recorded a liability of $1.0 million related to the building contamination, which represents the low end of the estimated range, as no other amount in the range was more probable at that time.  To date, we have incurred $0.3 million in remediation costs at the site and the reserve at June 30, 2012 is $0.7 million which we believe is adequate to cover the remaining remediation work.

We believe that these situations will continue for several more years and no time frame for completion can be estimated at the present time.

21

Asbestos Litigation

A significant number of asbestos-related product liability claims have been brought against numerous United States industrial companies where the third-party plaintiffs allege personal injury from exposure to asbestos-containing products. We have been named, along with hundreds of other companies, as a defendant in some of these claims. In virtually all of these claims filed against us, the plaintiffs are seeking unspecified damages, or, if an amount is specified, such amount merely represents a jurisdictional amount.  However, occasionally specific damages are alleged and in such situations, plaintiffs’ lawyers often sue dozens of defendants, frequently without factual basis or support.  As a result, even when a specific amount of damages is alleged, such action can be arbitrary, both as to the amount being sought and the defendant being charged with such damages.

We did not mine, mill, manufacture or market asbestos; rather we made a limited number of products which contained encapsulated asbestos.  Such products were provided to industrial users.  We stopped manufacturing these products in the late 1980s.

● Claims

We have been named in asbestos litigation primarily in Illinois, Pennsylvania and Mississippi.  As of June 30, 2012, there were 298 pending claims compared to 242 pending claims at December 31, 2011.  The number of open claims at a particular time can fluctuate significantly from period to period depending on how successful we have been in getting these cases dismissed or settled.  Some jurisdictions prohibit specifying alleged damages in personal injury tort cases such as these, other than a minimum jurisdictional amount which may be required for such reasons as allowing the case to be litigated in a jury trial (which the plaintiffs believe will be more favorable to them than if heard only before a judge) or allowing the case to be litigated in federal court.  This is in contrast to commercial litigation, in which specific alleged damage claims are often permitted.  The prohibition on specifying alleged damages sometimes applies not only to the suit when filed but also during the trial – in some jurisdictions the plaintiff is not actually permitted to specify to the jury during the course of the trial the amount of alleged damages the plaintiff is claiming.  Further, in those jurisdictions in which plaintiffs are permitted to claim specific alleged damages, many plaintiffs nonetheless still choose not to do so. In those cases in which plaintiffs are permitted to and choose to assert specific dollar amounts in their complaints, we believe the amounts claimed are typically not meaningful as an indicator of a company’s potential liability. This is because (1) the amounts claimed may bear no relation to the level of the plaintiff’s injury and are often used as part of the plaintiff’s litigation strategy, (2) the complaints typically assert claims against numerous defendants, and often the alleged damages are not allocated against specific defendants, but rather the broad claim is made against all of the defendants as a group, making it impossible for a particular defendant to quantify the alleged damages that are being specifically claimed against it and therefore its potential liability, and (3) many cases are brought on behalf of plaintiffs who have not suffered any medical injury, and ultimately are resolved without any payment or payment of a small fraction of the damages initially claimed.  Of the 298 claims pending as of  June 30, 2012,  71 claims do not specify the amount of damages sought,  224 claims cite jurisdictional amounts, and only three (3) claims (approximately 1.0% of the total pending claims) specify the amount of damages sought not based on jurisdictional requirements. Of these three (3) claims, one (1) claim alleges compensatory and punitive damages of $20 million each; one (1) claim alleges compensatory damages of $65 million and punitive damages of $60 million and one (1) claim alleges compensatory and punitive damages of $1 million each.  These three (3) claims name between ten (10) and 109 defendants.  However, for the reasons cited above, we do not believe that this data allows for an accurate assessment of the relation that the amount of alleged damages claimed might bear to the ultimate disposition of these cases.

We believe the rate at which plaintiffs filed asbestos-related suits against us increased in 2001, 2002, 2003 and 2004 because of increased activity on the part of plaintiffs to identify those companies that sold asbestos-containing products, but which did not directly mine, mill or market asbestos.  A significant increase in the volume of asbestos-related bodily injury cases arose in Mississippi in 2002.  This increase in the volume of claims in Mississippi was apparently due to the passage of tort reform legislation (applicable to asbestos-related injuries), which became effective on September 1, 2003 and which resulted in a higher than average number of claims being filed in Mississippi by plaintiffs seeking to ensure their claims would be governed by the law in effect prior to the passage of tort reform.  The number of asbestos related suits filed against us decreased slightly in 2005 and 2006, but increased slightly in 2007, declined in 2008 and increased again in 2009 and 2010.  The number of lawsuits filed against us in 2011 was significantly higher than in 2010.  However, it is still too early to be able to determine if this is a meaningful trend even though more such lawsuits were filed against us in the first two quarters of 2012 compared to the comparable period in 2011. Regardless, these new claims, and all previously filed claims, may take a significant period of time to resolve.

● Defenses

In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of exposure to our asbestos-containing products.  We continue to believe that a majority of the claimants in pending cases will not be able to demonstrate exposure or loss.  This belief is based in large part on two factors: the limited number of asbestos-related products manufactured and sold by us and the fact that the asbestos was encapsulated in such products.  In addition, even at sites where the presence of an alleged injured party can be verified during the same period those products were used, our liability cannot be presumed because even if an individual contracted an asbestos-related disease, not everyone who was employed at a site was exposed to the asbestos containing products that we manufactured.  Based on these and other factors, we have and will continue to vigorously defend ourselves in asbestos-related matters.

22

● Dismissals and Settlements

Cases involving us typically name 50-300 defendants, although some cases have had as few as one (1) and as many as 833 defendants.  We have obtained dismissals of many of these claims.  For the six months ended June 30, 2012, we were able to have 44 claims dismissed and settled nine (9) claims.  For the year ended December 31, 2011, 120 claims were dismissed and eight (8) were settled.  The majority of costs have been paid by our insurance carriers, including the costs associated with the small number of cases that have been settled.  Such settlements totaled approximately $3.1 million for the six months ended June 30, 2012, compared to $8.1 million for the year ended 2011.   Although these figures provide some insight into our experience with asbestos litigation, no guarantee can be made as to the dismissal and settlement rates that we will experience in the future.

Settlements are made without any admission of liability.  Settlement amounts may vary depending upon a number of factors, including the jurisdiction where the action was brought, the nature and extent of the disease alleged and the associated medical evidence, the age and occupation of the claimant, the existence or absence of other possible causes of the alleged illness of the alleged injured party and the availability of legal defenses, as well as whether the action is brought alone or as part of a group of claimants.  To date, we have been successful in obtaining dismissals for many of the claims and have settled only a limited number.  The majority of settled claims were settled for immaterial amounts, and the majority of such costs have been paid by our insurance carriers.  In addition, to date, we have not been required to pay any punitive damage awards.

● Potential Liability

National Economic Research Associates, Inc. (NERA), a consulting firm with expertise in the field of evaluating mass tort litigation asbestos bodily-injury claims, has historically been engaged to assist us in projecting our future asbestos-related liabilities and defense costs with regard to pending claims and future unasserted claims.  Projecting future asbestos costs is subject to numerous variables that are extremely difficult to predict, including the number of claims that might be received, the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, dismissal rates, costs of medical treatment, the financial resources of other companies that are co-defendants in claims, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case and the impact of potential changes in legislative or judicial standards, including potential tort reform.  Furthermore, any predictions with respect to these variables are subject to even greater uncertainty as the projection period lengthens.  In light of these inherent uncertainties, the  variability of our claims history and consultations with NERA, we currently believe that five years is the most reasonable period for recognizing a reserve for future costs, and that costs that might be incurred after that period are not reasonably estimable at this time.  As a result, we also believe that our ultimate asbestos-related contingent liability (i.e., our indemnity or other claim disposition costs plus related legal fees) cannot be estimated with certainty.

● Insurance Coverage

Our applicable insurance policies generally provide coverage for asbestos liability costs, including coverage for both resolution and defense costs.  Following the initiation of asbestos litigation, an effort was made to identify all of our primary and excess level insurance carriers that provided applicable coverage beginning in the 1950s through the mid-1980s.  Where appropriate, carriers were put on notice of the litigation.  Marsh USA, Inc., a consulting firm with expertise in the field of evaluating insurance coverage and the likelihood of recovery for asbestos-related claims, has historically been engaged to work with us to project our insurance coverage for asbestos-related claims. Marsh’s conclusions are based primarily on a review of our coverage history, application of reasonable assumptions on the allocation of coverage consistent with certain industry practices, an assessment of the creditworthiness of the insurance carriers, analysis of applicable deductibles, retentions and policy limits, the experience of NERA and a review of NERA’s reports.

● Cost Sharing Agreement

To date, our insurance carriers have paid for substantially all of the settlement and defense costs associated with our asbestos-related claims.  The current cost sharing agreement between us and such insurance carriers is primarily designed to facilitate the ongoing administration and payment of such claims by the carriers until the applicable insurance coverage is exhausted.  This four year agreement expires on January 25, 2015 and replaced an older agreement that had expired.

● Impact on Financial Statements

Given the inherent uncertainty in making future projections, we have had the projections of current and future asbestos claims periodically re-examined, and we will have them further updated if needed based on our experience, changes in the underlying assumptions that formed the basis for NERA’s and Marsh’s models, and other relevant factors, such as changes in the tort system and our success in resolving claims. As of December 31, 2011, the estimated liability and estimated insurance recovery, for the five-year period through 2016, was $28.8 million and $28.4 million respectively.  During the first quarter of 2012, NERA and Marsh provided revised projections for the asbestos liability and related insurance receivable, which resulted in revised projections for the five-year period through 2016 of $27.9 million and $27.7 million for the estimated liability and insurance receivable, respectively.

23

The amounts recorded for the asbestos-related liability and the related insurance receivables described above were based on facts known at the time and a number of assumptions.  However, projecting future events, such as the number of new claims to be filed each year, the average cost of disposing of such claims, the length of time it takes to dispose of such claims, coverage issues among insurers and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States could cause the actual liability and insurance recoveries for us to be higher or lower than those projected or recorded.

There can be no assurance that our accrued asbestos liabilities will approximate our actual asbestos-related settlement and defense costs, or that our accrued insurance recoveries will be realized.  We believe that it is reasonably possible that we will incur additional charges for our asbestos liabilities and defense costs in the future, which could exceed existing reserves, but such excess amount cannot be reasonably estimated at this time.  We will continue to vigorously defend ourselves and believe we have substantial unutilized insurance coverage to mitigate future costs related to this matter.

Other Environmental and General Litigation

● In the second quarter of 2010, the CT DEEP contacted us to discuss a disposal site in Killingly, Connecticut.  We are currently in the very early stages of evaluating this matter and have initiated internal due diligence work related to the site to better understand the issue and our alleged involvement.  Currently, we do not know the nature and extent of any alleged contamination at the site, how many parties could be potentially involved in any remediation, if necessary, or the extent to which we could be deemed a potentially responsible party.  CT DEEP has not made any assessment of the nature of any potential remediation work that may be done, nor have they made any indication of any potential costs associated with such remediation.  Therefore, based on the facts and circumstances known to us at the present time, we are not able to estimate the probability of incurring a contingent liability related to this site, nor or we able to reasonably estimate any potential range of exposure at this time.  As such, no reserve has been established for this matter at this time. We continually monitor this situation and are in correspondence with the CT DEEP as appropriate.  When and if facts and circumstances related to this mater change, we will review our position and our ability to estimate the probability of any potential loss contingencies, as well as the range of any such potential exposure.

● The Rogers Corporate Headquarters located in Rogers, Connecticut is part of the Connecticut Voluntary Corrective Action Program (VCAP).  As part of this program, we have recently started conversations with the CT DEEP to begin to determine if any corrective actions need to be taken at the site related to any potential contamination issues. We are currently in the very early stages of this evaluating this matter and have initiated internal due diligence work related to the site to better understand any potential issues. However, at this time, it is currently unknown what the nature and extent of any potential contamination is at the site, nor what any potential remediation or associated costs would be if any such issues were found.  Therefore, based on the facts and circumstances known to us at the present time, we are unable to estimate the probability of incurring a contingent liability related to this site, nor or we able to reasonably estimate any potential range of exposure at this time.  As such, no reserve has been established for this matter at this time.

In addition to the above issues, the nature and scope of our business brings us in regular contact with the general public and a variety of businesses and government agencies.  Such activities inherently subject us to the possibility of litigation, including environmental and product liability matters that are defended and handled in the ordinary course of business.  We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation, after taking into account insurance coverage and the aforementioned accruals, will have a material adverse impact on our results of operations, financial position, or cash flows.

Note 15 – Income Taxes

Our effective tax rate was 32.5% in the second quarter of 2012 as compared to 20.4% in the second quarter of 2011. On a year to date basis, the effective tax rate was 4.3% in the first six months of 2012 as compared to 21.8% in the first half of 2011. In the second quarter of 2012, our tax rate was higher than in the second quarter of 2011 due primarily to a shift of income generated in those periods to higher taxing jurisdictions in the second quarter of 2012. In the first half of 2012, our tax rate benefited from certain discrete items, including a $1.5M benefit related to the reversal of the valuation allowance related to the sale of the auction rate securities portfolio, as compared to the first half of 2011 which drove the lower effective tax rate in the first half of 2012 as compared to the first half of 2011. In both the first half of 2012 and 2011, our tax rate benefited from favorable tax rates on certain foreign business activity as compared to our statutory rate of 35%. We project the effective tax rate will be 26% for the balance of 2012, with some quarter to quarter volatility.

In 2009, we established a valuation allowance against substantially all of our U.S. deferred tax asset based upon the consideration of all available evidence, both positive and negative, using a “more likely than not” standard.  A valuation allowance for deferred tax assets is recorded to the extent we cannot determine if it is more likely than not that we will ultimately realize our deferred tax assets. In determining the need for a valuation allowance, we assess the available positive and negative evidence as well as consider available tax planning strategies. As of June 30, 2012, we have concluded, based on this standard, that a valuation allowance is still appropriate against a significant portion of our U.S. deferred tax assets.

24

We may in appropriate circumstances undertake tax planning strategies that provide a basis for the realization of a portion of our U.S. deferred tax assets.  Such a strategy to utilize these assets would be based primarily upon our ability to make a tax election to capitalize certain expenses that will result in generating taxable income and utilizing our foreign tax credits before they expire.  We would undertake such a strategy to realize such tax benefits prior to expiration only if we determined it was reasonable, prudent, and feasible. Accordingly, because we believe it is reasonably likely this strategy will be available, along with other positive evidence, we recognized our foreign tax credit and deferred tax assets at June 30, 2012 and June 30, 2011, respectively.

The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and the deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the entity’s financial statements.  We are subject to income taxes in the United States and in numerous foreign jurisdictions.  No provision is made for U.S. income taxes on the undistributed earnings of substantially all of our wholly-owned foreign subsidiaries because such earnings are indefinitely reinvested in those companies. If circumstances change and it becomes apparent that some or all of the undistributed earnings of our wholly-owned foreign subsidiaries will not be indefinitely reinvested, a provision for the tax consequences, if any, will be recorded in the period in which the circumstances change.

Our accounting policy is to account for interest expense and penalties related to uncertain tax positions as income tax expense.  As of June 30, 2012, we have approximately $1.8 million of accrued interest related to uncertain tax positions included in the $18.6 million of unrecognized tax benefits, $11.3 million of which, if recognized, would impact the effective tax rate.

We are subject to numerous tax filings including U.S. Federal, various state and certain foreign jurisdictions.  Currently, the following tax years remain open to the possibility of audit, by jurisdiction - U.S. Federal: 2008 – 2011; various states: 2007 – 2011; and foreign: 2007 – 2011.

Note 16 – Restructuring/ Impairment Charges

In the first half of 2012, we began several initiatives to streamline our organization and rationalize our cost structure in order to better position the Company for profitable growth in the future.  The goal of these initiatives is to become a more streamlined organization both from an organizational and cost perspective, with efficient manufacturing capabilities that is focused on meeting our customer’s needs.

First Quarter 2012:

In the first quarter of 2012, weannounced several initiatives as part of the streamlining plan. These initiatives included the following:

● Implementing an early retirement program for certain eligible employees;

● Realigning our organizational structure by consolidating a number of senior executive positions, reorganizing certain business functions and redeploying resources across the Company;

● Exiting the Thermal Management Solutions business (previously announced in the fourth quarter of 2011);

● Initiating a plan to shut down the Power Distribution Systems startup operation in North America, which is anticipated to be completed in the third quarter of 2012; and

● Liquidating our remaining auction rate securities.

Second Quarter 2012:

In the second quarter of 2012, we announced several additional streamlining actions as follows:

● We announced the shutdown of the High Performance Foams manufacturing facility in Bremen, Germany, which is scheduled to be completed by the end of 2012.  The manufacture of certain silicone foam materials produced in the Bremen facility will be consolidated into our existing facility in Carol Stream, Illinois.  The expenses and charges related to the termination of the operations at the Bremen facility are estimated to be approximately $3.1 million and are comprised primarily of (i) $0.9 million for the early termination of the lease on the building; (ii) $0.8 million for severance charges for employees in Bremen; (iii) $1.1 million  impairment of certain assets; and (iv) $0.3 million of costs to remove and transport certain equipment to Carol Stream and prepare the building for return to the landlord.  We recognized approximately $1.5 million of these charges in the second quarter of 2012, and expect to recognize the remaining charges in the second half of 2012.

● We made the decision to cease production of our non-woven composite materials products in an effort to redeploy resources to focus on our Core Strategic segments.  Sales of these products have been steadily declining for several years and totaled approximately $1.4 million in the second quarter of 2012 and $4.8 million in fiscal 2011.  The shutdown of production is expected to occur by the end of 2012 and is not expected to have a material impact on our overall operations.  No material charges are expected from this initiative.

25

The following table summarizes the restructuring and impairment charges related to these activities recorded in our operating results in the second quarter and first six months of 2012.

(Dollars in thousands)
	Three Months Ended			Six Months Ended
Cost of Sales	June 30, 2012			June 30, 2012
High Performance Foams
Accelerated depreciation expense related to Bremen shut-down	$	585		$	585
Inventory impairment related to Bremen shut-down		191		$	191
Power Distribution Systems
Accelerated depreciation expense related to U.S. shut-down		360			360
Total charges for cost of sales	$	1,136		$	1,136
Restructuring and Impairment
High Performance Foams
Fixed asset impairment for Bisco and Poron asset disposal	$	-		$	79
Severance and related costs (1)		670		$	3,088
Power Distribution Systems
Impairment of investment related receivable		264			264
Severance and related costs (1)		(13	)		477
Printed Circuit Materials
Severance and related costs (1)		(276	)	$	3,046
Curamik Electronics Solutions
Severance and related costs (1)		213			957
Other
Severance and related costs (1)		(28	)		303
Total charges for restructuring and impairment	$	830		$	8,214

(1) For the three and six month periods ended June 30, 2012, this line item includes an estimated change of 2.3 million recorded in the first quarter of 2012, offest by a favorable adjustment of $0.7 million recorded in the second quarter of 2012. Total net charge of $1.6 million, for the first six months of 2012, was related to the early retirement program implemented in the first quarter of 2012.

A summary of the activity in the severance accrual as of June 30, 2012 and changes during the three month period then ended is as follows:

(Dollars in thousands)
	June 30, 2012
Balance at March 31, 2012	$	4,545
Provisions		1,273
Payments		(1,911	)
Balance at June 30, 2012	$	3,907

Note 17 – Discontinued Operations

In the fourth quarter of 2011, we made the strategic decision to end the operations of our TMS operating segment.  We had invested in its operations for the last few years, but had difficulty gaining traction in the market and working through issues in the manufacturing process.  Therefore, we determined that we would not achieve future success in this operation and chose to shut down operations rather than invest further. For the six month period ended June 30, 2012, operating losses of $0.1 million, net of tax, were reflected as discontinued operations in the accompanying condensed consolidated statements of comprehensive income (loss). There was no activity for this segment in the second quarter of 2012. For the three and six month periods ended June 30, 2011, operating losses of $1.3 million and $2.9 million, net of tax, respectively, were reflected as discontinued operations in the accompanying condensed consolidated statements of comprehensive income (loss). Net sales associated with the discontinued operations were $0.1 million for the six months ended June 30, 2012 and for the three and six month periods ended June 30, 2011.  There was no sales activity for the second quarter of 2012.

Note 18 – Subsequent Events

On July 17, 2012, we committed to a plan to move Curamik’s final inspection operations of our indirect wholly owned subsidiary Curamik Electronics GmbH (“Curamik”) from Curamik’s manufacturing site in Eschenbach, Germany to Hungary.  The move is expected to enable more cost effective performance of the inspecting operations, which is an important part of Curamik’s manufacturing process for direct bonded copper ceramic substrates.  We expect the move to be substantially complete by the end of 2012 or early in 2013 and related expenses and charges will be incurred over that time period.  These expenses and charges, which cannot be reasonably estimated at this time, will include, without limitation, the following major components: (i) costs associated with the separation from employment of employees at the Eschenbach facility; and; (ii) costs to start up the new facility in Hungary.  

26

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

As used herein, the “Company”, “Rogers”, “we”, “us”, “our” and similar terms include Rogers Corporation and its subsidiaries, unless the context indicates otherwise.

Forward Looking Statements

This information should be read in conjunction with the unaudited financial statements and related notes included in Item 1 of this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Form 10-K for the year-ended December 31, 2011.

Certain statements in this Quarterly Report on Form 10-Q may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Such forward-looking statements are based on management’s expectations, estimates, projections and assumptions.  Words such as “expects,” “anticipates,” “intends,” “believes,” “estimates,” “should,” “target,” “may,” “project,” “guidance,” and variations of such words and similar expressions are intended to identify such forward-looking statements.  Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results or performance to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing business, economic, and political conditions both in the United States and in foreign countries, particularly in light of the sovereign debt crisis being experienced globally; increasing competition; any difficulties in integrating acquired businesses into our operations and the possibility that anticipated benefits of acquisitions may not materialize as expected; delays or problems in completing planned operational enhancements to various facilities; our achieving less than anticipated benefits and/or incurring greater than anticipated costs relating to streamlining initiatives or that such initiatives may be delayed or not fully implemented due to operational, legal or other challenges; changes in product mix; the development and marketing of new products and manufacturing processes and the inherent risks associated with such efforts and the ability to identify and enter new markets; the outcome of current and future litigation; our ability to retain key personnel; our ability to adequately protect our proprietary rights; the possibility that we may be required to recognize impairment charges against goodwill and non-amortizable assets in the future; increases in our employee benefit costs could reduce our profitability; the accuracy of our analysis of our potential asbestos-related exposure and insurance coverage; the fact that our stock price has historically been volatile and may not be indicative of future prices; changes in the availability and cost and quality of raw materials; changes in environmental regulation, which could increase expenses and affect operating results; our ability to accurately predict reserve levels; our ability to service our debt; certain covenants in our debt documents could adversely restrict our financial and operating flexibility; fluctuations in foreign currency exchange rates; and changes in tax rates and exposure which may increase our tax liabilities.  Such factors also apply to our joint ventures.  We make no commitment to update any forward-looking statement or to disclose any facts, events, or circumstances after the date hereof that may affect the accuracy of any forward-looking statements, unless required by law. Additional information about certain factors that could cause actual results to differ from such forward-looking statements include, but are not limited to, those items described in our filings with the Securities and Exchange Commission, including Item 1A, Risk Factors, to the Company’s Form 10-K for the year-ended December 31, 2011 and previously filed Form 10-Q's.

Company Background and Strategy

We are a global enterprise that provides our customers with innovative solutions and industry leading products in a variety of markets, including portable communications, communications infrastructure, consumer electronics, mass transit, automotive, defense and clean technology.  We generate revenues and cash flows through the development, manufacture, and distribution of specialty material-based products that are sold to multiple customers, primarily original equipment manufacturers (OEMs) and contract manufacturers that, in turn, produce component products that are sold to end-customers for use in various applications.  As such, our business is highly dependent, although indirectly, on market demand for these end-user products.  Our ability to forecast future sales growth is largely dependent on management’s ability to anticipate changing market conditions and how our customers will react to these changing conditions.  It is also highly limited due to the short lead times demanded by our customers and the dynamics of serving as a relatively small supplier in the overall supply chain for these end-user products.  In addition, our sales represent a number of different products across a wide range of price points and distribution channels that do not always allow for meaningful quantitative analyses of changes in demand or price per unit with respect to the effect on sales and earnings.

Strategically, our current focus is on three mega trends that we believe will fuel the future growth of our Company – continued growth of the internet, expansion of mass transit, and further investment in clean technology.  These trends and their related markets all require materials that perform to the highest standards, which has been a key strength of our products over the years.  We are also focused on growing our business both organically and through strategic acquisitions or technology investments that will add to or expand our product portfolio, as well as strengthen our presence in existing markets or expand into new markets.  We will continue to focus on business opportunities and invest in expansion around the globe.  Our vision is to be the leading innovative, growth oriented, and high technology materials solutions provider for our selective markets.  To achieve this vision, we must have an organization that can cost effectively develop, produce and market products and services that provide clear advantages for our customers and markets.

27

2012 Second Quarter Executive Summary

In the second quarter of 2012, we achieved quarterly sales of $126.7 million, an 11.7% decrease from the second quarter of 2011 sales of $143.5 million.  Net income, from continuing operations, declined by 51.9% from $13.4 million in the second quarter of 2011 to $6.5 million in the second quarter of 2012.  Net income from continuing operations, included approximately $1.4 million of net one-time charges related to stream-lining initiatives, including the shutdown of the High Performance Foams manufacturing facility in Bremen, Germany, all of which are further described in the following commentary. Overall, our High Performance Foams operating segment is performing well as sales volumes remained relatively consistent quarter over quarter and improved by 7.2% on a sequential basis from the first quarter of 2012.  Our Printed Circuit Materials operating sales volumes are down by 6.6% quarter over quarter, but up by 2.9% from the first quarter of 2012, and we believe that future prospects remain strong in this segment, particularly as spending in wireless infrastructure is projected to increase in the future.  Our Curamik Electronics Solutions and Power Distribution Systems operating segments have both struggled in 2012 as their primary target markets of transportation infrastructure and wind and solar power have experienced significant declines in spending in Europe and China, as the economic situation in both regions has resulted in the government scaling back on many spending initiatives.  Sales for Curamik Electronic Solutions are down by 30.9% quarter over quarter, but down by only 1.6% as compared to the first quarter of 2012, while Power Distributions Systems sales are down by 17.2% quarter over quarter, but increased by 10.0% as compared to the first quarter of 2012.  We anticipate that many of the infrastructure spending projects in Europe and China will return in the future, although the timing of such projects remains unclear and we believe that the wind and solar markets will continue to struggle for the foreseeable future.

During the first half of 2012, our management team, under the guidance of our new President and Chief Executive Officer, Bruce D. Hoechner, started to implement several measures to streamline our organization and rationalize our cost structure in order to better position the Company for profitable growth in the future.  The goal of these initiatives is to become a more streamlined organization, both from an organizational and cost perspective that is focused on customer needs, with efficient manufacturing capabilities.

Specifically, in the first quarter of 2012, we took the following actions:  (i)  implemented an early retirement program for certain eligible employees; (ii)  realigned our organizational structure by consolidating a number of senior executive positions, reorganizing certain business functions and redeploying resources across the Company; (iii) exited the Thermal Management Systems business (previously announced in the fourth quarter of 2011); (iv) initiated a plan to shut down the Power Distribution Systems start-up operation in North America, which should be completed in the third quarter of 2012; and (v) liquidated our remaining auction rate securities.

Further, in the second quarter of 2012, we announced the shutdown of the High Performance Foams manufacturing facility in Bremen, Germany, which is scheduled to be completed by the end of 2012.  Certain manufacturing capability at this location will be relocated to our Carol Stream, Illinois, facility, while other unprofitable product lines will be shut down.  We expect to incur approximately $3.1 million of charges as a result of this initiative and recognized approximately $1.5 million in the second quarter of 2012.  We also decided to shut down the operations of our  non-woven composite materials product lines at our facility in Rogers, Connecticut.  These product lines have gradually declined for many years and we anticipate that the shutdown of these lines will be completed by the end of 2012.  No material charges will result from this initiative.

Overall, as a result of these streamlining and rationalization initiatives, we incurred approximately $12.7 million of net pre-tax one-time charges in the first half of 2012 ($7.5 million after tax), with approximately $2.1 million recognized in the second quarter of 2012 ($1.4 million net of tax) and $10.6 million in the first quarter of 2012 ($6.1 million net of tax).  We anticipate these actions will result in annualized cost savings of approximately $13.0 million by the fourth quarter of 2012.

We will continue to pursue other initiatives aimed at further streamlining our business and reducing our overall cost structure, enabling us to continue to profitably grow the Company.  Early in the third quarter of 2012, we announced a plan to relocate the final inspection operations of our Curamik Electronics Solutions’ operating segment from our facility in Eschenbach, Germany to Hungary. The move is expected to enable more cost effective performance of the inspecting operations. We expect the move to be substantially complete by the end of 2012 or early in 2013 and related expenses and charges will be incurred over that time period, including charges related to a reduction in force at the German facility, as well as startup costs for the new facility in Hungary, but we are not able to reasonably estimate those charges at this time.

While we will always look for ways to improve and streamline our Company, we expect these announced initiatives to extend over the remainder of 2012 and into 2013 and that these actions will, ultimately, position the Company to achieve its strategic vision, while increasing value to our shareholders.

28

Results of Operations

The following table sets forth, for the periods indicated, selected operations data expressed as a percentage of net sales.

	Three Months Ended						Six Months Ended
	June 30, 2012			June 30, 2011			June 30, 2012			June 30, 2011
Net sales		100.0	%		100.0	%		100.0	%		100.0	%
Gross margin		29.1	%		33.8	%		29.6	%		32.6	%
Selling and administrative expenses		17.7	%		18.4	%		18.9	%		18.1	%
Research and development expenses		3.6	%		3.9	%		4.0	%		3.9	%
Restructuring and impairment charges		0.7	%		0.0	%		3.3	%		0.0	%
Operating income (loss)		7.2	%		11.5	%		3.4	%		10.6	%
Equity income in unconsolidated joint ventures		1.0	%		0.9	%		0.8	%		1.0	%
Other income (loss), net		0.2	%		0.2	%		0.0	%		0.6	%
Net realized gains (losses)		0.0	%		0.0	%		(1.3	%)		0.0	%
Interest income (expense), net		(0.8	%)		(0.9	%)		(0.9	%)		(1.0	%)
Income (loss) before income taxes		7.6	%		11.8	%		2.0	%		11.2	%
Income tax expense (benefit)		2.5	%		2.4	%		0.1	%		2.4	%
Income (loss) from continuing operations		5.1	%		9.4	%		1.9	%		8.8	%

Net Sales

Net sales in the second quarter of 2012 were $126.7 million as compared to $143.5 million in the second quarter of 2011, a decrease of 11.7%.  On a year to date basis, sales in the first half of 2012 were $248.0 million, a decline of 11.2% from $279.4 million in the first half of 2011.  The decline in sales on both a quarterly and year to date comparison basis is primarily attributable to volume decreases in three of our Core Strategic operating segments, Curamik Electronic Solutions, Printed Circuit Materials, and Power Distribution Systems, while sales in the High Performance Foams operating segment were relatively flat year over year for both periods.  Overall, our sales were negatively impacted by weakness in certain core markets, including wireless infrastructure, mass transit, and wind and solar markets, driven by the economic situations in Europe and China. Also impacting sales levels were negative effects from foreign currency exchange rates, as the depreciation of the Euro against the U.S. dollar drove a 2.5% or $3.6 million decrease in net sales during the second quarter of 2012 and a 1.7% or $4.6 million decrease on a year to date basis.  See “Segment Sales and Operations” below for further discussion on segment performance.

Gross Margin

Gross margin as a percentage of sales decreased from 33.8% in the second quarter of 2011 to 29.1% in the second quarter of 2012. Margins also decreased from 32.6% in the first half of 2011 to 29.6% in the first half of 2012. Second quarter and first half of 2012 results included approximately $1.1 million of one-time charges related to the shutdown of Power Distribution Systems operations in Arizona and High Performance Foams operations in Bremen, Germany. These charges were accelerated depreciation as the useful lives of certain equipment used in the manufacturing process were shortened.  These charges negatively impacted second quarter 2012 results by approximately 90 basis points and first half 2012 results by approximately 40 basis points.  The first half of 2011 results included approximately $1.8 million of one-time non-cash costs incurred in the first quarter of 2011 related to the write up of Curamik inventory to fair value as required under purchase accounting, negatively impacting margins by approximately 130 basis points.  The decline in volumes during the second quarter and first half of 2012, as compared to the comparable prior year periods, negatively impacted margin by approximately 200 basis points in each period, respectively.  Inventory fluctuations also negatively impacted margins during the second quarter and the first half of 2012 as inventory levels declined by approximately 8.2% and 4.7%, respectively, during those periods, which negatively impacted margins by approximately 100 basis points in the second quarter of 2012 and approximately 30 basis points in the first half of 2012.  These declines were the result of the Company managing inventory closely to better align inventory levels with the lower sales volumes experienced during the second quarter and first half of 2012 as compared to the comparable prior year periods.  Conversely, in the second quarter and first half of 2011, inventory levels increased by approximately 10.3% and 19.5%, respectively, which favorably impacted margins by approximately 100 basis points in both the second quarter and first half of 2011.  These increases are attributable to the ramp up in sales volumes experienced during the first half of 2011, as well as the startup of production in our Printed Circuit Materials manufacturing operation in Suzhou, China.  We expect that margins will gradually improve as the impacts of our streamlining initiatives are realized, as well as if and when sales volumes improve.

29

Selling and Administrative Expenses

Selling and administrative expenses declined 15.0% from $26.4 million in the second quarter of 2011 to $22.5 million in the second quarter of 2012.  As a percentage of sales, selling and administrative expenses declined from 18.4% in the second quarter of 2011 to 17.7% in the second quarter of 2012.  The $3.9 million quarterly decline in expenses was primarily driven by a reduction of $3.3 million in incentive and equity compensation costs due to the performance of the business in 2012 as compared to 2011.  This decline was partially offset by a $1.0 million increase in costs related to the defined benefit pension and retiree medical plans in the second quarter of 2012 as compared to the second quarter of 2011, due to unfavorable changes to market assumptions that drive the pension calculations for accounting purposes. The remaining decrease in selling and administrative costs for the quarter can be primarily attributable to the streamlining and cost reduction efforts that were initiated in the first quarter of 2012.

On a year to date basis, selling and administrative expenses declined 7.1% from $50.5 million in the first half of 2011 to $46.9 million in the first half of 2012.  As a percentage of sales, selling and administrative expenses increased slightly from 18.1% in the first half of 2011 to 18.9% in the first half of 2012.  The $3.6 million decline in expenses was primarily driven by a reduction of $4.2 million in incentive and equity compensation costs due to the performance of the business in 2012 as compared to 2011.  This decline was partially offset by a $3.1 million increase in costs related to the defined benefit pension and retiree medical plans in the first half of 2012 as compared to the first half of 2011, due to unfavorable changes to market assumptions that drive the pension calculations for accounting purposes. The remaining decrease in selling and administrative costs for the quarter can be primarily attributable to the streamlining and cost reduction efforts that were initiated in the first half of 2012.

Research and Development Expenses

Research and development (R&D) expense declined by 19.6% from $5.6 million in the second quarter of 2011 to $4.5 million in the second quarter of 2012.  Year to date, R&D expense declined by 9.3% from $10.8 million in the first half of 2011 to $9.8 million in the first half of 2012.  As a percentage of sales, research and development expenses were relatively consistent both on a quarterly and year to date basis.  In the second quarter of 2012, R&D expenses as a percentage of sales were 3.6% as compared to 3.9% in the second quarter of 2011 and, on a year to date basis, 4.0% in 2012 as compared to 3.9% in 2011.  The overall decline in spending on both a quarterly and year to date basis can be primarily attributable to our overall streamlining initiatives and intent to invest a certain percentage of our sales back into R&D activities.  Going forward, in the near term, we believe that our R&D spending as a percentage of sales will continue to remain consistent with levels incurred in the most recent quarters and average in the 3%-5% range.

Equity Income/Loss in Unconsolidated Joint Ventures

Equity income in unconsolidated joint ventures was $1.3 million in both the second quarters of 2012 and 2011.  In the first half of 2012, equity income in unconsolidated joint ventures was $2.0 million as compared to $2.8 million in the first half of 2011.  While the quarter over quarter results are consistent, the overall year to date decline in operating results at the joint ventures is due primarily to the softening in certain domestic and export markets in Japan, particularly in LCD televisions, domestic mobile phones and general industrial applications.

Other Income/Expense, Net

In the second quarter of 2012 and 2011, other income/expense, net was income of approximately $0.3 million in both periods.  On a year to date basis, other income/expense, net was income of $0.1 million in the first half of 2012 as compared to income of $1.6 million in the first half of 2011. The results for the first half of 2011 included a one-time gain on the sale of a building in China of approximately $1.9 million.  The remaining change is primarily due to the impact of unfavorable exchange rate fluctuations that resulted in expense of $0.3 million in the first half of 2012 as compared to expense of $0.6 million in the first half of 2011.

Realized Investment Gain (Loss), Net

Realized investment gain (loss), net was de minimis in the second quarter in both 2012 and 2011, as well as in the first half of 2011, while we recognized a loss of $3.2 million in the first half of 2012.  The loss was due to the liquidation of our auction rate securities portfolio in the first quarter of 2012, which resulted in the Company receiving net cash proceeds of approximately $25.4 million during such period.

Interest Income/Expense, Net

Interest expense, net, decreased from $1.3 million of expense in the second quarter of 2011 to $1.1 million of expense in the second quarter of 2012, and from expense of $2.8 million for the first half of 2011 to expense of $2.3 million in the first half of 2012.  These decreases can be attributable to lower interest expense on our debt facility, as we have paid down the principal from $145.0 million at the beginning of 2011 to approximately $120.0 million at June 30, 2012.

30

Income Taxes

Our effective tax rate was 32.5% in the second quarter of 2012 as compared to 20.4% in the second quarter of 2011.  On a year to date basis, the effective tax rate was 4.3% in the first six months of 2012 as compared to 21.8% in the first half of 2011.  In the second quarter of 2012, our tax rate was higher than in the second quarter of 2011 due primarily to a shift of income generated in those periods to higher taxing jurisdictions in the second quarter of 2012.  In the first half of 2012, our tax rate benefited from certain discrete items, including a $1.5M benefit related to the reversal of the valuation allowance related to the sale of the auction rate securities portfolio, as compared to the first half of 2011 which drove the lower effective tax rate in the first half of 2012 as compared to the first half of 2011.  In both the first half of 2012 and 2011, our tax rate benefited from favorable tax rates on certain foreign business activity as compared to our statutory rate of 35%.  We project the effective tax rate will be 26% for the balance of 2012, with some quarter to quarter volatility.

In 2009, we established a valuation allowance against substantially all of our U.S. deferred tax asset based upon the consideration of all available evidence, both positive and negative, using a “more likely than not” standard.  A valuation allowance for deferred tax assets is recorded to the extent we cannot determine that the ultimate realization of our deferred tax assets is more likely than not. In determining the need for a valuation allowance, we assess the available positive and negative evidence as well as consider available tax planning strategies. As of June 30, 2012, we have concluded, based on this standard, that a valuation allowance is still appropriate against a significant portion of our U.S. deferred tax assets.

We may in appropriate circumstances undertake tax planning strategies that provide a basis for the realization of a portion of our U.S. deferred tax assets.  Such a strategy to utilize these assets would be based primarily upon our ability to make a tax election to capitalize certain expenses that will result in generating taxable income and utilizing our foreign tax credits before they expire.  We would undertake such a strategy to realize such tax benefits prior to expiration only if we determined it was reasonable, prudent, and feasible. Accordingly, because we believe it is reasonably likely this strategy will be available, along with other positive evidence, we recognized our deferred tax assets related to certain foreign tax credits at June 30, 2012, and June 30, 2011, respectively.

Segment Sales and Operations

Core Strategic

High Performance Foams

(Dollars in millions)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net sales	$	43.3	$	44.0	$	83.8	$	83.2
Operating income (loss)		5.7		6.7		7.2		11.3

Our High Performance Foams operating segment is comprised of our polyurethane and silicone foam products, which are sold into a wide variety of markets for various applications, such as portable communications, consumer electronics, and mass transit markets for gaskets, sealing, and cushioning applications.

We announced the shutdown of the High Performance Foams manufacturing facility in Bremen, Germany, which is scheduled to be completed by the end of 2012.  The manufacture of certain silicone foam materials produced in the Bremen facility will be consolidated into our existing facility in Carol Stream, Illinois.  The expenses and charges related to the termination of the operations at the Bremen facility are estimated to be approximately $3.1 million and are comprised primarily of (i) the early termination of the lease on the building; (ii) severance charges for employees in Bremen; (iii) impairment of certain assets; and (iv) costs to remove and transport certain equipment to Carol Stream and prepare the building for return to the landlord. We recognized approximately $1.5 million of these charges in the second quarter of 2012, and expect to recognize the remaining charges in the second half of 2012.

Q2 2012 versus Q2 2011:

Net sales in this segment declined by 1.6% from $44.0 million in the second quarter of 2011 to $43.3 million in the second quarter of 2012. The slight decline in sales volumes was due primarily to an 11.7% decline in sales into general industrial applications.  These declines were partially offset by continued strong demand in tablet computers, which increased 3.8% quarter over quarter and for PORON® XRD® extreme impact protection materials for protective cases for smart phones and tablets, as well as sports impact apparel which incrementally increased by $1.3 million during the quarter.

Operating results declined by 14.9% from operating income of $6.7 million in the second quarter of 2011 to operating income of $5.7 million in the second quarter of 2012.  Second quarter 2012 results included approximately $1.5 million of one-time charges primarily related to the shutdown of the silicone foams manufacturing facility in Bremen, Germany.  Excluding these charges, operating results for High Performance Foams improved by approximately 7.5% quarter over quarter due to lower costs as a result of the streamlining initiatives which created better operating leverage on similar sales levels, partially offset by approximately $1.0 million of additional costs incurred related to the startup of the PORON® XRD® product line.

31

YTD 2012 versus YTD 2011:

On a year to date basis, net sales increased by 0.7% to $83.8 million in the first half of 2012 from $83.2 million in the first half of 2011.  Sales were driven by the continued strong demand in large touch-screen portable electronic devices, which increased by 23.6% year over year, as well as incremental sales of the segment’s newest product introduction, PORON®XRD® extreme impact materials, which added $2.1 million in sales in 2012.  These increases were partially offset by declines of sales into the wind and solar markets, which were down by 45.4%.

Operating income declined by 36.3% from $11.3 million in the first half of 2011 to $7.2 million in the first half of 2012.  2012 year to date results included approximately $3.9 million of one-time charges comprised primarily of approximately $2.3 million of net severance related charges as a result of our streamlining initiatives, as well as approximately $1.5 million of one-time charges related primarily to the shutdown of the segments silicone foams manufacturing facility in Bremen, Germany.  Excluding these charges, operating results were down slightly year over year as the change in sales mix described above negatively impacted results by approximately $1.0 million and the startup of the PORON® XRD® product line added approximately $1.6 million in additional costs.  These declines were partially offset by lower operating costs resulting from the streamlining initiatives, which created better leverage on similar sales volumes.

Printed Circuit Materials

(Dollars in millions)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net sales	$	40.5	$	43.4	$	79.9	$	86.2
Operating income (loss)		3.1		4.4		2.8		9.2

Our Printed Circuit Materials operating segment is comprised of our high frequency circuit material products used for making circuitry that receive, process and transmit high frequency communications signals, primarily in wireless communications systems applications.

Q2 2012 versus Q2 2011:

Net sales in this segment declined by 6.7% from $43.4 million in the second quarter of 2011 to $40.5 million in the second quarter of 2012. The decline was due primarily to weaker global demand from many OEM’s in the wireless infrastructure market, as deployments of base-stations were softer in the second quarter of 2012 as compared to the second quarter of 2011, partially offset by increased demand in fourth generation wireless (4G) antennae applications in Korea and Japan, which resulted in a net 6.1% quarter over quarter decline in sales into this market.   Sales into high reliability applications declined by approximately 16.4% as customers continued to bring inventories into alignment with market demand.  These declines were partially offset by an over 50% increase in sales into the automotive market for radar safety and base station antenna applications, where the segment continues to get design wins with our new laminate products.

Operating results declined by 29.5% from operating income of $4.4 million in the second quarter of 2011 to operating income of $3.1 million in the second quarter of 2012.  2012 results included approximately $0.8 million of one-time benefits related primarily to an insurance reimbursement of a previously settled product liability claim of $0.5 million.  This decline in results can be primarily attributable to the decline in volumes ($1.5 million).  Also negatively impacting the quarter over quarter comparisons were inventory fluctuations, as net inventory decreased by 10.2% in the second quarter of 2012 and increased by 13.1% in the second quarter of 2011, which negatively impacted quarter over quarter comparisons by approximately $1.6 million.  These declines were partially offset by favorable product mix and lower spending as a result of our streamlining initiatives.

YTD 2012 versus YTD 2011:

On a year to date basis, net sales declined by 7.3% from $86.2 million in the first half of 2011 to $79.9 million in the first half of 2012.  The decline was due primarily to weaker sales into the wireless infrastructure market in the first half of 2012 as compared to the first half of 2011, which contributed to a 2.4% volume decline into this market.  Sales into high reliability applications also declined by 17.2% on a year to date basis, as customers continued to closely manage their inventories.  These declines were partially offset by a 38.2% increase in sales into the automotive market for radar safety sensor applications, as our new laminate products continue to gain traction in the market.

32

Operating results declined from operating income of $9.2 million in the first half of 2011 to operating income of $2.8 million in the first half of 2012.  2012 results included approximately $2.5 million of net one-time charges comprised primarily of $3.0 million in net severance related charges as part of our overall streamlining initiatives, partially offset by the one-time benefit of $0.8 million related to an insurance reimbursement of a previously settled product liability claim.  This decline in results can be primarily attributable to the decline in volume of $3.3 million.  Also negatively impacting the year to date comparisons were inventory fluctuations, as net inventory decreased by 10.2% in the first half of 2012 and increased by 13.1% in the first half of 2011, which negatively impacted quarter over quarter comparisons by approximately $1.6 million.  These declines were partially offset by favorable product mix and lower spending as a result of our streamlining initiatives.

Power Electronic Solutions

● Curamik Electronics Solutions

(Dollars in millions)	Three Months Ended					Six Months Ended
	June 30, 2012			June 30, 2011		June 30, 2012			June 30, 2011
Net sales	$	23.9		$	34.6	$	48.2		$	67.5
Operating income (loss)		(1.2	)		2.9		(3.0	)		3.2

 Our Curamik Electronic Solutions operating segment is comprised of our power electronic substrate products, which are used primarily in the design of intelligent power management devices, such as IGBT (insulated gate bipolar transistor) modules that enable a wide range of products including highly efficient industrial motor drives, wind and solar energy converters and electrical systems in automobiles. We acquired the business on January 4, 2011.

As Curamik Electronics Solutions works through the current downturn, the segment continues to look for ways to improve its cost structure and better serve its customers.  Early in the third quarter of 2012, we announced a plan to relocate the final inspection operations of our Curamik Electronics Solutions’ operating segment from our facility in Eschenbach, Germany to Hungary. The move is expected to enable more cost effective performance of the inspecting operations. We expect the move to be substantially complete by the end of 2012 or early in 2013 and related expenses and charges will be incurred over that time period, including charges related to a reduction in force at the German facility, as well as startup costs for the new facility in Hungary, but we are not able to reasonably estimate those charges at this time.

Q2 2012 versus Q2 2011:

Net sales in this segment were $23.9 million in the second quarter of 2012, a 30.9% decline from $34.6 million in the second quarter of 2011.  This decline was due primarily to the continued lower demand in wind energy and industrial motor drive applications, which declined 62% and 30%, respectively, in the second quarter of 2012 as compared to the second quarter of 2011 as well as further inventory corrections in the supply chain.  Also contributing to the decline in net sales is the impact of foreign currency exchange rates, which contributed approximately $2.4 million to the overall sales decline as the USD appreciated against the Euro by approximately 10.4% quarter over quarter.  Curamik Electronics Solutions transacted approximately 83% of its second quarter 2012 sales in Euro as compared to 78% in the second quarter of 2011.  We believe that some of this downturn in demand is temporary and the long term outlook for energy efficient motor drives remains strong; however, the outlook for the wind energy market continues to be weak for the foreseeable future as the markets are highly dependent upon government programs, which are being impacted by the economic conditions in Europe and China.  Contrary to these trends, the demand for Curamik Electronic Solutions’ direct bonded copper materials in x-by-wire technology for the automotive industry remained consistent quarter over quarter.  This technology replaces traditional mechanical systems with electrical systems in automobiles to help improve overall performance and fuel efficiency.

Operating results for the quarter declined from an operating income of $2.9 million in the second quarter of 2011 to an operating loss of $1.2 million in the second quarter of 2012.  Second quarter 2012 results included approximately $0.8 million of one-time costs associated primarily with $0.2 million in severance charges and $0.6 million to the write off of an uncollectible receivable.  The decline in results can be directly attributable to the decline in volumes and the associated contribution loss on those sales.  Going forward, we expect continued pressure in this segment due to existing market conditions and increasing competition, particularly in Asia.

YTD 2012 versus YTD 2011:

On a year to date basis, net sales declined by 28.6% from $67.5 million in the first half of 2011 to $48.2 million in the first half of 2012.  This decline was due primarily to the continued lower demand in wind energy and industrial motor drive applications, which declined 61% and 25%, respectively, in the first half of 2012 as compared to the first half of 2011 as well as further inventory corrections in the supply chain.  Also contributing to the decline in sales is the impact of foreign currency exchange rates, which contributed approximately $2.8 million to the overall sales decline as the USD appreciated against the Euro by approximately 6.4% on a year to date basis.  The segment transacted approximately 82% of its first half 2012 sales in Euro as compared to 77% in the first half of 2011. We believe that some of this downturn in demand is temporary and the long term outlook for energy efficient motor drives remains strong; however, the outlook for the wind energy market continues to be weak for the foreseeable future, as the markets are highly dependent upon government programs, which are being impacted by the economic conditions in Europe and China. These declines were partially offset by increasing demand for Curamik Electronics Solutions’ direct bonded copper materials in x-by-wire technology for the automotive industry, which increased 4% period over period.  This technology replaces traditional mechanical systems with electrical systems in automobiles to help improve overall performance and fuel efficiency.

33

Operating results declined from operating income of $3.2 million in the first half of 2011 to an operating loss of $3.0 million in the first half of 2012.  First half 2012 results included approximately $1.5 million of one-time cost consisting of $1.0 million of net severance charges and $0.6 million to the write off of an uncollectible receivable.  This decline in results can be directly attributable to the decline in volumes and the associated contribution loss on those sales.  We are also facing increased competition, particularly in Asia, which we believe has and will continue to pressure our average selling price.

● Power Distribution Systems

(Dollars in millions)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012			June 30, 2011
Net sales	$	11.6	$	14.0	$	22.1		$	26.4
Operating income (loss)		0.1		1.6		(0.5	)		3.9

Our Power Distribution Systems operating segment is comprised of our busbar products, which are used primarily in power distribution systems products in mass transit and clean technology applications.

Q2 2012 versus Q2 2011:

Net sales in this segment declined by 17.1% from $14.0 million in the second quarter of 2011 to $11.6 million in the second quarter of 2012. The decline was due primarily to weaker demand for its products in the second quarter of 2012 due to the significant slowdown in spending on infrastructure projects in mass transit, particularly in Europe and China, as sales declined by 27.5% into these regions.    Also, overall sales into renewable energy declined by 52.3% as the wind and solar energy markets continue to lag.  These declines were partially offset by strong sales into the mass transit and transportation markets in the U.S., which increased by 125.1% during the quarter as a result of increased demand for locomotives and mining vehicles.

Operating results declined from operating income of $1.6 million in the second quarter of 2011 to operating income of $0.1 million in the second quarter of 2012.  Second quarter 2012 results include approximately $0.6 million of one-time charges related primarily to the shutdown of operations of the Power Distribution Systems manufacturing capability in North America.  This decline in results can be primarily attributable to the contribution related to the decline in sales volumes described above, partially offset by lower spending as a result of our streamlining initiatives.

YTD 2012 versus YTD 2011:

On a year to date basis, net sales declined by 16.4% from $26.4 million in the first half of 2011 to $22.1 million in the first half of 2012.  The decline was due primarily to weaker demand for its products in the second quarter of 2012 due to the significant slowdown in spending on infrastructure projects in mass transit, particularly in Europe and China, as sales declined by 32.5% into these regions.    Also, overall sales into renewable energy declined by 27.5% as the wind and solar energy markets continue to lag.  These declines were partially offset by strong sales into the mass transit and transportation markets in the U.S., which increased by 325.6% during the quarter as a result of increased demand for freight trains and mining vehicles.

Operating results declined from operating income of $3.9 million in the first half of 2011 to an operating loss of $0.5 million in the first half of 2012.  First half 2012 results include approximately $1.1 million of one-time charges related primarily to the shutdown of operations of the Power Distribution Systems manufacturing capability in North America and other severance charges.  This decline in results can be primarily attributable to the contribution related to the decline in sales volumes described above, partially offset by lower spending as a result of our streamlining initiatives.

Other

(Dollars in millions)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net sales	$	7.3	$	7.5	$	14.1	$	16.1
Operating income (loss)		1.3		0.9		2.0		2.2

34

Our Other reportable segment consists of our elastomer rollers, floats, and non-woven composite materials products, as well as our inverters distribution business.

We made the decision to cease production of our non-woven composite materials products in an effort to redeploy resources to focus on our Core Strategic segments.  Sales of these products have been steadily declining for several years and totaled approximately $1.4 million in the second quarter of 2012 and $4.8 million in fiscal 2011.  The shutdown of production is expected to occur by the end of 2012 and is not expected to have a material impact on our overall operations.  No material charges are expected from this initiative.

Q2 2012 versus Q2 2011:

Net sales declined slightly from $7.5 million in the second quarter of 2011 to $7.3 million in the second quarter of 2012.  The decline in sales is primarily due to a 45.6% decline in sales of inverter products from our legacy Durel business; which was partially offset by a 7.5% increase in sales of elastomer component products.

Operating income improved from $0.9 million in the second quarter of 2011 to $1.3 million in the second quarter of 2012 due primarily to the increase in sales volumes of elastomer components, which contributed to a 49.2% improvement in profits.  This increase was partially offset by a 55.0% decrease in operating income related to inverter products as a result of the lower sales volumes.

YTD 2012 versus YTD 2011:

Net sales declined 12.4% from $16.1 million in the first half of 2011 to $14.1 million in the first half of 2012.  The decline in sales is primarily due to a 62.7% decline in sales of inverter products from our legacy Durel business; which was partially offset by a 5.4% increase in sales of elastomer component products.

Operating profit declined from $2.2 million in the first half of 2011 to $2.0 million in the first half of 2012 due primarily to a 55.6% decrease in operating profit related to inverter products as a result of the lower sales volumes. This decrease was partially offset by the increase in sales volumes of elastomer components, which contributed to a 51.8% improvement in profits.

Liquidity, Capital Resources and Financial Position

We believe that our ability to generate cash from operations to reinvest in our business is one of our fundamental strengths. While the U.S. financial markets have grown more stable since the global recession of 2008, significant volatility still remains in the global markets particularly in Europe, and credit markets in general have diminished liquidity and capital availability globally.  We believe that our existing sources of liquidity and future cash flows that are expected to be generated from our operations, together with our available credit facilities, will be sufficient to fund our operations, capital expenditures, research and development efforts, and debt service commitments, as well as our other operating and investing needs, for at least the next twelve months.  We continue to have access to the remaining portion of the line of credit available under the Amended Credit Agreement should any issue or strategic opportunities impact the business.  We continually review and evaluate the adequacy of our cash flows, borrowing facilities and banking relationships to ensure that we have the appropriate access to cash to fund both our near-term operating needs and our long-term strategic initiatives.

(Dollars in thousands)	June 30, 2012		December 31, 2011
Key Balance Sheet Accounts:
Cash and cash equivalents	$	95,786	$	79,728
Accounts receivable		81,767		77,682
Inventory		74,678		78,320
Outstanding borrowing on credit facilities (short term and long term)		120,000		122,500
	Six Months Ended
	June 30, 2012		June 30, 2011
Key Cash Flow Measures:
Cash provided by (used in) operating activities of continuing operations	$	4,301	$	(3,381	)
Cash provided by (used in) investing activities of continuing operations		13,550		(137,931	)
Cash provided by (used in) financing activities of continuing operations		277		133,408

At the end of the second quarter of 2012, cash and cash equivalents were $95.8 million as compared to $79.7 million at the end of 2011, an increase of $16.1 million, or approximately 20.2%.  This increase was due primarily to the liquidation of the auction rate securities portfolio, resulting in net proceeds of $25.4 million, $3.5 million received for stock option exercises and $1.4 million received for the sale of our facility in Richmond, Virginia, partially offset by $16.0 million in contributions to our defined benefit pension plan and the payout of $6.6 million of annual incentive compensation awards.

35

The following table illustrates the location of our cash and cash equivalents by our three major geographic areas as of the periods indicated:

(Dollars in thousands)
	June 30,		December 31,
	2012		2011
U.S.	$	24,168	$	20,027
Europe		35,404		35,259
Asia		36,214		24,442
Total cash and cash equivalents	$	95,786	$	79,728

Cash held in certain foreign locations could be subject to additional taxes if we repatriated such amounts back to the U.S. from foreign countries that have a lower tax rate than in the U.S.  Our current policy is that such earnings and cash will be permanently reinvested in those foreign locations.

Significant changes in our balance sheet accounts from December 31, 2011 to June 30, 2012 are as follows:

o Accounts receivable increased $4.1 million, or 5.3%, from $77.7 million at December 31, 2011 to $81.8 million at June 30, 2012. Due primarily to increased sales volume at June 30, 2012 versus December 31, 2011. The Days Sales Outstanding has remained relatively consistent period to period.

o Inventories decreased $3.5 million, or 4.4%, from $78.3 million at December 31, 2011 to $74.9 million at June 30, 2012. This decrease is primarily attributable to our focus on working capital management and lowering inventory levels to better match current demand.

o Long-term marketable securities declined by $25.9 million from December 31, 2011 due to the liquidation of our auction rate securities portfolio. As of June 30, 2012, we do not have any long-term marketable securities on our balance sheet.

o Accrued employee benefits and compensation increased by $3.3 million, or 10.8%, from $30.1 million at December 31, 2011 to $33.4 million at June 30, 2012. This increase was due to the accrual of the first six (months of the 2012 portion of our pension and postretirement benefit costs of $5.1 million, as well as a curtailment charge related to the acceleration of $1.6 million of costs associated with postretirement benefit obligations as a result of the early retirement program that occurred in the first quarter of 2012. Also contributing to this increase is the $4.0 million severance accrual related to the restructuring program put in place in the first quarter of 2012. These increases to the accrual were offset by the payout of the 2012 annual incentive compensation plan of $6.6 million.

o Current portion of long term debt increased $20.0 million from December 31, 2011 to June 30, 2012, to $27.5 million. This increase is due to management anticipating additional voluntary principal payments, in our debt facility, over the next twelve months.

o Pension liability declined by 23.2% from $68.9 million at December 31, 2011 to $52.9 million at June 30, 2012 due to $16.0 million in contributions made to the defined benefit pension plan during the first half of 2012.

o Other accrued liabilities declined by 32.5% from $15.4 million at December 31, 2011 to $10.4 million at June 30, 2012 due to a $3.1 million payment of the deferred purchase price on the acquisition of SK Utis Co., Ltd, which was consummated in the first quarter of 2009.

Credit Facilities

On July 13, 2011, we entered into an amended and restated $265 million secured five year credit agreement.  This credit agreement (“Amended Credit Agreement”) is with (i) JPMorgan Chase Bank, N.A., as administrative agent; (ii) HSBC Bank USA, National Association; (iii) RBS Citizens, National Association; (iv) Fifth Third Bank; and (v) Citibank, N.A.  JPMorgan Securities LLC and HSBC Bank USA, National Association acted as joint bookrunners and joint lead arrangers; HSBC Bank USA, National Association and RBS Citizens, National Association acted as co-syndication agents; and Fifth Third Bank and Citibank, N.A. acted as co-documentation agents.  The Amended Credit Agreement amends and restates the credit agreement signed between the Company and the same banks on November 23, 2010 and increased our borrowing capacity from $165.0 million under the original agreement to $265.0 million under the Amended Credit Agreement.

Key features of the Amended Credit Agreement, as compared to the November 23, 2010 credit agreement, include (1) an increase in credit from $165.0 million to $265.0 million with the addition of a $100.0 million term loan; (2) the extension of maturity from November 23, 2014 to July 13, 2016; (3) a 25 basis point reduction in  interest costs; (4) an increase in the size of permitted acquisitions from $25.0 million to $100.0 million; and (5) an increase in permitted additional indebtedness from $20.0 million to $120.0 million.

36

The Amended Credit Agreement provides for the extension of credit in the form of (1) a $100.0 million term loan (which refinances outstanding borrowings in the amount of $100.0 million from the existing revolving credit line), as further described below; and (2) up to $165.0 million of revolving loans, in multiple currencies, at any time and from time to time until the maturity of the Amended Credit Agreement, on July 13, 2016.  We may borrow, pre-pay and re-borrow amounts under the $165.0 million revolving portion of the Amended Credit Agreement; however, with respect to the $100.0 million term loan portion, any principal amounts re-paid may not be re-borrowed.  Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Amended Credit Agreement).  

Borrowings under the Amended Credit Agreement will bear interest based on one of two options.  Alternate base rate loans will bear interest that includes a base reference rate plus a spread of 75 - 150 basis points, depending on our leverage ratio.  The base reference rate will be the greater of the (1) prime rate; (2) federal funds effective rate plus 50 basis points; and (3) adjusted 1-month London interbank offered (“LIBO”) rate plus 100 basis points.  Eurocurrency loans will bear interest based on the adjusted LIBO rate plus a spread of 175 - 250 basis points, depending on our leverage ratio.

In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Amended Credit Agreement, the Company is required to pay a quarterly fee of 0.20% to 0.35% (based upon its leverage ratio) of the unused amount of the lenders’ commitments under the Amended Credit Agreement.  

In connection with the Amended Credit Agreement, we transferred borrowings in the amount of $100.0 million from the revolving credit line under the November 23, 2010 credit agreement to the term loan under the Amended Credit Agreement.  The Amended Credit Agreement requires the mandatory quarterly repayment of principal of amounts borrowed under such term loan.  Payments commenced on September 30, 2011, and are scheduled to be completed on June 30, 2016.  The aggregate payments due are as follows:

2011	$2.5 million
2012	$7.5 million
2013	$12.5 million
2014	$17.5 million
2015	$35.0 million
2016	$25.0 million

The Amended Credit Agreement is secured by many of the assets of Rogers and our World Properties, Inc, subsidiary, including but not limited to, receivables, equipment, intellectual property, inventory, stock in certain subsidiaries and real property.

As part of the Amended Credit Agreement, we are restricted in our ability to perform certain actions, including, but not limited to, our ability to pay dividends, incur additional debt, sell certain assets, and make capital expenditures, with certain exceptions.  Further, we are required to maintain certain financial covenant ratios, including a leverage ratio of no more than 3.0 to 1 and a fixed charge coverage ratio (FCRR).  In the first quarter of 2012, the FCRR was modified from 2.5X to 1.25X of Adjusted EBITDA.  This ratio measures Roger’s ability to cover its fixed charge obligations.  The key components of Fixed Charges are capital expenditures, scheduled debt payments, capital lease payments, rent and interest expenses. Several factors contributed to the need for an amendment to this covenant.  The 2.5X ratio was based on a more robust set of financial projections, and these have moderated somewhat with the recent events in the marketplace and the overall global economy, particularly the situations in Europe and China.  Additionally, the original ratio did not anticipate the inclusion of mandatory term loan payments that would further stress the ratio.  Finally, an increase in planned capital investment added pressure to the ratio as well.

Relevant Fixed Charge metrics are detailed in the table below.

Periods	Q4 2011	Q1 2012	Q2 2012
Covenant Limit	2.5x	1.25x	1.25x
Actual FCCR	2.60	2.27	2.09

As of June 30, 2012, we were in compliance with all of our covenants, as we achieved actual ratios of approximately 1.6 on the leverage ratio and 2.09 on the fixed charge coverage ratio.

If an event of default occurs, the lenders may, among other things, terminate their commitments and declare all outstanding borrowings to be immediately due and payable together with accrued interest and fees.  We are in compliance with all financial and other covenants as of June 30, 2012.

As part of the initial debt offering in 2010, we capitalized approximately $2.3 million of debt issuance costs and, as part of this amendment; we capitalized an additional $0.1 million of debt issuance costs in 2011. These costs will be amortized over the  life of the Amended Credit Agreement, as amended, which will terminate in June 2016.  We incurred expense of $0.1 million in the second quarters of 2012 and 2011, respectively, and expenses of $0.2 million in the first six months of 2012 and 2011, respectively.  At June 30, 2012, we have approximately $2.0 million of debt issuance costs remaining to be amortized.

37

In the first quarter of 2011, we made an initial draw on the line of credit of $145.0 million to fund the acquisition of Curamik.  During the first six months of 2012, we made principal payments of $2.5 million on the debt. We made $22.5 million of principal payments in fiscal 2011.  We are obligated to pay $10.0 million on this debt obligation within the next 12 months but anticipate paying down $27.5 million.  As of June 30, 2012, our outstanding debt related to the Amended Credit Agreement, as amended, consists of $95.0 million of term loan debt and $25.0 million on the revolving line of credit.  We have the option to pay part of or the entire amount at any time over the remaining life of the Amended Credit Agreement, as amended, with any balance due and payable at the agreement's expiration.

In addition, at June 30, 2012 we had the following standby letter of credit (LOC) and guarantee that were backed by the Amended Credit Agreement, as amended:

● $1.1 million letter of credit to guarantee Rogers workers compensation plan;

● $0.6 million letter guarantee to guarantee a payable obligation for a Chinese subsidiary (Rogers Suzhou).

No amounts were owed on the LOC or guarantee as of June 30, 2012 or December 31, 2011.

Interest

We incurred interest expense on our outstanding debt of $0.7 million and $1.5 million in the three and six month periods ended June 30, 2012, respectively, and $1.0 million and $2.1 million in the three and six months ended June 30, 2011, respectively.  We incurred an unused commitment fee of approximately $0.1 million and $0.2 million in the three and six month periods ended June 30, 2012, respectively, and of approximately $0.2 million and $0.4 million in the three and six month periods ended June 30, 2011.  In July 2012, we entered into an interest rate swap to hedge the variable interest rate on 65% of the term loan debt, effective July 2013. At June 30, 2012, the term loan debt amounted to $95.0 million of our outstanding debt facility.  The interest rate swap results in the variable portion of the interest rate for this portion of the debt being fixed at 0.75% and is for the period from July 2013 to June 2016. (At June, 30 2012, the rate charged on this debt is 0.25% on the variable portion of the rate plus a spread of 2.25%.)

We also incurred interest expense on the capital lease of $0.4 million and $0.8 million in the three and six month periods ended June 30, 2012, respectively, and of $0.3 million and $0.7 million in the three and six month periods ended June 30, 2011.

Auction Rate Securities

During the first quarter of 2012, we liquidated our auction rate securities portfolio, receiving net proceeds of $25.4 million on a stated par value of $29.5 million.  As a result of this liquidation, we recognized a loss on the discount of the securities of $3.2 million (the remaining difference between the liquidation and par value of $0.9 million had previously been recognized as an impairment loss).  Since the markets for these securities failed in the first quarter of 2008, due to the events in the credit markets, we had already redeemed $24.9 million of these securities, mostly at par.  However, due to the fact that par value redemptions had slowed in recent quarters with no clear path for full redemption over the next several years and the rate of return on these securities was very low, management determined that at this time a discounted redemption of the remainder of the portfolio was in our best interest.

Prior to the first quarter of 2012, we had recognized an other–than-temporary impairment (OTTI) on these securities.  An OTTI is recognized in earnings for a security in an unrealized loss position when an entity either (a) has the intent to sell the security or (b) more likely than not will be required to sell the security before its anticipated recovery.  

When an OTTI of a security occurs, the amount of the OTTI recognized in earnings depends on whether the security holder intended to sell the security or it is more likely than not that the holder would be required to sell the security before recovery of its cost basis. If the holder does not intend to sell the security and it is not more likely than not that the holder would be required to sell the security before the recovery of its cost basis, the other-than-temporary loss would be separated into (i) the amount representing the credit loss and (ii) the amount related to all other factors.  The amount representing the credit loss would be recognized in earnings, and, the remaining amount would be recorded in other comprehensive income. This is the approach we used to recognize the OTTI taken prior to the first quarter of 2012.  Upon the liquidation of the entire auction rate securities portfolio in the first quarter of 2012, a reclassification from other comprehensive income was made as disclosed earlier in Note 2 of Part I, Item I of this Form 10-Q.

Prior to the first quarter of 2008, our available-for-sale auction rate securities were recorded at fair value as determined in the active market at the time.  However, due to events in the credit markets, the auctions failed during the first quarter of 2008 for the auction rate securities that we held at the end of the first quarter of 2008, and all of our auction rate securities had been in a loss position since that time until the first quarter of 2012.  In addition, it was no longer possible to establish fair value using Level 1 methodology and valuation according to Level 3 methodology was adopted.

Additionally, due to our belief that it would have taken more than twelve months for the auction rate securities market to recover, these securities were classified as long-term assets, except for those that were scheduled to be redeemed within the next twelve months, which were classified as short-term investments.

38

Contingencies

During the second quarter of 2012, we did not become aware of any new material developments related to environmental matters or other contingencies.  We have not had any material recurring costs and capital expenditures related to environmental matters.  Refer to Note 14 “Commitments and Contingencies”, to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q, for further discussion on ongoing environmental and contingency matters.

Contractual Obligations

As of June 30, 2012, we had outstanding borrowings on our credit facilities of $120.0 million, which relates to the funding of the Curamik acquisition, as well as a capital lease obligation of $8.5 million associated with the purchase of Curamik. There were no significant changes outside of the ordinary course of business in our contractual obligations during the second quarter of 2012.

The following table summarizes our significant contractual obligations as of June 30, 2012:

(Dollars in thousands)	Payments Due by Period
	Total		Less than 1 Year		1-3 Years		3-5 Years		More than 5 Years
Operating leases	$	7,617	$	1,327	$	3,888	$	1,893	$	509
Capital lease		8,515		1,560		1,746		1,550		3,659
Interest payments on capital lease		3,796		549		955		867		1,425
Inventory purchase obligation		2,777		2,777		-		-		-
Capital commitments		2,542		2,542		-		-		-
Pension and retiree health and life insurance benefits (1)		95,067		6,208		17,023		17,925		53,911
Outstanding borrowings on credit facilities		120,000		27,500		50,000		42,500		-
Interest payments on outstanding borrowings (2)		9,258		3,068		4,770		1,420		-
Total	$	249,572	$	45,531	$	78,382	$	66,155	$	59,504

(1) Pension benefit payments, which amount to $86.5 million, are expected to be paid through the utilization of pension plan assets; retiree health and life insurance benefits, which amount to $8.6 million, are expected to be paid from operating cash flows.

(2) Estimated future interest payments are based on rates that range from 0.25% to 1.56%, which take into consideration projected forward LIBOR rates and the related impact of the interest rate swap.

Other long-term liabilities, such as deferred taxes, unrecognized tax benefits and asbestos-related product liability reserves, have been excluded from the table due to the uncertainty of the timing of payments combined with the absence of historical trends to be used as a predictor for such payments.

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements that have or are, in the opinion of management, likely to have a current or future material effect on our financial condition or results of operations.

Critical Accounting Policies

There have been no material changes in our critical accounting policies during the second quarter of 2012.

39

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

See the discussion of the liquidation of our auction rate securities portfolio in Note 2 “Fair Value Measurements”, to the condensed consolidated financial statements in Part I, Item I of this Form 10-Q.  There have been no significant changes in our exposure to market risk during the second quarter of 2012.  For discussion of our exposure to market risk, refer to Item 7A, Quantitative and Qualitative Disclosures About Market Risk, contained in our 2011 Annual Report on Form 10-K.

Item 4.  Controls and Procedures

The Company, with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the design and operation of our disclosure controls and procedures, as defined under Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act), as of June 30, 2012.  Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of June 30, 2012 to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in the Company’s internal control over financial reporting during its most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act.

Part II - Other Information

Item 1.  Legal Proceedings

See a discussion of environmental, asbestos and other litigation matters in Note 14, “Commitments and Contingencies”, to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

40

Item 6.   Exhibits

List of Exhibits:
10.1	Rogers Corporation 2009 Long-Term Equity Compensation Plan, as amended, filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-181199) filed May 7, 2012.*
10.2	General Release and Settlement Agreement with Peter G. Kaczmarek (with attachment), filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 13, 2012.*
10.3	General Release and Settlement Agreement with Michael D. Bessette [(with attachment)], filed herewith
23.1	Consent of National Economic Research Associates, Inc., filed herewith.
23.2	Consent of Marsh U.S.A., Inc., filed herewith.
31.1	Certification of President and Chief Executive Officer (Principal Executive Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
31.2	Certification of Vice President, Finance and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
32	Certification of President and Chief Executive Officer (Principal Executive Officer) and Vice President, Finance and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith.
101	The following materials from Rogers Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2012 formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Comprehensive Income (loss) for the three months ended March 31, 2012 and March 31, 2011, (ii) Condensed Consolidated Statements of Financial Position at March 31, 2012 and December 31, 2011, (iii) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2012 and March 31, 2011 and (iv) Notes to Condensed Consolidated Financial Statements.+
*	In accordance with Rule 12b-23 and Rule 12b-32 under the Securities Exchange Act of 1934, as amended, reference is made to the documents previously filed with the Securities and Exchange Commission, which documents are hereby incorporated by reference.
+	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

41

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ROGERS CORPORATION

(Registrant)

/s/  Dennis M. Loughran	/s/ Ronald J. Pelletier
Dennis M. Loughran Vice President, Finance and Chief Financial Officer Principal Financial Officer	Ronald J. Pelletier Corporate Controller and Principal Accounting Officer

Dated: August 1, 2012

42

EX-10.3

Exhibit 10.3

GENERAL RELEASE AND SETTLEMENT AGREEMENT

This General Release and Settlement Agreement (hereinafter "Agreement") is made as of the “Effective Date” (as defined in Section 6(f) below) by and between Michael Bessette (hereinafter "Bessette") and ROGERS CORPORATION (hereinafter "Rogers").  The purpose of this Agreement is to fully and finally dispose of all issues regarding Bessette’s employment and separation from employment with Rogers as described below.

1.           The parties agree and acknowledge that there is good and sufficient consideration for the settlement of any and all issues between Bessette and Rogers and for the mutual promises contained herein.  Also, the parties agree and acknowledge that the terms of this Agreement are fair and equitable, reflecting both the corporate interests of Rogers and its recognition of Bessette’s years of valuable service.

2.           Bessette is voluntarily entering into this Agreement of his own free will and without influence by Rogers or any of its present or former officers, representatives, agents or employees.  Bessette was advised of his right to be represented by his own legal counsel regarding this matter.  Bessette understands that he may take as long as twenty-one (21) days to consider this Agreement before signing it.  Bessette’s execution of this Agreement before the expiration of that period will constitute his representation and warranty that he has decided that he does not need any additional time to decide whether to execute it.

3.           This Agreement constitutes the complete understanding between the parties.  Its purpose is to resolve any and all disputes or potential disputes without any party incurring additional time and expense.  All agree that full settlement would best serve all interests.

4.           Bessette represents and warrants that he has the authority to enter into this Agreement, and that he has not assigned any claims being released under this Agreement to any person or entity.

5.           Neither the negotiation, undertaking or execution of this Agreement shall constitute an admission by Rogers of a violation of any federal or state constitution, statute or regulation, or common law right, whether in contact or in tort.

Initialed by:  __________  (Employee) ______________ (H.R. Director)

AZ >40

Rev 07/09

Exhibit 10.3

6.           By accepting the terms of this Agreement, Bessette, for himself, his heirs, executors and administrators, releases and forever discharges the Released Parties of and from any and all liability in manner of suits, claims, charges or demands whatsoever, whether in law or in equity, under federal, state and municipal constitutions, statutes, charters, regulations and common law, including, but not limited to, the Family and Medical Leave Act under Federal and State laws, discrimination or retaliation claims under any fair employment practices law, including, without limitation, the Age Discrimination in Employment Act of 1967, as amended, 29 U.S.C. § 621 et seq. (the "ADEA"), Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000 et seq., the Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1001 et seq., the Americans with Disabilities Act, 42 U.S.C. §  12101 et seq., the Arizona Civil Rights Act, Ariz. Stat. §§ 41-1401, et seq.; any and all claims for violation of any public policy having any bearing whatsoever on the terms or conditions of Bessette’s employment or cessation of employment by Rogers; all claims for relief or other benefits under any federal, state, or local statute, ordinance, regulation, rule of decision, or principle of common law, all claims that the Released Parties engaged in conduct prohibited on any basis under any federal, state, or local statute, ordinance, regulation, rule of decision, or principle of common law, and all claims against the Released Parties, whether in contract, expressed or implied, or in tort, including, but not limited to, breach of covenant of good faith and fair dealing, breach of contract - expressed or implied, defamation, slander, the tortious or wrongful discharge from employment, claims for outplacement services, the intentional or negligent infliction of emotional or mental distress, claims of inducement, promissory estoppel, collateral estoppel, fraud, misrepresentation - negligent or intentional, and including any claims for attorneys' fees or costs.  This is a good and final release of all claims of every nature and kind whatsoever, and, by this Agreement, Bessette releases the Released Parties from all claims that are known and unknown, suspected and unsuspected, arising out of his employment and separation from employment with Rogers, except for claims for unemployment or workers’ compensation, unpaid wages and retirement benefits (e.g., 401(k) and pension benefits).

The term “Released Parties” used  immediately above means Rogers, all of its related companies, subsidiaries and affiliates, their successors and assigns, and all of its and their present, former and future officers, representatives, agents or employees.

Rogers, on behalf of itself and all of its related companies, subsidiaries and affiliates, their successors and assigns releases Bessette, his heirs and assigns from any and all liability in manner of suits, claims, charges or demands whatsoever, whether in law or in equity, under federal, state and municipal constitutions, statutes, charters, regulations and common law with respect to all acts or omissions taken or not taken, as the case may be, by him in good faith in the reasonable belief such acts or omissions were in the best interest of Rogers and its shareholders.

Bessette acknowledges that certain states provide that a general release of claims does not extend to claims which the person executing the release does not know or suspect to exist in his favor at the time of executing the release which, if known by him, may have materially affected his entering the release of claims.  Being aware that such statutory protection may be available to him, Bessette expressly, voluntarily and knowingly waives any arguable benefit or protection of any such statute in executing this Agreement, known or unknown.

Page 2 of 6

Exhibit 10.3

Bessette acknowledges and understands that the release of claims under the ADEA is subject to special waiver protections under 29 U.S.C. § 626(f).  In accordance with that section, Bessette specifically agrees that he is knowingly and voluntarily releasing and waiving any rights or claims of discrimination under the ADEA.  In particular, he acknowledges that he understands the following:

(a)           he is not waiving rights or claims for age discrimination under the ADEA that may arise after the date he signs this Agreement;

(b)           he is waiving rights or claims for age discrimination under the ADEA in exchange for the consideration set forth in Section 12 of this Agreement, which is in addition to anything of value to which he is already entitled;

(c)           he is hereby advised to consult with an attorney before signing this Agreement;

(d)           he has twenty-one (21) days within which to consider this Agreement which will expire at 11:59 p.m. and must be postmarked or received in person by April 30, 2012;

(e)           he understands that for a period of seven (7) days after his execution of this Agreement, he may revoke this Agreement after execution by notifying Rogers in writing.  Such writing must be received by Rogers by 11:59 p.m. on the seventh consecutive day after his execution of this Release of Claims at the following address:

Susan Flanigan

U.S. Director of Human Resources

Rogers Corporation

PO Box 188

Rogers, CT   06263-0188

(f)            he understands that this Agreement will not become effective or enforceable unless and until he has not revoked it and the applicable revocation period set forth above has expired.  The date on which the revocation period expires, if Bessette does not first revoke it, is the Effective Date of this Agreement;

(g)            he understands that nothing in this Agreement restricts his right to challenge the validity of the General Release of ADEA claims, to file a charge with the EEOC or to participate or cooperate in EEOC investigations or proceedings.

7.           Bessette agrees that by this Agreement, he is expressly waiving his right to bring or pursue any judicial action, any administrative agency or action, any contractual action, any statutory action or procedure or any other action which he could have brought with respect to any matter arising from his employment with Rogers and separation therefrom with Rogers, provided, however, that this Agreement shall not preclude Bessette from seeking unemployment compensation or workers’ compensation benefits, nor shall it constitute a waiver with respect to any claims he may have for retirement benefits (e.g., 401(k) and pension benefits).  Bessette also agrees that by entering into this Agreement, he is waiving any right he may have to seek or accept damages or relief of any kind with respect to the claims released by this Agreement or by reason of termination of his employment.

Page 3 of 6

Exhibit 10.3

8.           Bessette agrees to abide in full with the terms of his Employment Agreement with Rogers, dated August 4, 1976, which is specifically incorporated herein as terms of this Agreement.

9.           Once all major project work for Rogers has been completed, Bessette agrees to return promptly all Rogers’ property in his possession including, but not limited to, credit cards, keys, company files and internal documents, and any office/computer equipment which has been available for his personal use.

10.           This Agreement may be used as evidence in a subsequent proceeding in which any of the parties allege a breach of this Agreement.

11.           Bessette understands that regardless of whether he enters into this Agreement, he will be paid for all earned but unpaid wages as of his termination date, all accrued but unused vacation and will be classified under severance continuation status and receive four (4) weeks of Basic Severance Pay and benefits as provided for in the Rogers Severance Policy (“Continuing Benefits”) during the Basic Severance Pay Period.  He will also be eligible for those benefits, payments and awards outlined in his April 9, 2012, Termination  Letter which are payable without regard to whether this Agreement is signed .

12.           In consideration of entering into this Agreement, following the Effective Date, Rogers will provide the following additional consideration for the satisfactory fulfillment by Bessette of the promises contained in Sections (6), (7), (8), (9), (10), (11), (12), (13)  and (14) of this Agreement:

(a)           additional Severance Pay of 90 weeks of pay (54 weeks in accordance with our standard Severance Policy and a supplemental 36 weeks of pay ) which is paid in bi-weekly amounts from the end of the Basic Severance Pay Period, as well as continuing benefits during the entire severance period in accordance with the appropriate laws and policies and as outlined under the section “Benefit End Dates” in the Termination Letter;

(b)           six (6) months of outplacement consulting services which begin only after the Release is signed and received;

(c)           Time Based Restricted Stock:  You will receive your full payout following the third anniversary of the grant which is May 12, 2014.

Page 4 of 6

Exhibit 10.3

(d)           a Lump Sum Payment of $6000 which is subject to appropriate tax and withholding and will be paid along with a severance payment.

13.           Bessette has carefully read this Agreement and fully understands its contents and significance, and he acknowledges that he has not relied upon any representation or statement, written or oral, not set forth in this document.  He fully understands that this Agreement constitutes a waiver of all rights available under federal and state statutes, municipal charter and common law, with regard to any matter related to his employment with Rogers, and separation therefrom with Rogers.

14.           Bessette agrees not to disclose the contents of the provisions of this Agreement, its terms or conditions or the circumstances that resulted in or followed Bessette’s separation from employment, to any party, excluding immediate family, except as required by law or as is reasonably necessary for purposes of securing counsel from his attorney, accountant or financial adviser.  Bessette and Rogers both agree not to make any statement, publicly or privately, written or verbal, to any third parties which may disparage or injure the goodwill, reputation and business standing of you or the Company.  In the event of any violation of this provision, and the Agreement, either party may seek all appropriate legal and equitable relief.  Nothing in this Section 14 is intended to impose restrictions on either party beyond those that are permitted by law.

15.           This Agreement represents the complete understanding of the parties and no other promises, or agreements, shall be binding or shall modify this Agreement, unless in writing, signed by these parties.

16.           If  this  Agreement is postmarked after the expiration of the seven (7)  day revocation period (referred to in section 6e) then, and if Rogers agrees to accept the signed agreement, you will receive your severance but benefits and outplacement will not be extended after the basic severance period.

17.           Bessette agrees that the terms of this Agreement shall be interpreted in accordance with the laws of the State of Arizona.

18.           If any term or provision of this Agreement, or any application thereof to any circumstances, is declared invalid, in whole or in part, or otherwise unenforceable, such term or provision or application shall be deemed to have been modified to the minimum extent necessary for it to be enforceable, and shall not affect other terms or provisions or applications of this Agreement.

Page 5 of 6

Exhibit 10.3

	/s/ Michael Bessette
Initial all pages.  Sign last	Michael Bessette
page.  Return all pages
of both originals in the	____________________
envelope provided.	Date
	/s/ Susan P. Flanigan
	By: _________________
	Susan P. Flanigan
	Its U.S. Director of Human Resources
	____________________
	Date

Page 6 of 6

Exhibit 10.3

One Technology Drive / P.O. Box 188 / Rogers, CT 06263-0188 / 860.774.9605 / Fax: 860.779.5777

Rev.  April 9, 2012

Michael Bessette

23823 South Glenburn Dr.

Sun Lakes, AZ 85248

Dear Mike,

This letter explains your severance arrangement and other benefits that you have available.  Your last day of work for Rogers Corporation has been changed to March 9, 2012.

The check you will receive via direct deposit tomorrow, March 9, 2012, includes the following elements of pay:

Pay from February 27, 2012 through March 9, 2012

The check you will receive via direct deposit on Friday, March 23, 2012, will include the following elements of pay.

256 hours of unused vacation, allocated from 03/12/12 to 04/24/12

$20,308.00 lump sum payment equal to another four weeks of base pay due to the status of executive officer not being eligible for the lump sum payment in the Auto Reimbursement policy.

Your severance checks will be direct deposit or live in keeping with your current election.

Severance Pay:

In accordance with the severance policy, you have 38 years of service, resulting in four (4) weeks of basic severance.  Basic severance will begin on April 25, 2012, and pay will resume on May 4, 2012.  If you sign the General Release and Settlement Agreement you will receive 54 weeks of additional severance which will begin on May 23, 2012. As an added benefit to signing the General Release and Settlement Agreement, Rogers will supplement your severance by 36 weeks providing you with a total of 94 full weeks of benefit.   You MUST initial all pages, sign the last page of both originals, and return all pages of two originals to me.

Page 7 of 15

Exhibit 10.3

Due to signing deadlines established in the General Release and Settlement Agreement, there may be a gap between basic severance end date and the initiation of additional severance pay.  Should this occur, additional severance will be paid retroactive from the date immediately following the last day of basic severance pay and pay will resume on the 1st regular payday administratively possible after signing and revocation period(s) have expired.  However, if the General Release and Settlement Agreement is returned after the time limit described in the Agreement, although severance pay will be retroactive, benefits and outplacement will not be provided.

Annual Incentive Compensation Plan (AICP)

You are eligible to earn and should have received your full incentive payment under the AICP based on Rogers' performance for the 2011 fiscal year.  You are also entitled to any pro-rata bonus under the AICP for the 2012 fiscal year.  Payments will be made prior to the end of the first quarter and will be direct deposit or live in keeping with your current payroll election.

Paid Through Date:

Throughout this letter you will see several references to your “Paid Through Date”.

· If you do not sign the General Release and Settlement Agreement, your paid through date will be May 22, 2012.

· If you do sign the General Release and Settlement Agreement within the timeframe specified in that document, and return two signed originals to the me, US Director of Human Resources in the envelope provided, your paid through date will be February 11, 2014.

Benefit End Dates:

· Your present benefit coverage, including Medical, Dental, and the Employee Assistance Program (EAP) will continue through your paid through date.  Payroll deductions for benefits will continue throughout your severance period for as long as you continue coverage in the benefit plan(s).

· Your Basic Group Term Life Insurance coverage will end on March 9, 2013.

· IRS regulations prohibit RESIP deductions and loan repayments from severance pay; therefore this benefit will end on April 24, 2012.

· Your Short-Term and Long-Term Disability coverages end on March 12, 2012.

Page 8 of 15

Exhibit 10.3

· Your Health Care FSA will continue through April 24, 2012.  If you choose to extend your FSA benefit through your severance period, you must contact Rogers to continue the deduction(s) by March 13, 2012.

· Since you have Supplemental Term Life Insurance, your deductions will continue throughout your severance period for as long as you continue to participate in the plan.  In the event you wish to convert your Supplemental Insurance or your current Standard Term Life Insurance to a whole life policy, you will need to contact your location HR representative to request a completed Standard Portability Application and Conversion form.  You are then responsible for completing your portion of the Portability Application and Conversion form and returning them, with payment, to the address indicated in the booklet within 31 days of your last date paid.  Your current Life coverage amounts are:

Basic Group Term Life Insurance                                                      $793,000.00

Supplemental Life                                                       $200,000.00

COBRA:

Federal Law (COBRA) requires that we offer you the opportunity to continue your Medical and Dental coverage for up to 18 months beyond your paid through date.  After your paid through date, you will receive information through the mail from Discovery Benefits with details on how to continue your coverage.  Since you have been contributing to a Flexible Spending Account (FSA), there is also a way to extend your coverage through COBRA.  However, because the provisions are different, please contact the Corporate Benefits Department at (860) 774-9605, for further explanation if you are interested in this extension through the end of the current year.

RESIP:

As you have participated in RESIP, you have two options after April 24, 2012:

Option 1 Based on current government regulations, you may leave your funds in the Plan if you have a current balance of at least $5,000.  This minimum balance amount may change in the future.  The following provisions apply if you choose this option.  You can continue to make transfers among investment fund options in the same manner as active participants.  No future loans or hardship withdrawals are available.  When you withdraw your funds, the value will be calculated as of the close of business on the day after Prudential receives your distribution request form.

Option 2 Withdraw or transfer your funds.  You can choose a direct rollover of your funds.  In a direct rollover the distribution is paid directly from the plan to an IRA or another employer plan that accepts rollovers.  If you choose a direct rollover, you are not taxed until you take your funds out of the IRA or the employer plan.  If you have the payment made to you, it is subject to 20% income tax withholding.  Additionally, the premature distribution may be subject to a 10% penalty.  You may be able to defer taxes on all or part of your distribution by making a tax deferred "rollover" to another qualified plan or IRA.  Current law requires that this be done within 60 days of your receiving the RESIP distribution.

Page 9 of 15

Exhibit 10.3

For more information call Prudential Retirement at 1-877-778-2100.

Global Stock Ownership Plan:

To be eligible to purchase stock at the end of an offering period, you must participate in the plan during the entire offering period.  Your right to purchase common stock under this plan ends on June 30, 2012.

Since your paid through date extends beyond the current offering period, you have the following options:

· You may continue to participate in the plan through the last day of the current offering period, or

· You may elect to discontinue participation at any time during the current offering period and receive a refund of deductions taken during this offering period.  To do so, you must contact your location HR Representative.

You have the option of leaving stock purchased prior to the current offering period in your Wells Fargo Shareowner Services account, or removing it.  To access your account call the interactive telephone system at 800-468-9716, or log on to http://www.shareowneronline.com

Pension:

You will continue to accrue credited service in the pension plan until April 24, 2012.  Please contact Prudential Retirement at 1-877-778-2100 for pension information.

Pension Restoration Plan:

You will be eligible to receive a lump sum payment from the non-qualified Amended and Restated Pension Restoration Plan. The value is going to be slightly higher than the $451,432 amount you were given due to the change in your last day worked to March 9, 2012.  John Packard will provide you with a final calculation based on the last day worked of March 9, 2012.  Your payment will be made six months and one day from your last day worked (September 10, 2012).

Due to the overpayment of Fed MED/EE tax paid in January 2012, you will be provided with a Lump Sum payment of $600 which will be direct deposited along with your severance pay.  This will be paid after the signed General Release has been returned.

Page 10 of 15

Exhibit 10.3

Deferred Compensation:

You will be entitled to receive your deferred compensation and bonus amounts, along with appropriate interest and Company match in accordance with the Voluntary Deferred Compensation Plan for Key Employees, as amended.  If you have questions, please contact     Bob Soffer at 860-779-5566.

Retiree Medical:

You will become eligible for a retirement medical benefit from Rogers Corporation because you  will turn 60 during your period of severance. If during your time of severance you wish to retire, you must contact Prudential to initiate your final pension calculation. You must also notify Rogers Corporation of your intent to retire using the enclosed Notification of Intent to Retire Form.

If you begin to receive a monthly pension check before your period of severance ends, you are eligible to receive retiree medical coverage.  Once retirees and/or their eligible dependents reach age 65, Rogers offers a Medicare Supplement Plan, Anthem Blue Cross and Blue Shield Group Plan F and Blue MedicareRx plan.  This is a generous plan that provides you with a Medicare (Part A and Part B) supplementary benefit that covers deductibles and coinsurance for all Medicare approved services and a Prescription (Part D) plan with a formulary and co-payments of $15 generic/$30 brand drugs/non-preferred brand drugs plus catastrophic coverage benefits.  Please be sure to enroll in Medicare Part B at age 65.  Another important feature that might interest you is that you may elect to continue in the Rogers’ Medicare Supplement Plan beyond age 70 by paying the group rate premium.

Your monthly contribution toward your retiree medical insurance will be automatically deducted from your pension check.  While these rates do not apply to you, they provide you with the information which applies to retirees in 2012 and is based on the plan chosen:

	$100 PPO Plan		$500 PPO Plan		Coinsurance Plan
Retiree/Spouse Only	$	66.00	$	31.00	$	16.00
Retiree/Spouse + One Dependent	$	132.00	$	62.00	$	32.00
Retiree/Spouse + Two+ Deps	$	212.00	$	99.00	$	51.00

Rogers’ Medicare Supplement Plan
Retiree age 65+	$35.00
Both Retiree and Spouse age 65+	$70.00

Medical plan options and costs for future years will be communicated during the annual open enrollment period.

Page 11 of 15

Exhibit 10.3

If you do not begin to receive a monthly pension check before your period of severance ends you will be considered a vested terminee eligible for a pension benefit to be paid at a later date.  Your medical coverage will end at the end of your period of severance, on your last date paid and you will not be eligible for retiree medical benefits.

If you have any questions about this benefit, please call our Corporate Benefits department at 860-774-9605.

Stock Options:

Please read your stock option agreement(s) and any amendment(s) carefully.  Pay particular attention to the sections referencing termination of employment (for any other reason than death, disability or retirement), vesting, exercisability, and if applicable when the related shares can be sold.  In general, most stock options are exercisable in one-third increments on the second, third and fourth anniversary dates of the grant date.  You may exercise your vested stock options for a period of three months from your last day worked.  If you agree to sign the General Release and Settlement Agreement, you may exercise any outstanding and vested stock options through your initial severance period of 58 weeks. After this extension period has expired, any remaining stock options will be cancelled.

However, should you choose to retire at the end of your severance period and you notify Rogers ahead of the expiration of your exercise period noted above (which you have done), your options will continue to vest as if you were an employee.  At the time you retire, all of your options would fully vest and be exercisable for the lesser of the original expiration date, or five years from your termination date of 3/9/12, whichever is earlier.

To exercise your stock options, contact Charles Schwab & Co. at 1-800-654-2593 (Participant Services) or log on to https://optioncenter.schwab.com.

If you have any questions about your stock options, please call the Office of the Corporate Secretary at (860) 774-9605.

Time-Based Restricted Stock Unit Award:

According to your Award Agreement, your unvested Time-Based Restricted Stock Units will be forfeited.  However, an exception has been approved by the Board of Directors.  If you agree to sign the General Release and Settlement Agreement, you will receive a payout for 3/3rds of all shares after the third anniversary of the Grant Date of May 12, 2014, has passed.  Applicable taxes, if any, will be deducted.

Page 12 of 15

Exhibit 10.3

Performance-Based Restricted Stock Unit Awards:

For the award due to be paid this year, you will be paid within the next 30 days.  All shares are pending approval by the Compensation and Organization Committee for the performance period ending 12/31/2011.  Your will receive approximately 3056 shares once it is approved by the Board.  When payments are made to the grantees, this payment will be made in stock based on achievement at 97% of the target award.

Since you are retiring, you will be entitled to a pro-rated payout of shares up to your retirement date and paid at the normal distribution time for each eligible year.

Outplacement Services:

Rogers will provide you with outplacement services for a period of six (6) months to assist in your job search.  This outplacement assistance is contingent upon your signing the General Release and will begin after May 21, 2012, per your request.  Please coordinate the workshop and services directly with Right Management Consultants within 90 days after May 21, 2012.  Please contact Loren Wise once you are ready to begin using the services so she can initiate the process with Right Management and provide you with appropriate contact information.

Reference Policy:

By policy, Rogers limits release of personal information to external requestors.  The Human Resources Department will only provide potential new employers with dates of employment and job titles.  All requests for information or employment references must be referred to the Human Resources Department.

Confidentiality Agreement:

During the course of your employment with Rogers, you may have gained proprietary technical or business information regarding Rogers and/or Rogers customers.  It is our policy to remind you in writing of your obligations under the Employment, Invention Confidentiality and Non-Compete Agreement (Employment Agreement) that you signed and to provide you with a copy of this agreement, which is enclosed.

The information contained in this letter is based on our Plans and Policies as they currently exist. If there are any changes that will affect you, information will be sent to the address on file in Human Resources.

If you have any questions, please feel welcome to call me at (860) 779-4718.

Page 13 of 15

Exhibit 10.3

Sincerely,

/s/  Susan P. Flanigan

Susan P. Flanigan

U.S. Director of Human Resources

Enclosures

SF/mw

Page 14 of 15

Exhibit 10.3

Supplement to General Release and Settlement Agreement

This document (the “Amendment”) amends the General Release and Settlement Agreement (the “Settlement Agreement”) entered into by Rogers Corporation (the “Company”) and Michael Bessette (each a “Party” and together being the “Parties”) on May 1, 2012.  All capitalized terms used and not otherwise defined in this Amendment shall have the meanings set forth in the Agreement.

WHEREAS, Section 3(c) of the Company’s Standard Form of Time-Based Restricted Stock Unit Agreement (the “RSU Agreement”), which governs the grant of Time Based Restricted Stock Units (the “RSUs”) granted to Mr. Bessette on May 12, 2011, provides that in the event of a separation of service which meets the definition of Retirement (as such term is defined in the RSU Agreement) of a “specified employee” (within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended), the Company shall deliver the grantee’s vested shares under the May 12, 2011 grant of RSUs as soon as practicable following the earlier of (A) the first business day after the six month anniversary of the date of such Retirement or (B) the date of the grantee’s death; and

WHEREAS, the intention of the Parties is that the Settlement Agreement not amend or otherwise supersede the payment provisions of the RSU Agreement ,

NOW, THEREFORE, the Parties hereby agree to amend the Settlement Agreement, effective as of May 4, 2012, consistent with the intention of the Parties as follows:

1. Section 12(c): this section shall be deleted in its entirety and replaced with the following:

“Time Based Restricted Stock: The total number of shares specified in the Time-Based Restricted Stock Unit Agreement under which the May 12, 2011 grant was made (the  “RSU Agreement”) -- 1,880 shares-- will be delivered to you at the time specified under the RSU Agreement..

2. Except as specifically modified or amended hereby, the Settlement Agreement shall remain in full force and effect.

IN WITNESS WHEREOF, the Parties have caused this Amendment to be executed by their duly authorized representatives.

ROGERS CORPORATION

By:  /s/  Susan P. Flanigan	By: /s/  Michael Bessette
(Signature)	(Signature)
Print Name: Susan P. Flanigan	Print Name:  Michael Bessette
Title: U.S. Director of Human Resources
Date:	Date:

Page 15 of 15

EX-23.1

Exhibit 23.1

CONSENT OF MARSH USA, INC.

We hereby consent to the references to our firm with respect to the analysis we performed regarding Rogers Corporation’s insurance coverage for its asbestos-related liabilities and defense costs contained in the Form 10-Q for the fiscal quarter ended June 30, 2012 of Rogers Corporation and any amendments thereto, and to all references to us as having conducted such analysis.  In giving the foregoing consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended (the “Securities Act”), or the rules and regulations promulgated thereunder, nor do we admit that we are experts with respect to any part of such Form 10-Q within the meaning of the term “experts” as used in the Securities Act or the rules and regulations promulgated thereunder.

 MARSH USA, INC.

By:     /s/ John H. Denton

Name: John H. Denton

 Title:   Senior Vice President

New York, New York

July 25 , 2012

EX-23.2

Exhibit 23.2

CONSENT OF NATIONAL ECONOMIC RESEARCH ASSOCIATES, INC.

We hereby consent to the references to our firm with respect to the economic analysis we performed regarding Rogers Corporation’s projected liability for its asbestos-related liabilities and defense costs contained in the Form 10-Q for the fiscal quarter ended June 30, 2012 of Rogers Corporation and any amendments thereto, and to all references to us as having conducted such analysis.  In giving the foregoing consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended (the “Securities Act”), or the rules and regulations promulgated thereunder, nor do we admit that we are experts with respect to any part of such Form 10-Q within the meaning of the term “experts” as used in the Securities Act or the rules and regulations promulgated thereunder.

National Economic Research Associates, Inc.

By:   /s/ Mary Elizabeth Stern

   Name: Mary Elizabeth Stern

 Title:   Vice President

New York, New York

July 23, 2012

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Bruce D. Hoechner, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Rogers Corporation;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  August 1, 2012

/s/ Bruce D Hoechner

Bruce D. Hoechner

President and Chief Executive Officer

Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Dennis M. Loughran, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Rogers Corporation;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  August 1, 2012

/s/ Dennis M. Loughran

Dennis M. Loughran

Vice President, Finance and Chief Financial Officer

Principal Financial Officer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Rogers Corporation, a Massachusetts corporation (the “Corporation”), does hereby certify that:

The Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2012 (the “Form 10-Q”) of the Corporation fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

/s/ Bruce D Hoechner

Bruce D. Hoechner

President and Chief Executive Officer

Principal Executive Officer

August 1, 2012

/s/ Dennis M. Loughran

Dennis M. Loughran

Vice President, Finance and Chief Financial Officer

Principal Financial Officer

August 1, 2012

XML

Fair Value Measurements - Additional Information (Detail) (USD $)		3 Months Ended
	Jun. 30, 2012	Mar. 31, 2012 Auction Rate Securities	Mar. 31, 2012 Auction Rate Securities Securities Redeemed at Less Than Par Value	Mar. 31, 2012 Auction Rate Securities Securities Redeemed at Par Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Net proceeds from liquidation of auction rate security		$ 25,400,000
Par value of auction rate securities redeemed			29,500,000	24,900,000
Loss on liquidation of the securities		3,200,000
Impairment on auction rate securities		900,000
Derivative instruments, carrying value	$ 100,000

XML

Summary of Activity Under Stock Option Plans (Detail) (USD $)	3 Months Ended				6 Months Ended
	Jun. 30, 2012		Mar. 31, 2012	Jun. 30, 2011	Jun. 30, 2012		Jun. 30, 2011
Options Outstanding
Beginning Balance	2,440,999		2,401,809		2,401,809
Options granted				58,550	46,950		58,550
Options exercised	(112,531)				(116,491)
Options cancelled	(28,999)				(32,799)
Ending Balance	2,299,469		2,440,999		2,299,469
Options exercisable at June 30, 2012	1,594,269				1,594,269
Options vested or expected to vest at June 30, 2012	2,273,222	[1]			2,273,222	[1]
Weighted-Average Exercise Price Per Share
Beginning Balance	$ 37.59		$ 37.54		$ 37.54
Options granted				$ 47.89	$ 41.27		$ 47.89
Options exercised	$ 29.74				$ 29.72
Options cancelled	$ 46.78				$ 44.06
Ending Balance	$ 38.07		$ 37.59		$ 38.07
Options exercisable at June 30, 2012	$ 41.39				$ 41.39
Options vested or expected to vest at June 30, 2012	$ 38.19	[1]			$ 38.19	[1]
Weighted-Average Remaining Contractual Life in Years
Options outstanding	4 years 9 months 18 days		4 years 10 months 24 days
Options exercisable at June 30, 2012	3 years 8 months 12 days
Options vested or expected to vest at June 30, 2012	4 years 8 months 12 days	[1]
Aggregate Intrinsic Value
Beginning Balance	$ 14,667,018
Ending Balance	14,513,131		14,667,018		14,513,131
Options exercisable at June 30, 2012	7,279,532				7,279,532
Options vested or expected to vest at June 30, 2012	$ 14,247,752	[1]			$ 14,247,752	[1]

[1] In addition to the vested options, we expect a portion of the unvested options to vest at some point in the future. Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options.

XML

Comprehensive Income or Loss (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Comprehensive Income (Loss) [Line Items]
Net income (loss)	$ 6,455	$ 12,128	$ 4,646	$ 21,563
Foreign currency translation adjustments	(10,857)	6,298	(4,886)	21,262
Unrealized gain (loss) on marketable securities, net of tax		420	1,168	501
Unrealized gain (loss) on derivative instruments, net of tax	(43)		212
Total comprehensive income (loss)	$ (4,445)	$ 18,846	$ 1,140	$ 43,326

XML

Weighted Average Amortization Period by Intangible Asset Class (Detail)	Jun. 30, 2012 Year
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	7.3
Trademarks and patents
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	9.1
Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	6.1
Covenant not-to-compete
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	3.7
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	9.3

XML

Performance Based Restricted Stock Awards (Detail) (Performance-Based Restricted Stock)	6 Months Ended
	Jun. 30, 2012
Performance-Based Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested awards outstanding at beginning balance	101,730
Awards granted	22,120
Stock issued	(43,750)
Awards forfeited	(6,642)
Non-vested awards outstanding ending balance	73,458

XML

Discontinued Operations - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income (loss) from discontinued operations, net of income taxes	$ 0.1	$ 1.3		$ 2.9
Net sales associated with the discontinued operations	$ 0.1	$ 0.1	$ 0.1	$ 0.1

XML

Preliminary Fair Market Value Assigned to Acquired Assets and Liabilities of Curamik Electronics Gmbh (Detail) (Curamik Electronics GmbH, USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jan. 04, 2011
Curamik Electronics GmbH
Assets:
Cash	$ 11,256
Accounts receivable	11,876
Other current assets	1,386
Inventory	12,259
Property, plant & equipment	32,312
Other non-current assets	2,276
Intangible assets	52,354	52,400
Goodwill	79,837	79,800
Total assets	203,556
Liabilities
Accounts payable	6,053
Other current liabilities	20,427
Deferred tax liability	9,329
Other long-term liabilities	16,666
Total liabilities	52,475
Fair value of net assets acquired	$ 151,081

XML

Segment Information (Tables)

6 Months Ended

Jun. 30, 2012

Reportable Segment Information

The following table sets forth the information about our reportable segments for the periods indicated:

(Dollars in thousands)	Three Months Ended						Six Months Ended
	June 30, 2012			June 30, 2011			June 30, 2012			June 30, 2011
Net sales
Core Strategic
High Performance Foams	$	43,329		$	44,021		$	83,763		$	83,156
Printed Circuit Materials		40,533			43,375			79,914			86,228
Power Electronics Solutions
Curamik Electronics Solutions		23,908			34,613			48,200			67,510
Power Distribution Systems		11,573			13,978			22,089			26,413
Other		7,328			7,514			14,078			16,122
Net sales		126,671			143,501			248,044			279,429
Operating income (loss)
Core Strategic
High Performance Foams		5,708			6,658			7,153			11,293
Printed Circuit Materials		3,123			4,405			2,777			9,234
Power Electronics Solutions
Curamik Electronics Solutions		(1,205	)		2,855			(2,978	)		3,157
Power Distribution Systems		135			1,644			(515	)		3,909
Other		1,315			945			1,953			2,146
Operating income (loss)		9,076			16,507			8,390			29,739
Equity income in unconsolidated joint ventures		1,305			1,323			1,962			2,751
Other income (expense), net		261			280			122			1,629
Net realized investment gain (loss)		-			29			(3,245	)		32
Interest income (expense), net		(1,072	)		(1,265	)		(2,262	)		(2,843	)
Income (loss) before income tax expense (benefit)	$	9,570		$	16,874		$	4,967		$	31,308

XML

Income Taxes - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Income Taxes [Line Items]
Effective tax rate	32.50%	20.40%	4.30%	21.80%
Statutory rate	35.00%	35.00%	35.00%	35.00%
Reversal of valuation allowance related to sale of auction rate securities portfolio			$ 1.5
Unrecognized tax benefits, interest and penalties accrued	1.8		1.8
Unrecognized tax benefits	18.6		18.6
Unrecognized tax benefits that would decrease the effective tax rate if recognized	$ 11.3		$ 11.3
For the balance of 2012
Income Taxes [Line Items]
Effective tax rate			26.00%

XML

Deferred Stock Units (Detail) (Deferred Stock Units)	6 Months Ended
	Jun. 30, 2012
Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested awards outstanding at beginning balance	27,350
Awards granted	17,600
Stock issued	(14,800)
Awards forfeited
Non-vested awards outstanding ending balance	30,150

XML

Restructuring and Impairment Charges (Parenthetical) (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Mar. 31, 2012	Jun. 30, 2012 Employee Severance
Restructuring Cost and Reserve [Line Items]
Severance and related costs		$ 2,300,000	$ 1,600,000
Severance and related costs, favorable adjustment	$ 700,000

XML

Summary of Severance Accrual Activity (Detail) (Employee Severance, USD $) In Thousands, unless otherwise specified	3 Months Ended
	Jun. 30, 2012
Employee Severance
Restructuring Cost and Reserve [Line Items]
Beginning Balance	$ 4,545
Provisions	1,273
Payments	(1,911)
Ending Balance	$ 3,907

XML

Changes in Carrying Amount of Goodwill by Segment (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012
Goodwill [Line Items]
Beginning Balance	$ 102,178
Foreign currency translation adjustment	(1,584)
Ending Balance	100,594
High Performance Foams
Goodwill [Line Items]
Beginning Balance	22,597
Foreign currency translation adjustment	195
Ending Balance	22,792
Printed Circuit Materials
Goodwill [Line Items]
Beginning Balance
Foreign currency translation adjustment
Ending Balance
Curamik Electronics Solutions
Goodwill [Line Items]
Beginning Balance	77,357
Foreign currency translation adjustment	(1,779)
Ending Balance	75,578
Power Electronics Solutions
Goodwill [Line Items]
Beginning Balance
Foreign currency translation adjustment
Ending Balance
Other
Goodwill [Line Items]
Beginning Balance	2,224
Foreign currency translation adjustment
Ending Balance	$ 2,224

XML

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2012

Assets Measured at Fair Value on a Recurring Basis, Categorized by the Level of Inputs Used in the Valuation

(Dollars in thousands)	Carrying amount as of June 30, 2012			Level 1		Level 2			Level 3
Foreign currency option contracts	$	-		$	-	$	-		$	-
Copper derivative contracts		(82	)		-		(82	)		-

Reconciliation of Assets Measured at Fair Value on a Recurring Basis using Unobservable Inputs (Level 3)

The reconciliation of our assets measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:

(Dollars in thousands)	Auction Rate Securities
Balance at December 31, 2011	$	25,960
Cash received for redemptions at par		-
Cash received for redemptions below par		(25,438	)
Reclassified from other comprehensive income		2,723
Reported in earnings		(3,245	)
Balance at June 30, 2012	$	-

Rollforward of Credit Losses Recognized in Earnings

2012.  Below is a roll forward of credit losses recognized in earnings for the six months ended June 30, 2011.

(Dollars in thousands)
	Credit Losses
Balance at December 31, 2010	$	917
Credit losses recorded		39
Reduction in credit losses due to redemptions		(71	)
Balance at June 30, 2011	$	885

XML

Computation of Basic and Diluted Earnings Per Share (Detail) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Numerator:
Income (loss)	$ 6,455	$ 13,432	$ 4,754	$ 24,497
Denominator:
Denominator for basic earnings per share - Weighted-average shares	16,309,053	15,944,483	16,270,955	15,918,978
Effect of dilutive stock options	555,000	733,000	572,000	685,000
Denominator for diluted earnings per share - Adjusted weighted-average shares and assumed conversions	16,864,166	16,678,377	16,842,768	16,603,543
Basic income (loss) per share:	$ 0.40	$ 0.84	$ 0.29	$ 1.54
Diluted income (loss) per share:	$ 0.38	$ 0.81	$ 0.28	$ 1.48

XML

Hedging Transactions and Derivative Financial Instruments - Additional Information (Detail) (Bank Term Loan, USD $) In Millions, unless otherwise specified	Jun. 30, 2012 Contract	Jul. 31, 2012 Cash Flow Hedging [Member] Subsequent Event
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Number of derivative contracts related to minimizing risk associated with potential rise in copper prices	2
Term loan debt	$ 95.0
Interest rate swap, fixed interest rate for the period from July 2013 to June 2016	0.75%
Variable interest rate	0.25%
Interest rate spread over variable rate	2.25%
Interest rate swap derivative, percentage of debt hedged		65.00%

XML

Restructuring and Impairment Charges (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2012		Mar. 31, 2012	Jun. 30, 2012		Jun. 30, 2011
Cost of Sales
Inventory impairment related to Bremen shut-down						$ 1,805
Total charges for cost of sales	1,136			1,136
Restructuring and Impairment
Severance and related costs			2,300
Total charges for restructuring and impairment	830			8,214
High Performance Foams
Cost of Sales
Accelerated depreciation expense related to Bremen shut-down	585			585
Inventory impairment related to Bremen shut-down	191			191
Restructuring and Impairment
Fixed asset impairment for Bisco and Poron asset disposal				79
Severance and related costs	670	[1]		3,088	[1]
Power Electronics Solutions | Power Distribution Systems
Cost of Sales
Accelerated depreciation expense related to Bremen shut-down	360			360
Restructuring and Impairment
Impairment of investment related receivable	264			264
Severance and related costs	(13)	[1]		477	[1]
Power Electronics Solutions | Curamik Electronics Solutions
Restructuring and Impairment
Severance and related costs	213	[1]		957	[1]
Printed Circuit Materials
Restructuring and Impairment
Severance and related costs	(276)	[1]		3,046	[1]
Other
Restructuring and Impairment
Severance and related costs	$ (28)	[1]		$ 303	[1]

[1] For the three and six month periods ended June 30, 2012, this line item includes an estimated change of 2.3 million recorded in the first quarter of 2012, offest by a favorable adjustment of $0.7 million recorded in the second quarter of 2012. Total net charge of $1.6 million, for the first six months of 2012, was related to the early retirement program implemented in the first quarter of 2012.

XML

Restructuring/ Impairment Charges (Tables)

6 Months Ended

Jun. 30, 2012

Restructuring and Impairment Charges

The following table summarizes the restructuring and impairment charges related to these activities recorded in our operating results in the second quarter and first six months of 2012.

(Dollars in thousands)
	Three Months Ended			Six Months Ended
Cost of Sales	June 30, 2012			June 30, 2012
High Performance Foams
Accelerated depreciation expense related to Bremen shut-down	$	585		$	585
Inventory impairment related to Bremen shut-down		191		$	191
Power Distribution Systems
Accelerated depreciation expense related to U.S. shut-down		360			360
Total charges for cost of sales	$	1,136		$	1,136
Restructuring and Impairment
High Performance Foams
Fixed asset impairment for Bisco and Poron asset disposal	$	-		$	79
Severance and related costs (1)		670		$	3,088
Power Distribution Systems
Impairment of investment related receivable		264			264
Severance and related costs (1)		(13	)		477
Printed Circuit Materials
Severance and related costs (1)		(276	)	$	3,046
Curamik Electronics Solutions
Severance and related costs (1)		213			957
Other
Severance and related costs (1)		(28	)		303
Total charges for restructuring and impairment	$	830		$	8,214

(1) For the three and six month periods ended June 30, 2012, this line item includes an estimated change of 2.3 million recorded in the first quarter of 2012, offest by a favorable adjustment of $0.7 million recorded in the second quarter of 2012. Total net charge of $1.6 million, for the first six months of 2012, was related to the early retirement program implemented in the first quarter of 2012.

Summary of Severance Accrual Activity

A summary of the activity in the severance accrual as of June 30, 2012 and changes during the three month period then ended is as follows:

(Dollars in thousands)
	June 30, 2012
Balance at March 31, 2012	$	4,545
Provisions		1,273
Payments		(1,911	)
Balance at June 30, 2012	$	3,907

XML

Stock Based Compensation - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended	6 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended		12 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012 Employee Stock Purchase Plan	Jun. 30, 2011 Employee Stock Purchase Plan	Jun. 30, 2012 Employee Stock Purchase Plan	Jun. 30, 2011 Employee Stock Purchase Plan	Mar. 31, 2012 Stock Options	Jun. 30, 2012 Stock Options	Jun. 30, 2012 Stock Options Maximum	Jun. 30, 2012 Performance-Based Restricted Stock	Jun. 30, 2011 Performance-Based Restricted Stock	Jun. 30, 2012 Performance-Based Restricted Stock	Jun. 30, 2011 Performance-Based Restricted Stock	Dec. 31, 2010 Performance-Based Restricted Stock	Dec. 31, 2011 Performance-Based Restricted Stock	Dec. 31, 2010 Performance-Based Restricted Stock Maximum	Dec. 31, 2010 Performance-Based Restricted Stock Minimum	Jun. 30, 2012 Time Based Restricted Stock	Jun. 30, 2011 Time Based Restricted Stock	Jun. 30, 2012 Time Based Restricted Stock	Jun. 30, 2011 Time Based Restricted Stock	Jun. 30, 2012 Deferred Stock Units	Jun. 30, 2011 Deferred Stock Units	Jun. 30, 2012 Deferred Stock Units	Jun. 30, 2011 Deferred Stock Units	Jun. 30, 2012 Stock Option	Jun. 30, 2011 Stock Option	Jun. 30, 2012 Stock Option	Jun. 30, 2011 Stock Option
Compensation Related Costs Share Based Payments Disclosure [Line Items]
Stock options, contractual term											10 years
Stock options, expected dividend yield										0.00%
Stock-based compensation, approximate forfeitures rate									3.00%
Compensation expense			$ 2,678,000	$ 3,610,000	$ 100,000	$ 100,000	$ 200,000	$ 200,000				$ 500,000	$ 900,000	$ 400,000	$ 1,100,000					$ 400,000	$ 200,000	$ 900,000	$ 200,000	$ 700,000	$ 700,000	$ 700,000	$ 700,000	$ 600,000	$ 800,000	$ 1,300,000	$ 1,300,000
Options exercised, total intrinsic value			1,100,000
Total amount of cash received from exercise of options			$ 3,500,000
Restricted stock award program, measurement period																3 years
Restricted stock award program, awarded shares as a percentage of the original award amount																		200.00%	0.00%
Restricted stock award program, payment of award as percentage of target																	97.40%
Restricted stock award program, vesting period																						3 years
Employee stock purchase plan, purchase price discount							15.00%
Employee stock purchase plan, number of offering			2
Employee stock purchase plan, offering period			6 months

XML

Fixed Charge Metrics (Detail)	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011
Debt Disclosure [Line Items]
Covenant Limit	1.25	1.25	2.50
Actual FCCR	2.09	2.27	2.60

XML

Information About Reportable Segments (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Segment Reporting Information [Line Items]
Net sales	$ 126,671	$ 143,501	$ 248,044	$ 279,429
Segment operating income (loss)	9,076	16,507	8,390	29,739
Equity income in unconsolidated joint ventures	1,305	1,323	1,962	2,751
Other income (expense), net	261	280	122	1,629
Net realized investment gain (loss)		29	(3,245)	32
Interest income (expense), net	(1,072)	(1,265)	(2,262)	(2,843)
Income (loss) before income tax expense (benefit)	9,570	16,874	4,967	31,308
Reportable Segment
Segment Reporting Information [Line Items]
Net sales	126,671	143,501	248,044	279,429
Segment operating income (loss)	9,076	16,507	8,390	29,739
Equity income in unconsolidated joint ventures	1,305	1,323	1,962	2,751
Other income (expense), net	261	280	122	1,629
Net realized investment gain (loss)		29	(3,245)	32
Interest income (expense), net	(1,072)	(1,265)	(2,262)	(2,843)
Income (loss) before income tax expense (benefit)	9,570	16,874	4,967	31,308
Reportable Segment | High Performance Foams
Segment Reporting Information [Line Items]
Net sales	43,329	44,021	83,763	83,156
Segment operating income (loss)	5,708	6,658	7,153	11,293
Reportable Segment | Printed Circuit Materials
Segment Reporting Information [Line Items]
Net sales	40,533	43,375	79,914	86,228
Segment operating income (loss)	3,123	4,405	2,777	9,234
Reportable Segment | Power Electronics Solutions | Curamik Electronics Solutions
Segment Reporting Information [Line Items]
Net sales	23,908	34,613	48,200	67,510
Segment operating income (loss)	(1,205)	2,855	(2,978)	3,157
Reportable Segment | Power Electronics Solutions | Power Distribution Systems
Segment Reporting Information [Line Items]
Net sales	11,573	13,978	22,089	26,413
Segment operating income (loss)	135	1,644	(515)	3,909
Reportable Segment | Other
Segment Reporting Information [Line Items]
Net sales	7,328	7,514	14,078	16,122
Segment operating income (loss)	$ 1,315	$ 945	$ 1,953	$ 2,146

XML

Inventories (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Schedule of Inventory [Line Items]
Raw materials	$ 30,517	$ 30,655
Work-in-process	15,982	14,919
Finished goods	28,179	32,746
Inventories	$ 74,678	$ 78,320

XML

Hedging Transactions and Derivative Financial Instruments

6 Months Ended

Jun. 30, 2012

Hedging Transactions and Derivative Financial Instruments

Note 3 – Hedging Transactions and Derivative Financial Instruments

The guidance for the accounting and disclosure of derivatives and hedging transactions requires companies to recognize all of their derivative instruments as either assets or liabilities at fair value in the condensed consolidated statements of financial position.  The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies for special hedge accounting treatment as defined under the applicable accounting guidance.  For derivative instruments that are designated and qualify for hedge accounting treatment (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss).  This gain or loss is reclassified into earnings in the same line item of the condensed consolidated statements of comprehensive (loss) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings.  The remaining gain or loss on the derivative instrument in excess of the cumulative change in the present value of the future cash flows of the hedged item (i.e., the ineffective portion) if any, is recognized in the condensed consolidated statements of comprehensive income (loss) during the current period. 

As of the end of the second quarter of 2012, we have two contracts in place to hedge our exposure related to the purchase of copper at our German subsidiary, Curamik.  These contracts are held with financial institutions and minimize our risk associated with a potential rise in copper prices.  These two contracts cover our 2012 monthly copper exposure and qualify for hedge accounting treatment; therefore, any mark-to-market adjustments on these contracts are recorded in accumulated other comprehensive income (loss) in the equity section of our condensed consolidated statements of financial position. At June 30, 2012, the term loan debt represents $95.0 million of our outstanding facility.  The interest rate swap results in the variable portion of the interest rate for this portion of the debt being fixed at 0.075% for the period from July 2013 to June 2016. (At June 30, 2012, the rate charged on this debt is 0.25% on the variable portion of the rate plus a spread of 2.25%.)

In July 2012, we entered into an interest rate swap derivative instrument to hedge the variable portion of the interest rate on 65% of the term loan debt, effective July 2013. This transaction has been designated as a cash flow hedge.  

Notional Value of Copper Derivatives
Copper	70 metric tons per month

(Dollars in thousands)	The Effect of Current Derivative Instruments on the Financial Statements for the six-month period ended June 30, 2012				Fair Values of Derivative Instruments as of June 30, 2012
Foreign Exchange Option Contracts	Location of gain (loss)	Amount of gain (loss)			Other Assets (Liabilities)
Contracts not designated as hedging instruments	Other income, net	$	81		$	-
Copper Derivative Instruments
Contracts designated as hedging instruments	Other comprehensive income (loss)		(82	)		(82	)

Concentration of Credit Risk

By using derivative instruments, we are subject to credit and market risk.  If a counterparty fails to fulfill its performance obligations under a derivative contract, our credit risk will equal the fair value of the derivative instrument. Generally, when the fair value of a derivative contract is positive, the counterparty owes the Company, thus creating a receivable risk for the Company. We minimize counterparty credit (or repayment) risk by entering into derivative transactions with major financial institutions of investment grade credit rating.

XML

Joint Ventures - Additional Information (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012 Entity	Jun. 30, 2011	Jun. 30, 2012 Entity	Jun. 30, 2011
Schedule of Equity Method Investments [Line Items]
Number of joint ventures that are 50% owned	2		2
Equity income related to joint ventures	$ 1,305	$ 1,323	$ 1,962	$ 2,751
Rogers INOAC Corporation
Schedule of Equity Method Investments [Line Items]
Ownership interest in joint venture	50.00%		50.00%
Rogers INOAC Suzhou Corporation
Schedule of Equity Method Investments [Line Items]
Ownership interest in joint venture	50.00%		50.00%

XML

Notional Values of Derivative Instruments (Detail)	Jun. 30, 2012
Derivative [Line Items]
Notional Value of Copper Derivatives	70

XML

Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Comprehensive Income (Loss)

Comprehensive income (loss) for the periods ended June 30, 2012 and 2011 were as follows:

	Three Months Ended					Six Months Ended
(Dollars in thousands)	June 30,			June 30,		June 30,			June 30,
	2012			2011		2012			2011
Net income (loss)	$	6,455		$	12,128	$	4,646		$	21,563
Foreign currency translation adjustments		(10,857	)		6,298		(4,886	)		21,262
Unrealized gain (loss) on marketable securities, net of tax		-			420		1,168			501
Unrealized gain (loss) on derivative instruments, net of tax		(43	)		-		212			-
Comprehensive income (loss)	$	(4,445	)	$	18,846	$	1,140		$	43,326

Accumulated Balances Related to Each Component of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) at June 30, 2012 and December 31, 2011 were as follows:

	June 30,			December 31,
(Dollars in thousands)	2012			2011
Foreign currency translation adjustments	$	989		$	5,875
Funded status of pension plans and other postretirement benefits, net of tax		(67,239	)		(67,239	)
Unrealized gain (loss) on derivative instruments, net of tax		(58	)		(270	)
Unrealized gain (loss) on marketable securities, net of tax		-			(1,168	)
Accumulated other comprehensive income (loss)	$	(66,308	)	$	(62,802	)

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2012

Inventories

Inventories were as follows:

	June 30,		December 31,
(Dollars in thousands)	2012		2011
Raw materials	$	30,517	$	30,655
Work-in-process		15,982		14,919
Finished goods		28,179		32,746
	$	74,678	$	78,320

XML

Time Based Restricted Stock Awards (Detail) (Time Based Restricted Stock)	6 Months Ended
	Jun. 30, 2012
Time Based Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested awards outstanding at beginning balance	86,707
Awards granted	46,180
Stock issued	(980)
Awards forfeited	(3,782)
Non-vested awards outstanding ending balance	128,125

XML

Effect and Fair Value of Derivative Instruments (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012
Foreign Exchange Option Contracts
Derivative [Line Items]
Foreign exchange option contracts not designated as hedging instruments, amount of gain (loss)	$ 81
Foreign exchange option contracts not designated as hedging instruments, fair value
Copper Derivative Instruments
Derivative [Line Items]
Copper derivative instruments contracts designated as hedging instruments, amount of gain (loss)	(82)
Copper derivative instruments designated as hedging instruments	$ (82)

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2012

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:

(In thousands, except per share amounts)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Numerator:
Income (loss)	$	6,455	$	13,432	$	4,754	$	24,497
Denominator:
Denominator for basic earnings per share -
Weighted-average shares		16,309		15,945		16,271		15,919
Effect of dilutive stock options		555		733		572		685
Denominator for diluted earnings per share - Adjusted
weighted-average shares and assumed conversions		16,864		16,678		16,843		16,604
Basic income (loss) per share:	$	0.40	$	0.84	$	0.29	$	1.54
Diluted income (loss) per share:		0.38		0.81		0.28		1.48

Anti-dilutive shares and Potential Ordinary Shares That Were Not Otherwise Antidilutive excluded From Calculation of Diluted Weighted Average Shares Outstanding

	Three Months Ended
	June 30, 2012		June 30, 2011
Anti-dilutive shares excluded		932,104		722,903

XML

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2012

Fair Value of Options Granted Calculated Using Weighted Average Assumptions

The fair value of options granted during the three and six month periods ended June 30, 2012 and 2011 were calculated using the following weighted-average assumptions:

	Three Months Ended					Six Months Ended
	June 30, 2012		June 30, 2011			June 30, 2012			June 30, 2011
Options granted		-		58,550			46,950			58,550
Weighted average exercise price	$	-	$	47.89		$	41.27		$	47.89
Weighted-average grant date fair value		-		22.30			19.08			22.30
Assumptions:
Expected volatility		-		45.15	%		47.70	%		45.15	%
Expected term (in years)		-		6.0			5.9			6.0
Risk-free interest rate		-		2.64	%		1.43	%		2.64	%
Expected dividend yield		-		-			-			-

Summary of Activity Under Stock Option Plans

A summary of the activity under our stock option plans as of June 30, 2012 and changes during the three and six month periods then ended, is presented below:

	Options Outstanding			Weighted- Average  Exercise Price Per Share		Weighted-Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options outstanding at March 31, 2012		2,440,999		$	37.59		4.9	$	14,667,018
Options granted		-			-
Options exercised		(112,531	)		29.74
Options cancelled		(28,999	)		46.78
Options outstanding at June 30, 2012		2,299,469			38.07		4.8		14,513,131
Options exercisable at June 30, 2012		1,594,269			41.39		3.7		7,279,532
Options vested or expected to vest at June 30, 2012*		2,273,222			38.19		4.7		14,247,752

* In addition to the vested options, we expect a portion of the unvested options to vest at some point in the future.  Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options.

	Options Outstanding			Weighted- Average Exercise Price Per Share
Options outstanding at December 31, 2011		2,401,809		$	37.54
Options granted		46,950			41.27
Options exercised		(116,491	)		29.72
Options cancelled		(32,799	)		44.06
Options outstanding at June 30, 2012		2,299,469

Performance-Based Restricted Stock

Restricted Stock Activities

	Performance Based Restricted Stock Awards
Non-vested awards outstanding at December 31, 2011		101,730
Awards granted		22,120
Stock issued		(43,750	)
Awards forfeited		(6,642	)
Non-vested awards outstanding at  June 30, 2012		73,458

Deferred Stock Units

Restricted Stock Activities

	Deferred Stock Units
Non-vested awards outstanding at December 31, 2011		27,350
Awards granted		17,600
Stock issued		(14,800	)
Awards forfeited		-
Non-vested awards outstanding at  June 30, 2012		30,150

Time Based Restricted Stock

Restricted Stock Activities

	Time-Based Restricted Stock Awards
Non-vested awards outstanding at December 31, 2011		86,707
Awards granted		46,180
Stock issued		(980	)
Awards forfeited		(3,782	)
Non-vested awards outstanding at  June 30, 2012		128,125

XML

Fair Value Measurements

6 Months Ended

Jun. 30, 2012

Fair Value Measurements

Note 2 –Fair Value Measurements

The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

● Level 1 – Quoted prices in active markets for identical assets or liabilities.

● Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

● Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

From time to time we enter into various instruments that require fair value measurement, including foreign currency option contracts and copper derivative contracts.

(Dollars in thousands)	Carrying amount as of June 30, 2012			Level 1		Level 2			Level 3
Foreign currency option contracts	$	-		$	-	$	-		$	-
Copper derivative contracts		(82	)		-		(82	)		-

Auction Rate Securities

During the first quarter of 2012, we liquidated our auction rate security portfolio, receiving net proceeds of $25.4 million on a stated par value of $29.5 million.  As a result of this liquidation, we recognized a loss on the discount of the securities of $3.2 million (the remaining difference between the liquidation and par value of $0.9 million had previously been recognized as an impairment loss) in our condensed consolidated statements of comprehensive income (loss). Since the markets for these securities failed in the first quarter of 2008, we had redeemed $24.9 million of these securities, mostly at par prior to the liquidation in the first quarter of 2012.  Since par value redemptions had slowed in recent quarters with no clear path for full redemption over the next several years and the rate of return on these securities was very low, management determined that a discounted redemption in the first quarter of 2012 was in the best interests of the Company as the cash could be better utilized for other purposes going forward.

Prior to the first quarter of 2012, we had recognized an Other–than-temporary impairment (OTTI) on these securities. An OTTI is recognized in earnings for a security in an unrealized loss position when an entity either (a) has the intent to sell the security or (b) more likely than not will be required to sell the security before its anticipated recovery.  

When an OTTI of a security occurs, the amount of the OTTI recognized in earnings depends on whether the security holder intended to sell the security or it is more likely than not that the holder would be required to sell the security before recovery of its cost basis. If the holder does not intend to sell the security and it is not more likely than not that the holder would be required to sell the security before the recovery of its cost basis, the other-than-temporary loss would be separated into (i) the amount representing the credit loss and (ii) the amount related to all other factors.  The amount representing the credit loss would be recognized in earnings, and, the remaining amount would be recorded in other comprehensive income. This is the approach we used to recognize the OTTI taken prior to liquidation in the first quarter of 2012.  The amount representing the credit loss would have been recognized in earnings, and as long as the factors above were not met, the remaining amount would have been recorded in other comprehensive income.

Prior to the first quarter of 2008, our available-for-sale auction rate securities were recorded at fair value as determined in the active market at the time.  However, due to events in the credit markets, the auctions failed during the first quarter of 2008 for the auction rate securities that we held at the end of the first quarter of 2008, and all of our auction rate securities had been in a loss position since that time until we redeemed them in the first quarter of 2012. Given the lack of unobservable inputs in the auction markets since the first quarter of 2008, such securities were considered Level 3 securities.

Due to our belief that it would have taken more than twelve months for the auction rate securities market to recover, these securities were classified as long-term assets, except for those that were scheduled to be redeemed within a twelve month period, which were classified as short-term investments.

The reconciliation of our assets measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:

(Dollars in thousands)	Auction Rate Securities
Balance at December 31, 2011	$	25,960
Cash received for redemptions at par		-
Cash received for redemptions below par		(25,438	)
Reclassified from other comprehensive income		2,723
Reported in earnings		(3,245	)
Balance at June 30, 2012	$	-

There were no credit losses recognized for the six months ended June 30, 2012.  Below is a roll forward of credit losses recognized in earnings for the six months ended June 30, 2011.

(Dollars in thousands)
	Credit Losses
Balance at December 31, 2010	$	917
Credit losses recorded		39
Reduction in credit losses due to redemptions		(71	)
Balance at June 30, 2011	$	885

Derivatives Contracts

As of June 30, 2012, the carrying value of our derivative instruments was approximately $0.1 million.  As further explained below in Note 3, “Hedging Transactions and Derivative Financial Instruments”, we are exposed to certain risks relating to our ongoing business operations.  The primary risks being managed through the use of derivative instruments are foreign currency exchange rate risk and commodity pricing risk, particularly related to copper pricing.  The fair value of any foreign currency option derivatives is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics.  As of June 30, 2012, we did not have any outstanding foreign currency derivative contracts.

The fair value of the copper derivatives is computed using a combination of intrinsic and time value valuation models.  The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end.  The time value valuation model incorporates the constant changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative's strike price and the remaining time to the underlying copper derivative instrument's expiration date from the period end date.  Overall, fair value is a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate, and volatility.  We do not use derivative financial instruments for trading or speculation purposes.

XML

Pension Benefit and Other Postretirement Benefit Plans (Tables)

6 Months Ended

Jun. 30, 2012

Components of Net Periodic Benefit Cost

The components of net periodic benefit cost for the periods indicated are:

(Dollars in thousands)

(Dollars in thousands)
	Pension Benefits												Retirement Health and Life Insurance Benefits
	Three Months Ended						Six Months Ended						Three Months Ended						Six Months Ended
Change in benefit obligation:	June 30,			June 30,			June 30,			June 30,			June 30,			June 30,			June 30,			June 30,
	2012			2011			2012			2011			2012			2011			2012			2011
Service cost	$	1,108		$	1,060		$	2,297		$	2,120		$	149		$	176		$	331		$	352
Interest cost		2,124			2,116			4,242			4,232			92			97			180			194
Expected return on plan assets		(2,495	)		(2,591	)		(4,903	)		(5,182	)		-			-			-			-
Amortization of prior service cost		116			150			232			300			(113	)		(157	)		(226	)		(314	)
Amortization of net loss		1,442			553			2,791			1,106			66			81			181			162
Special termination benefit		-			-			-			-			-			-			2,300			-
Adjustment to termination benefit		-			-			-			-			(707	)		-			(707	)		-
Net periodic benefit cost	$	2,295		$	1,288		$	4,659		$	2,576		$	(513	)	$	197		$	2,059		$	394

XML

Reconciliation of Assets Measured at Fair Value on Recurring Basis using Unobservable Inputs Level 3 (Detail) (Auction Rate Securities, USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning Balance	$ 25,960
Reclassified from other comprehensive income	2,723
Reported in earnings	(3,245)
Securities Redeemed at Less Than Par Value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash received for redemptions	$ (25,438)

XML

Fair Value of Options Granted Calculated Using Weighted Average Assumptions (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted		58,550	46,950	58,550
Weighted average exercise price		$ 47.89	$ 41.27	$ 47.89
Weighted-average grant date fair value		$ 22.30	$ 19.08	$ 22.30
Assumptions:
Expected volatility		45.15%	47.70%	45.15%
Expected term (in years)		6 years	5 years 10 months 24 days	6 years
Risk-free interest rate		2.64%	1.43%	2.64%
Expected dividend yield

XML

Commitments and Contingencies - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended	12 Months Ended		12 Months Ended					3 Months Ended			3 Months Ended			3 Months Ended			3 Months Ended		6 Months Ended	3 Months Ended	6 Months Ended
	Jun. 30, 2012 LegalMatter	Dec. 31, 2011 LegalMatter	Mar. 31, 2012	Dec. 31, 2010 Minimum LegalMatter	Dec. 31, 2010 Maximum LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought LegalMatter	Jun. 30, 2012 Claims that Cite Jurisdictional Amounts LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Minimum LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Maximum LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 1 LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 1 Compensatory	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 1 Punitive	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 2 LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 2 Compensatory	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 2 Punitive	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 3 LegalMatter	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 3 Compensatory	Jun. 30, 2012 Claims that Specify Amount of Damages Sought not Based on Jurisdictional Requirements Legal Claim 3 Punitive	Jun. 30, 2012 Superfund Sites Proceedings LegalMatter	Mar. 31, 2010 PCB Contamination Proceedings	Jun. 30, 2012 PCB Contamination Proceedings	Jun. 30, 2012 PCB Contamination Proceedings Building
Commitments and Contingencies Disclosure [Line Items]
Number of pending claims	298	242				71	224	3			1			1			1			1
Estimated total cleanup costs, cost sharing percentage																				2.00%
Loss contingency, minimum possible loss																				$ 17.0	$ 1.0
Loss contingency, maximum possible loss																				24.0	2.6
Estimated total cleanup costs, accrual	0.3
Estimated total cleanup costs, insurance receivable																				0.3
Remediation and monitoring costs incurred since inception related to the PCB soil and building contamination																						2.5	0.3
PCB contamination of the building, liability recording during the period																					1.0
Percentage of pending claims								1.00%
Damages sought												20	20		65	60		1	1
Number of defendants				1	833				10	109
Description of named defendants	Cases involving us typically name 50-300 defendants
Number of claims dismissed	44	120
Number of claims settled	8	8
Claims settlements amount	3.1	8.1
Period for recognizing a reserve for future costs	5 years
Cost Sharing Agreement, Expiration Period	4 years
Cost Sharing Agreement, expiration date	Jan. 25, 2015
Asbestos-related liabilities, estimated liability		28.8	27.9
Asbestos-related liabilities, estimated insurance recovery		$ 28.4	$ 27.7

XML

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net sales	$ 126,671	$ 143,501	$ 248,044	$ 279,429
Cost of sales	89,799	94,930	174,731	188,316
Gross margin	36,872	48,571	73,313	91,113
Selling and administrative expenses	22,468	26,436	46,862	50,537
Research and development expenses	4,498	5,628	9,847	10,837
Restructuring and impairment charges	830		8,214
Operating income (loss)	9,076	16,507	8,390	29,739
Equity income in unconsolidated joint ventures	1,305	1,323	1,962	2,751
Other income (expense), net	261	280	122	1,629
Realized investment gain (loss):
Increase (decrease) in fair value of investments		602	(522)	699
Less: Portion reclassified to/from other comprehensive income		573	2,723	667
Net realized gain (loss)		29	(3,245)	32
Interest income (expense), net	(1,072)	(1,265)	(2,262)	(2,843)
Income (loss) before income tax expense (benefit)	9,570	16,874	4,967	31,308
Income tax expense (benefit)	3,115	3,442	213	6,811
Income (loss) from continuing operations	6,455	13,432	4,754	24,497
Income (loss) from discontinued operations, net of income taxes		(1,304)	(108)	(2,934)
Net income (loss)	6,455	12,128	4,646	21,563
Basic net income (loss) per share:
Income (loss) from continuing operations	$ 0.40	$ 0.84	$ 0.29	$ 1.54
Income (loss) from discontinued operations		$ (0.08)	$ (0.01)	$ (0.18)
Net income (loss)	$ 0.40	$ 0.76	$ 0.28	$ 1.36
Diluted net income (loss) per share:
Income (loss) from continuing operations	$ 0.38	$ 0.81	$ 0.28	$ 1.48
Income (loss) from discontinued operations		$ (0.08)	$ (0.01)	$ (0.18)
Net income (loss)	$ 0.38	$ 0.73	$ 0.27	$ 1.30
Comprehensive income (loss)	$ (4,445)	$ 18,846	$ 1,140	$ 43,326
Shares used in computing:
Basic	16,309,053	15,944,483	16,270,955	15,918,978
Diluted	16,864,166	16,678,377	16,842,768	16,603,543

XML

Acquisition of Business - Additional Information (Detail) (Curamik Electronics GmbH, USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2011	Dec. 31, 2010	Jun. 30, 2012	Jan. 04, 2011
Curamik Electronics GmbH
Business Acquisition [Line Items]
Acquisition of business, aggregate purchase price				$ 151.1
Acquisition of business, total costs incurred			3.4
Acquisition costs incurred during period	$ 1.3	$ 2.1

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Operating Activities:
Net income (loss)	$ 4,646	$ 21,563
Loss (earnings) from discontinued operations	108	2,934
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	13,561	13,149
Stock-based compensation expense	2,678	3,610
Loss from long-term investments	3,245
Deferred income taxes	(1,050)	2,148
Equity in undistributed income of unconsolidated joint ventures, net	(1,962)	(2,751)
Dividends received from unconsolidated joint ventures	2,929	2,762
Pension and postretirement benefits	6,718	2,970
Gain from the sale of property, plant and equipment	(579)	(1,900)
Impairment of assets	539
Amortization of inventory fair value		1,805
Changes in operating assets and liabilities excluding effects of acquisition and disposition of businesses:
Accounts receivable	(3,340)	(12,114)
Accounts receivable, joint ventures	(778)	(917)
Inventories	3,018	(12,107)
Pension contribution	(16,000)
Other current assets	(3,331)	(3,203)
Accounts payable and other accrued expenses	(7,433)	(22,097)
Other, net	1,332	767
Net cash provided by (used in) operating activities of continuing operations	4,301	(3,381)
Net cash provided by (used in) operating activites of discontinued operations		(2,979)
Net cash provided by (used in) operating activites	4,301	(6,360)
Investing Activities:
Capital expenditures	(10,767)	(8,006)
Proceeds from short-term investments	25,438	4,000
Proceeds from the sale of property, plant and equipment, net	1,979	5,900
Deferred purchase price for previous acquisition of business	(3,100)
Acquisition of business, net of cash received		(139,825)
Net cash provided by (used in) investing activities of continuing operations	13,550	(137,931)
Financing Activities:
Proceeds from long term borrowings		145,000
Repayment of debt principal and long term lease obligation	(2,992)	(10,000)
Payment of long term borrowings acquired through acquisition		(7,452)
Proceeds from sale of capital stock, net	3,427	5,464
Issuance of restricted stock shares	(571)
Proceeds from issuance of shares to employee stock purchase plan	413	396
Net cash provided by (used in) financing activities of continuing operations	277	133,408
Effect of exchange rate fluctuations on cash	(2,070)	2,395
Net increase (decrease) in cash and cash equivalents	16,058	(8,488)
Cash and cash equivalents at beginning of year	79,728	80,135
Cash and cash equivalents at end of quarter	95,786	71,647
Supplemental disclosure of noncash investing and financing activities
Capital lease obligation acquired through acquisition		$ 10,831

XML

Pension Benefit and Other Postretirement Benefit Plans - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Mar. 31, 2012	Jun. 30, 2011	Sep. 30, 2012 President and Chief Executive Officer	Mar. 31, 2012 Retirement Health and Life Insurance Benefits	Jun. 30, 2012 Retirement Health and Life Insurance Benefits
Pension and Other Postretirement Benefits Disclosure [Line Items]
Special termination benefit				$ 2,100,000	$ 1,600,000	$ 2,300,000
Defined benefit plan, one-time cash payment				6,000,000
Defined benefit pension plans, voluntary contributions	$ 6,000,000	$ 10,000,000	$ 0

XML

Debt (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Maturities of Long-term Debt

2016.  The aggregate payments due are as follows:

2011	$2.5 million
2012	$7.5 million
2013	$12.5 million
2014	$17.5 million
2015	$35.0 million
2016	$25.0 million

Fixed Charge Metrics

Relevant Fixed Charge metrics are detailed in the table below.

Periods	Q4 2011	Q1 2012	Q2 2012
Covenant Limit	2.5x	1.25x	1.25x
Actual FCCR	2.60	2.27	2.09

XML

Debt - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended			6 Months Ended				1 Months Ended					1 Months Ended	6 Months Ended	12 Months Ended		1 Months Ended
	Nov. 30, 2010	Jun. 30, 2012	Jun. 30, 2011	Mar. 31, 2011	Jun. 30, 2012	Jun. 30, 2011	Jul. 13, 2011	Nov. 23, 2010	Jul. 31, 2011 Credit Agreement	Jun. 30, 2012 Credit Agreement	Jul. 13, 2011 Credit Agreement	Jun. 30, 2012 Bank Term Loan	Jul. 31, 2012 Bank Term Loan Cash Flow Hedging [Member] Subsequent Event	Jul. 31, 2011 Amended Credit Facility	Jun. 30, 2012 Amended Credit Facility	Dec. 31, 2011 Amended Credit Facility	Jul. 13, 2011 Amended Credit Facility	Jul. 31, 2011 Amended Credit Facility Minimum	Jul. 31, 2011 Amended Credit Facility Maximum	Jul. 13, 2011 Amended Credit Facility Federal Funds Rate	Jul. 13, 2011 Amended Credit Facility One Month LIBOR	Jul. 13, 2011 Amended Credit Facility Bank Term Loan	Jul. 13, 2011 Eurocurrency loans Credit Agreement
Debt Instrument [Line Items]
Credit agreement, maximum borrowing capacity								$ 165,000,000									$ 265,000,000					$ 100,000,000
Credit agreement, agreement period																	5 years
Credit agreement, maturity date	Nov. 23, 2014													Jul. 13, 2016
Reduction in interest costs																	0.25%
Size of permitted acquisitions								25,000,000									100,000,000
Permitted additional indebtedness								20,000,000									120,000,000
Revolving credit outstanding borrowings							100,000,000								25,000,000
Debt Instrument Lower Range Basis Spread On Variable Rate											0.75%									0.50%
Debt Instrument Higher Range Basis Spread On Variable Rate											1.50%										1.00%
Line of credit, interest rate description									The base reference rate is the greater of the (1) prime rate; (2) federal funds effective rate plus 50 basis points; and (3) adjusted 1-month London interbank offered ("LIBO") rate plus 100 basis points.
Line of credit, LIBOR rate, minimum spread																							1.75%
Line of credit, LIBOR rate, maximum spread																							2.50%
Unused commitment fee percentage																		0.20%	0.35%
Payments commencement date														Sep. 30, 2011
Covenants, leverage ratio										3.0
Leverage ratio		1.6			1.6
Capitalized debt issuance costs		100,000			100,000			2,300,000
Amortization expense, debt issue costs		100,000	100,000		200,000	200,000
Capitalized debt issuance costs, net		2,000,000			2,000,000
Amount drawn on the line of credit to fund the acquisition of Curamik				145,000,000
Repayment of debt principal					2,992,000	10,000,000									2,500,000	22,500,000
Required payment on debt obligation within the next 12 months					10,000,000
Anticipate payment on debt obligation within the next 12 months					27,500,000
Term loan debt												95,000,000			95,000,000
Irrevocable standby letters of credit		1,100,000			1,100,000
Letter guarantee		600,000			600,000
Option to buy out capital lease, year					2013
Capital lease, expiration date					2021
Capital lease obligation		8,500,000			8,500,000
Amortization expense related to the capital lease		100,000	100,000		200,000	200,000
Interest expense on outstanding debt		700,000	1,000,000		1,500,000	2,100,000
Unused commitment fee		100,000	200,000		200,000	400,000
Interest rate swap derivative, percentage of debt hedged													65.00%
Interest rate swap, fixed interest rate for period from July 2013 to June 2016												0.75%
Interest expense on capital lease		$ 400,000	$ 300,000		$ 800,000	$ 700,000

XML

Restructuring/ Impairment Charges

6 Months Ended

Jun. 30, 2012

Restructuring/ Impairment Charges

Note 16 – Restructuring/ Impairment Charges

In the first half of 2012, we began several initiatives to streamline our organization and rationalize our cost structure in order to better position the Company for profitable growth in the future.  The goal of these initiatives is to become a more streamlined organization both from an organizational and cost perspective, with efficient manufacturing capabilities that is focused on meeting our customer’s needs.

First Quarter 2012:

In the first quarter of 2012, weannounced several initiatives as part of the streamlining plan. These initiatives included the following:

● Implementing an early retirement program for certain eligible employees;

● Realigning our organizational structure by consolidating a number of senior executive positions, reorganizing certain business functions and redeploying resources across the Company;

● Exiting the Thermal Management Solutions business (previously announced in the fourth quarter of 2011);

● Initiating a plan to shut down the Power Distribution Systems startup operation in North America, which is anticipated to be completed in the third quarter of 2012; and

● Liquidating our remaining auction rate securities.

Second Quarter 2012:

In the second quarter of 2012, we announced several additional streamlining actions as follows:

● We announced the shutdown of the High Performance Foams manufacturing facility in Bremen, Germany, which is scheduled to be completed by the end of 2012.  The manufacture of certain silicone foam materials produced in the Bremen facility will be consolidated into our existing facility in Carol Stream, Illinois.  The expenses and charges related to the termination of the operations at the Bremen facility are estimated to be approximately $3.1 million and are comprised primarily of (i) $0.9 million for the early termination of the lease on the building; (ii) $0.8 million for severance charges for employees in Bremen; (iii) $1.1 million  impairment of certain assets; and (iv) $0.3 million of costs to remove and transport certain equipment to Carol Stream and prepare the building for return to the landlord.  We recognized approximately $1.5 million of these charges in the second quarter of 2012, and expect to recognize the remaining charges in the second half of 2012.

● We made the decision to cease production of our non-woven composite materials products in an effort to redeploy resources to focus on our Core Strategic segments.  Sales of these products have been steadily declining for several years and totaled approximately $1.4 million in the second quarter of 2012 and $4.8 million in fiscal 2011.  The shutdown of production is expected to occur by the end of 2012 and is not expected to have a material impact on our overall operations.  No material charges are expected from this initiative.

The following table summarizes the restructuring and impairment charges related to these activities recorded in our operating results in the second quarter and first six months of 2012.

(Dollars in thousands)
	Three Months Ended			Six Months Ended
Cost of Sales	June 30, 2012			June 30, 2012
High Performance Foams
Accelerated depreciation expense related to Bremen shut-down	$	585		$	585
Inventory impairment related to Bremen shut-down		191		$	191
Power Distribution Systems
Accelerated depreciation expense related to U.S. shut-down		360			360
Total charges for cost of sales	$	1,136		$	1,136
Restructuring and Impairment
High Performance Foams
Fixed asset impairment for Bisco and Poron asset disposal	$	-		$	79
Severance and related costs (1)		670		$	3,088
Power Distribution Systems
Impairment of investment related receivable		264			264
Severance and related costs (1)		(13	)		477
Printed Circuit Materials
Severance and related costs (1)		(276	)	$	3,046
Curamik Electronics Solutions
Severance and related costs (1)		213			957
Other
Severance and related costs (1)		(28	)		303
Total charges for restructuring and impairment	$	830		$	8,214

(1) For the three and six month periods ended June 30, 2012, this line item includes an estimated change of 2.3 million recorded in the first quarter of 2012, offest by a favorable adjustment of $0.7 million recorded in the second quarter of 2012. Total net charge of $1.6 million, for the first six months of 2012, was related to the early retirement program implemented in the first quarter of 2012.

A summary of the activity in the severance accrual as of June 30, 2012 and changes during the three month period then ended is as follows:

(Dollars in thousands)
	June 30, 2012
Balance at March 31, 2012	$	4,545
Provisions		1,273
Payments		(1,911	)
Balance at June 30, 2012	$	3,907

XML

Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2012

Intangible Assets

Definite Lived Intangible Assets

(Dollars in thousands)	June 30, 2012						December 31, 2011
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trademarks and patents	$	1,006	$	177	$	829	$	879	$	140	$	739
Technology		35,095		6,335	$	28,760		35,769		4,655		31,114
Covenant-not-to-compete		968		235	$	733		956		135		821
Customer relationships		19,544		1,625	$	17,919		19,851		1,315		18,536
Total other intangible assets	$	56,613	$	8,372	$	48,241	$	57,455	$	6,245	$	51,210

Weighted Average Amortization Period, by Intangible Asset Class

The weighted average amortization period as of June 30, 2012, by intangible asset class, is presented in the table below:

Intangible Asset Class	Weighted Average Amortization Period
Trademarks and patents	9.1
Technology	6.1
Covenant not-to-compete	3.7
Customer relationships	9.3
Total other intangible assets	7.3

Changes in the Carrying Amount of Goodwill, by Segment

The changes in the carrying amount of goodwill for the period ending June 30, 2012, by reportable segment, are as follows:

(Dollars in thousands)	High Performance Foams		Printed Circuit Materials		Curamik Electronics Solutions			Power Distribution Systems		Other		Total
December 31, 2011	$	22,597	$	-	$	77,357		$	-	$	2,224	$	102,178
Foreign currency translation adjustment
		195		-		(1,779	)		-		-		(1,584	)
June 30, 2012	$	22,792	$	-	$	75,578		$	-	$	2,224	$	100,594

XML

Subsequent Events

6 Months Ended

Jun. 30, 2012

Subsequent Events

Note 18 – Subsequent Events

On July 17, 2012, we committed to a plan to move Curamik’s final inspection operations of our indirect wholly owned subsidiary Curamik Electronics GmbH (“Curamik”) from Curamik’s manufacturing site in Eschenbach, Germany to Hungary.  The move is expected to enable more cost effective performance of the inspecting operations, which is an important part of Curamik’s manufacturing process for direct bonded copper ceramic substrates.  We expect the move to be substantially complete by the end of 2012 or early in 2013 and related expenses and charges will be incurred over that time period.  These expenses and charges, which cannot be reasonably estimated at this time, will include, without limitation, the following major components: (i) costs associated with the separation from employment of employees at the Eschenbach facility; and; (ii) costs to start up the new facility in Hungary.

XML

Intangible Assets (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 56,613	$ 57,455
Accumulated Amortization	8,372	6,245
Net Carrying Amount	48,241	51,210
Trademarks and patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,006	879
Accumulated Amortization	177	140
Net Carrying Amount	829	739
Technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	35,095	35,769
Accumulated Amortization	6,335	4,655
Net Carrying Amount	28,760	31,114
Covenant not-to-compete
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	968	956
Accumulated Amortization	235	135
Net Carrying Amount	733	821
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	19,544	19,851
Accumulated Amortization	1,625	1,315
Net Carrying Amount	$ 17,919	$ 18,536

XML

Basis of Presentation

6 Months Ended

Jun. 30, 2012

Basis of Presentation

Note 1 - Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.  In our opinion, the accompanying statements of financial position and related interim statements of comprehensive income (loss), statements of shareholders equity, and statements of cash flows include all normal recurring adjustments necessary for their fair presentation in accordance with U.S. generally accepted accounting principles.  All significant intercompany transactions have been eliminated.

For all periods and amounts presented, reclassifications have been made for discontinued operations. On December 31, 2011 the Thermal Management Solutions business, which had been a separate operating segment, was discontinued.  See Note 17-Discontinued Operations for further discussion.

Interim results are not necessarily indicative of results for a full year.  For further information regarding our accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in our Form 10-K for the fiscal year ended December 31, 2011.

XML

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Current assets
Cash and cash equivalents	$ 95,786	$ 79,728
Accounts receivable, less allowance for doubtful accounts of $1,315 and $1,040	81,767	77,682
Accounts receivable from joint ventures	2,418	1,640
Accounts receivable, other	3,325	3,819
Taxes receivable	1,719	2,713
Inventories	74,678	78,320
Prepaid income taxes	4,934	4,315
Deferred income taxes	1,893	2,146
Asbestos-related insurance receivables	6,471	6,459
Other current assets	9,989	7,360
Assets held for sale		1,400
Assets of discontinued operations		50
Total current assets	282,980	265,632
Property, plant and equipment, net of accumulated depreciation of $206,509 and $198,075	146,472	148,182
Investments in unconsolidated joint ventures	22,774	23,868
Deferred income taxes	20,650	20,117
Goodwill and other intangibles	153,835	158,627
Asbestos-related insurance receivables	21,262	21,943
Investments, other	5,000	5,000
Other long-term assets	8,189	8,299
Long-term marketable securities		25,960
Total assets	661,162	677,628
Current liabilities
Accounts payable	15,561	15,787
Accrued employee benefits and compensation	33,315	30,135
Accrued income taxes payable	31	1,799
Current portion of lease obligation	1,560	1,596
Current portion of long term debt	27,500	7,500
Asbestos-related liabilities	6,471	6,459
Other accrued liabilities	10,376	15,368
Liabilities of discontinued operations		153
Total current liabilities	94,814	78,797
Long term debt	92,500	115,000
Long term lease obligation	6,955	7,610
Pension liability	52,862	68,871
Retiree health care and life insurance benefits	9,486	9,486
Asbestos-related liabilities	21,468	22,326
Non-current income tax	18,628	17,588
Deferred income taxes	18,489	19,259
Other long-term liabilities	617	435
Shareholders' Equity
Capital Stock - $1 par value; 50,000,000 authorized shares; 16,395,739 and 16,220,648 shares outstanding	16,396	16,221
Additional paid-in capital	58,510	52,738
Retained earnings	336,745	332,099
Accumulated other comprehensive income (loss)	(66,308)	(62,802)
Total shareholders' equity	345,343	338,256
Total liabilities and shareholders' equity	$ 661,162	$ 677,628

XML

Joint Ventures

6 Months Ended

Jun. 30, 2012

Joint Ventures

Note 11 – Joint Ventures

As of June 30, 2012, we had two joint ventures, each 50% owned, which are accounted for under the equity method of accounting.

Joint Venture	Location	Reportable Segment	Fiscal Year-End
Rogers INOAC Corporation (RIC)	Japan	High Performance Foams	October 31
Rogers INOAC Suzhou Corporation (RIS)	China	High Performance Foams	December 31

Equity income of $1.3 million and $2.0 million for the three and six month periods ended June 30, 2012 and equity income of $1.3 million and $2.8 million for the three and six month periods ended June 30, 2011, respectively, is included in the condensed consolidated statements of comprehensive income (loss) related to the joint ventures.

The summarized financial information for the joint ventures for the periods indicated is as follows:

(Dollars in thousands)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net sales	$	15,880	$	16,783	$	28,685	$	34,863
Gross profit (loss)		2,608		3,211		4,433		7,535
Net income (loss)		2,610		2,646		3,924		5,502

The effect of transactions between us and our unconsolidated joint ventures was accounted for on a consolidated basis.  Receivables from and payables to joint ventures arise during the normal course of business from transactions between us and the joint ventures, typically from the joint venture purchasing raw materials from us to produce end products, which are sold to third parties, or from us purchasing finished goods from our joint ventures, which are then sold to third parties.

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2012	Jul. 23, 2012
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2
Trading Symbol	ROG
Entity Registrant Name	ROGERS CORP
Entity Central Index Key	0000084748
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		16,431,245

XML

Debt

6 Months Ended

Jun. 30, 2012

Debt

Note 12 - Debt

On July 13, 2011, we entered into an amended and restated $265 million secured five year credit agreement.  This credit agreement (“Amended Credit Agreement”) is with (i) JPMorgan Chase Bank, N.A., as administrative agent; (ii) HSBC Bank USA, National Association; (iii) RBS Citizens, National Association; (iv) Fifth Third Bank; and (v) Citibank, N.A.  JPMorgan Securities LLC and HSBC Bank USA, National Association acted as joint bookrunners and joint lead arrangers; HSBC Bank USA, National Association and RBS Citizens, National Association acted as co-syndication agents; and Fifth Third Bank and Citibank, N.A. acted as co-documentation agents.  The Amended Credit Agreement amends and restates the credit agreement signed between the Company and the same banks on November 23, 2010 and increased our borrowing capacity from $165.0 million under the original agreement to $265.0 million under the Amended Credit Agreement.

Key features of the Amended Credit Agreement, as compared to the November 23, 2010 credit agreement, include (1) an increase in credit from $165.0 million to $265.0 million with the addition of a $100.0 million term loan; (2) the extension of maturity from November 23, 2014 to July 13, 2016; (3) a 25 basis point reduction in  interest costs; (4) an increase in the size of permitted acquisitions from $25.0 million to $100.0 million; and (5) an increase in permitted additional indebtedness from $20.0 million to $120.0 million.

The Amended Credit Agreement provided for the extension of credit in the form of (1) a $100.0 million term loan (which refinances outstanding borrowings in the amount of $100.0 million from the existing revolving credit line), as further described below; and (2) up to $165.0 million of revolving loans, in multiple currencies, at any time and from time to time until the maturity of the Amended Credit Agreement, on July 13, 2016.  We may borrow, pre-pay and re-borrow amounts under the $165.0 million revolving portion of the Amended Credit Agreement; however, with respect to the $100.0 million term loan portion, any principal amounts re-paid may not be re-borrowed.  Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Amended Credit Agreement).  

Borrowings under the Amended Credit Agreement bear interest based on one of two options.  Alternate base rate loans bear interest that includes a base reference rate plus a spread of 75 - 150 basis points, depending on our leverage ratio.  The base reference rate is the greater of the (1) prime rate; (2) federal funds effective rate plus 50 basis points; and (3) adjusted 1-month London interbank offered (“LIBO”) rate plus 100 basis points.  Eurocurrency loans bear interest based on the adjusted LIBO rate plus a spread of 175 - 250 basis points, depending on our leverage ratio.

In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Amended Credit Agreement, the Company is required to pay a quarterly fee of 0.20% to 0.35% (based upon its leverage ratio) of the unused amount of the lenders’ commitments under the Amended Credit Agreement.  

In connection with the Amended Credit Agreement, we transferred borrowings in the amount of $100.0 million from the revolving credit line under the November 23, 2010 credit agreement to the term loan under the Amended Credit Agreement.  The Amended Credit Agreement requires the mandatory quarterly repayment of principal of amounts borrowed under such term loan.  Payments commenced on September 30, 2011, and are scheduled to be completed on June 30, 2016.  The aggregate payments due are as follows:

2011	$2.5 million
2012	$7.5 million
2013	$12.5 million
2014	$17.5 million
2015	$35.0 million
2016	$25.0 million

The Amended Credit Agreement is secured by many of the assets of Rogers and our World Properties, Inc, subsidiary, including but not limited to, receivables, equipment, intellectual property, inventory, stock in certain subsidiaries and real property.

As part of the Amended Credit Agreement, we are restricted in our ability to perform certain actions, including, but not limited to, our ability to pay dividends, incur additional debt, sell certain assets, and make capital expenditures, with certain exceptions.  Further, we are required to maintain certain financial covenant ratios, including a leverage ratio of no more than 3.0 to 1 and a minimum fixed charge coverage ratio (FCRR).  In the first quarter of 2012, through an amendment to the Amended Credit Agreement, the FCRR was modified from 2.5X to 1.25X of Adjusted EBITDA.  This ratio measures the Company’s ability to cover its fixed charge obligations.  The key components of fixed charges are capital expenditures, scheduled debt payments, capital lease payments, rent and interest expenses. Several factors contributed to the need for an amendment to this covenant.  The 2.5X ratio was based on a more robust set of financial projections, and these have moderated somewhat with the recent events in the marketplace and the overall global economy, particularly the situations in Europe and China.  Additionally, there were no mandatory term loan payments when the original ratio was determined. These would further stress the ratio.  Finally, an increase in planned capital investment added pressure to the ratio as well.

Relevant Fixed Charge metrics are detailed in the table below.

Periods	Q4 2011	Q1 2012	Q2 2012
Covenant Limit	2.5x	1.25x	1.25x
Actual FCCR	2.60	2.27	2.09

As of June 30, 2012, we were in compliance with all of our covenants, as we achieved actual ratios of approximately 1.6 on the leverage ratio and 2.09 on the fixed charge coverage ratio.

If an event of default occurs, the lenders may, among other things, terminate their commitments and declare all outstanding borrowings to be immediately due and payable together with accrued interest and fees.  We are in compliance with all financial and other covenants as of June 30, 2012.

In connection with the establishment of the initial credit in 2010, we capitalized approximately $2.3 million of debt issuance costs and, in connection to the Amended Credit Agreement, we capitalized an additional $0.1 million of debt issuance costs in 2012. These costs will be amortized over the life of the Amended Credit Agreement, as amended, which will terminate in June 2016.  We incurred amortization expense of $0.1 million in the second quarters of 2012 and 2011, respectively, and expenses of $0.2 million in the first six months of 2012 and 2011, respectively.  At June 30, 2012, we have approximately $2.0 million of credit facility costs remaining to be amortized.

In the first quarter of 2011, we made an initial draw on the line of credit of $145.0 million to fund the acquisition of Curamik.  During the first six months of 2012, we made principal payments of $2.5 million on the debt. We made $22.5 million of principal payments in fiscal 2011.  We are obligated to pay $10.0 million on this debt obligation within the next 12 months but anticipate paying down $27.5 million.  As of June 30, 2012, our outstanding debt related to the Amended Credit Agreement, as amended, consists of $95.0 million of term loan debt and $25.0 million on the revolving line of credit.  We have the option to pay part of or the entire amount at any time over the remaining life of the Amended Credit Agreement, as amended, with any balance due and payable at the agreement's expiration.

In addition, at June 30, 2012 we had the following standby letter of credit (LOC) and guarantee that were backed by the Amended Credit Agreement, as amended:

● $1.1 million letter of credit to guarantee Rogers workers compensation plan;

● $0.6 million letter guarantee to guarantee a payable obligation for a Chinese subsidiary (Rogers Suzhou).

No amounts were owed on the LOC or guarantee as of June 30, 2012 or December 31, 2011.

Capital Lease

During the first quarter of 2011, we recorded a capital lease obligation related to the acquisition of Curamik for its primary manufacturing facility in Eschenbach, Germany. We have an option to purchase the property in either 2013 or upon the expiration of the lease 2021 at a price which is the greater of (i) the then-current market value; and (ii) the fiscal residual book value of the land including the buildings and installations thereon. The total obligation recorded for the lease as of June 30, 2012 is $8.5 million.  Amortization expense related to the capital lease was $0.1 million in each of the three month periods ending June 30, 2012 and 2011, and $.2 million in each of the six month periods ending June, 30 2012 and 2011.  These expenses are included as depreciation expense in Cost of Sales on our condensed consolidated statements of other comprehensive income (loss).  Interest expense related to the debt recorded on the capital lease is included in interest expense on the condensed consolidated statements of other comprehensive income (loss).  (See “Interest” section below for further discussion.)

Interest

We incurred interest expense on our outstanding debt of $0.7 million and $1.5 million in the three and six month periods ended June 30, 2012, respectively, and $1.0 million and $2.1 million in the three and six months ended June 30, 2011, respectively.  We incurred an unused commitment fee of approximately $0.1 million and $0.2 million in the three and six month periods ended June 30, 2012, respectively, and of approximately $0.2 million and $0.4 million in the three and six month periods ended June 30, 2011.  In July 2012, we entered into an interest rate swap to hedge the variable interest rate on 65% of the term loan debt, effective July 2013.  At June 30, 2012, the term loan debt amounted to $95.0 million.  This interest rate swap results in the interest rate for this portion of the debt being set at 0.75% and is for the period from July 2013 to June 2016.

We also incurred interest expense on the capital lease of $0.4 million and $0.8 million in the three and six month periods ended June 30, 2012, respectively, and of $0.3 million and $0.7 million in the three and six month periods ended June 30, 2011, respectively.

Restriction on Payment of Dividends

Pursuant to the Amended Credit Agreement, as amended, we cannot make a cash dividend payment if a default or event of default has occurred and is continuing or shall result from the cash dividend payment.

XML

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Accounts receivable, allowance for doubtful accounts	$ 1,315	$ 1,040
Property, plant and equipment, accumulated depreciation	$ 206,509	$ 198,075
Capital Stock, par value	$ 1	$ 1
Capital Stock, authorized shares	50,000,000	50,000,000
Capital Stock, shares outstanding	16,395,739	16,220,648

XML

Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Loss)

6 Months Ended

Jun. 30, 2012

Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Loss)

Note 6 - Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Loss)

Comprehensive income (loss) for the periods ended June 30, 2012 and 2011 were as follows:

	Three Months Ended					Six Months Ended
(Dollars in thousands)	June 30,			June 30,		June 30,			June 30,
	2012			2011		2012			2011
Net income (loss)	$	6,455		$	12,128	$	4,646		$	21,563
Foreign currency translation adjustments		(10,857	)		6,298		(4,886	)		21,262
Unrealized gain (loss) on marketable securities, net of tax		-			420		1,168			501
Unrealized gain (loss) on derivative instruments, net of tax		(43	)		-		212			-
Comprehensive income (loss)	$	(4,445	)	$	18,846	$	1,140		$	43,326

The components of accumulated other comprehensive income (loss) at June 30, 2012 and December 31, 2011 were as follows:

	June 30,			December 31,
(Dollars in thousands)	2012			2011
Foreign currency translation adjustments	$	989		$	5,875
Funded status of pension plans and other postretirement benefits, net of tax		(67,239	)		(67,239	)
Unrealized gain (loss) on derivative instruments, net of tax		(58	)		(270	)
Unrealized gain (loss) on marketable securities, net of tax		-			(1,168	)
Accumulated other comprehensive income (loss)	$	(66,308	)	$	(62,802	)

XML

Inventories

6 Months Ended

Jun. 30, 2012

Inventories

Note 5 - Inventories

Inventories were as follows:

	June 30,		December 31,
(Dollars in thousands)	2012		2011
Raw materials	$	30,517	$	30,655
Work-in-process		15,982		14,919
Finished goods		28,179		32,746
	$	74,678	$	78,320

XML

Discontinued Operations

6 Months Ended

Jun. 30, 2012

Discontinued Operations

Note 17 – Discontinued Operations

In the fourth quarter of 2011, we made the strategic decision to end the operations of our TMS operating segment.  We had invested in its operations for the last few years, but had difficulty gaining traction in the market and working through issues in the manufacturing process.  Therefore, we determined that we would not achieve future success in this operation and chose to shut down operations rather than invest further. For the six month period ended June 30, 2012, operating losses of $0.1 million, net of tax, were reflected as discontinued operations in the accompanying condensed consolidated statements of comprehensive income (loss). There was no activity for this segment in the second quarter of 2012. For the three and six month periods ended June 30, 2011, operating losses of $1.3 million and $2.9 million, net of tax, respectively, were reflected as discontinued operations in the accompanying condensed consolidated statements of comprehensive income (loss). Net sales associated with the discontinued operations were $0.1 million for the six months ended June 30, 2012 and for the three and six month periods ended June 30, 2011.  There was no sales activity for the second quarter of 2012.

XML

Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2012

Goodwill and Intangible Assets

Note 13 – Goodwill and Intangible Assets

Definite Lived Intangible Assets

(Dollars in thousands)	June 30, 2012						December 31, 2011
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trademarks and patents	$	1,006	$	177	$	829	$	879	$	140	$	739
Technology		35,095		6,335	$	28,760		35,769		4,655		31,114
Covenant-not-to-compete		968		235	$	733		956		135		821
Customer relationships		19,544		1,625	$	17,919		19,851		1,315		18,536
Total other intangible assets	$	56,613	$	8,372	$	48,241	$	57,455	$	6,245	$	51,210

Gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.

Amortization expense for the three and six month periods ended June 30, 2012 was approximately $1.0 million and $2.2 million, respectively. Amortization expense for the three and six month periods ending June 30, 2011 was approximately $1.4 million and $2.9 million, respectively. The estimated annual future amortization expense is $2.2 million, $5.7 million, $5.7 million, $5.5 million and $5.1 million for the remainder of 2012, 2013, 2014, 2015 and 2016, respectively.  These amounts could vary based on changes in foreign currency exchange rates.

The weighted average amortization period as of June 30, 2012, by intangible asset class, is presented in the table below:

Intangible Asset Class	Weighted Average Amortization Period
Trademarks and patents	9.1
Technology	6.1
Covenant not-to-compete	3.7
Customer relationships	9.3
Total other intangible assets	7.3

On January 4, 2011 we acquired Curamik, which contributed $52.4 million of intangible assets and $79.8 million of goodwill.  The intangible assets are comprised of trademarks, technology, and customer relationships and include $5.3 million of indefinite-lived intangible assets comprised of trademarks, which are assessed for impairment annually.  The definite-lived intangibles are amortized using a fair value methodology that is based on the projected economic use of the related underlying asset.

Goodwill

The changes in the carrying amount of goodwill for the period ending June 30, 2012, by reportable segment, are as follows:

(Dollars in thousands)	High Performance Foams		Printed Circuit Materials		Curamik Electronics Solutions			Power Distribution Systems		Other		Total
December 31, 2011	$	22,597	$	-	$	77,357		$	-	$	2,224	$	102,178
Foreign currency translation adjustment
		195		-		(1,779	)		-		-		(1,584	)
June 30, 2012	$	22,792	$	-	$	75,578		$	-	$	2,224	$	100,594

XML

Pension Benefit and Other Postretirement Benefit Plans

6 Months Ended

Jun. 30, 2012

Pension Benefit and Other Postretirement Benefit Plans

Note 9 – Pension Benefit and Other Postretirement Benefit Plans

Components of Net Periodic Benefit Cost

The components of net periodic benefit cost for the periods indicated are:

(Dollars in thousands)

(Dollars in thousands)
	Pension Benefits												Retirement Health and Life Insurance Benefits
	Three Months Ended						Six Months Ended						Three Months Ended						Six Months Ended
Change in benefit obligation:	June 30,			June 30,			June 30,			June 30,			June 30,			June 30,			June 30,			June 30,
	2012			2011			2012			2011			2012			2011			2012			2011
Service cost	$	1,108		$	1,060		$	2,297		$	2,120		$	149		$	176		$	331		$	352
Interest cost		2,124			2,116			4,242			4,232			92			97			180			194
Expected return on plan assets		(2,495	)		(2,591	)		(4,903	)		(5,182	)		-			-			-			-
Amortization of prior service cost		116			150			232			300			(113	)		(157	)		(226	)		(314	)
Amortization of net loss		1,442			553			2,791			1,106			66			81			181			162
Special termination benefit		-			-			-			-			-			-			2,300			-
Adjustment to termination benefit		-			-			-			-			(707	)		-			(707	)		-
Net periodic benefit cost	$	2,295		$	1,288		$	4,659		$	2,576		$	(513	)	$	197		$	2,059		$	394

As a result of the early retirement program that we offered in the first quarter of 2012, we incurred $1.6 million in charges related to a special termination benefit associated with our retirement health and life insurance benefits program, as we extended eligibility in the benefits to certain individuals who participated in the early retirement program.

Early in the third quarter of 2012, we made a one-time cash payment to our former President and Chief Executive Officer of approximately $6.0 million in accordance with the provisions of his retirement contract as part of his Pension Restoration Plan.  We expect that this payment will result in a settlement charge of approximately $2.1 million, which will be recognized in the third quarter of 2012.

Employer Contributions

We made $6.0 million in voluntary contributions to our qualified defined benefit pension plans during the second quarter of 2012 and $10.0 million in the first quarter of 2012.  For the first six months of 2011, we did not make any voluntary contributions.

We made no payments under our non-qualified defined benefit pension plan in the first half of 2012 and only de minimis payments were made in the first half of 2011.

XML

Segment Information - Additional Information (Detail) (Power Electronics Solutions)	6 Months Ended
	Jun. 30, 2012 Segment
Power Electronics Solutions
Segment Reporting Information [Line Items]
Number of operating segments	2

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2012

Earnings Per Share

Note 7- Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:

(In thousands, except per share amounts)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Numerator:
Income (loss)	$	6,455	$	13,432	$	4,754	$	24,497
Denominator:
Denominator for basic earnings per share -
Weighted-average shares		16,309		15,945		16,271		15,919
Effect of dilutive stock options		555		733		572		685
Denominator for diluted earnings per share - Adjusted
weighted-average shares and assumed conversions		16,864		16,678		16,843		16,604
Basic income (loss) per share:	$	0.40	$	0.84	$	0.29	$	1.54
Diluted income (loss) per share:		0.38		0.81		0.28		1.48

Certain potential ordinary shares were excluded from the calculation of diluted weighted-average shares outstanding because they would have an anti-dilutive effect on net income per share (see table below).

	Three Months Ended
	June 30, 2012		June 30, 2011
Anti-dilutive shares excluded		932,104		722,903

XML

Stock-Based Compensation

6 Months Ended

Jun. 30, 2012

Stock-Based Compensation

Note 8 – Stock-Based Compensation

Equity Compensation Awards

Stock Options

Stock options have been granted under various equity compensation plans.  While we may grant options to employees that become exercisable at different times or within different periods, we have generally granted options to employees that vest and become exercisable in one-third increments on the 2nd, 3rd and 4th anniversaries, of the grant dates.  The maximum contractual term for all options is normally ten years.

We use the Black-Scholes option-pricing model to calculate the grant-date fair value of an option.  The fair value of options granted during the three and six month periods ended June 30, 2012 and 2011 were calculated using the following weighted-average assumptions:

	Three Months Ended					Six Months Ended
	June 30, 2012		June 30, 2011			June 30, 2012			June 30, 2011
Options granted		-		58,550			46,950			58,550
Weighted average exercise price	$	-	$	47.89		$	41.27		$	47.89
Weighted-average grant date fair value		-		22.30			19.08			22.30
Assumptions:
Expected volatility		-		45.15	%		47.70	%		45.15	%
Expected term (in years)		-		6.0			5.9			6.0
Risk-free interest rate		-		2.64	%		1.43	%		2.64	%
Expected dividend yield		-		-			-			-

Expected volatility – In determining expected volatility, we have considered a number of factors, including historical volatility and implied volatility.

Expected term – We use historical employee exercise data to estimate the expected term assumption for the Black-Scholes valuation.

Risk-free interest rate – We use the yield on zero-coupon U.S. Treasury securities for a period commensurate with the expected term assumption as its risk-free interest rate.

Expected dividend yield – We do not currently pay dividends on our common stock; therefore, a dividend yield of 0% was used in the Black-Scholes model.

In most cases, we recognize expense using the straight-line attribution method for stock option grants.  The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest.  Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.  The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered option.  We currently expect, based on an analysis of our historical forfeitures, an annual forfeiture rate of approximately 3% and applied that rate to the grants issued.  This assumption will be reviewed periodically and the rate will be adjusted as necessary based on these reviews.  Ultimately, the actual expense recognized over the vesting period will only be for those options that vest.

During the three and six month periods ended June 30, 2012, we recognized approximately $0.6 million and $1.3 million of stock option compensation expense, respectively. During the three and six month periods ended June 30, 2011, we recognized approximately $0.8 million and $1.3 million of stock option compensation expense, respectively.

A summary of the activity under our stock option plans as of June 30, 2012 and changes during the three and six month periods then ended, is presented below:

	Options Outstanding			Weighted- Average  Exercise Price Per Share		Weighted-Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options outstanding at March 31, 2012		2,440,999		$	37.59		4.9	$	14,667,018
Options granted		-			-
Options exercised		(112,531	)		29.74
Options cancelled		(28,999	)		46.78
Options outstanding at June 30, 2012		2,299,469			38.07		4.8		14,513,131
Options exercisable at June 30, 2012		1,594,269			41.39		3.7		7,279,532
Options vested or expected to vest at June 30, 2012*		2,273,222			38.19		4.7		14,247,752

* In addition to the vested options, we expect a portion of the unvested options to vest at some point in the future.  Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options.

	Options Outstanding			Weighted- Average Exercise Price Per Share
Options outstanding at December 31, 2011		2,401,809		$	37.54
Options granted		46,950			41.27
Options exercised		(116,491	)		29.72
Options cancelled		(32,799	)		44.06
Options outstanding at June 30, 2012		2,299,469

During the six month period ended June 30, 2012, the total intrinsic value of options exercised (i.e., the difference between the market price at time of exercise and the price paid by the individual to exercise the options) was $1.1 million, and the total amount of cash received from the exercise of these options was $3.5 million.

Performance-Based Restricted Stock

In 2006, we began granting performance-based restricted stock grants to certain key executives.  These grants cliff vest at the end of the three-year measurement period, except for grants to those individuals who are retirement eligible during the grant period as such awards are subject to accelerated vesting as the grant is earned over the course of the vesting period (i.e. a pro-rata payout occurs based on the retirement date).  Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures. Compensation expense is recognized ratably over the vesting period, unless the employee has an accelerated vesting schedule.  Additionally, compensation expense is increased or decreased based on changes in the estimated pay out percentages each quarter. The 2009 grant, which vested as of December 31, 2011, met the performance criteria and was paid out at 97.4% of target.

	Performance Based Restricted Stock Awards
Non-vested awards outstanding at December 31, 2011		101,730
Awards granted		22,120
Stock issued		(43,750	)
Awards forfeited		(6,642	)
Non-vested awards outstanding at  June 30, 2012		73,458

During the three and six month periods ended June 30, 2012, due to reductions in the estimated payout percentages of outstanding grants, we recognized income for performance-based restricted stock awards of approximately $0.5 million and $0.4 million, respectively.  During the three and six month periods ended June 30, 2011, we recognized expense for performance-based restricted stock awards of approximately $0.9 million and $1.1 million, respectively.

Time-Based Restricted Stock

In 2011, we began granting time-based restricted stock awards to certain key executives and other key members of the Company’s management team.  Time-based restricted stock grants typically cliff vest at the end of the three-year vesting period, and we recognize compensation expense on these awards ratably over the vesting period.  The fair value of the award is determined based on the market value of the underlying stock price at the grant date.

	Time-Based Restricted Stock Awards
Non-vested awards outstanding at December 31, 2011		86,707
Awards granted		46,180
Stock issued		(980	)
Awards forfeited		(3,782	)
Non-vested awards outstanding at  June 30, 2012		128,125

During the three and six month periods ended June 30, 2012, we recognized compensation expense for time-based restricted stock awards of approximately $0.4 million and $0.9 million, respectively.  During the three and six month periods ended June 30, 2011, we recognized expense for time-based restricted stock awards of approximately $0.2 million of during each period.

Deferred Stock Units

We grant deferred stock units to non-management directors.  These awards are fully vested on the date of grant and the related shares are generally issued on the 13th month anniversary of the grant date unless the individual elects to defer the receipt of these shares.  Each deferred stock unit results in the issuance of one share of Rogers’ stock.  The grant of deferred stock units is typically done annually in the second quarter of each year.

	Deferred Stock Units
Non-vested awards outstanding at December 31, 2011		27,350
Awards granted		17,600
Stock issued		(14,800	)
Awards forfeited		-
Non-vested awards outstanding at  June 30, 2012		30,150

For each of the three and six month periods ended June 30, 2012 and 2011, we recognized compensation expense of $0.7 million related to deferred stock units.  There was no expense associated with these grants in the first quarter of either year.

Employee Stock Purchase Plan

We have an employee stock purchase plan (ESPP) that allows eligible employees to purchase, through payroll deductions, shares of our common stock at a discount to fair market value.  The ESPP has two six month offering periods each year, the first beginning in January and ending in June and the second beginning in July and ending in December.  The ESPP contains a look-back feature that allows the employee to acquire stock at a 15% discount from the underlying market price at the beginning or end of the applicable period, whichever is lower.  We recognize compensation expense on this plan ratably over the offering period based on the fair value of the anticipated number of shares that will be issued at the end of each offering period.  Compensation expense is adjusted at the end of each offering period for the actual number of shares issued.  Fair value is determined based on two factors: (i) the 15% discount amount on the underlying stock’s market value on the first day of the applicable offering period, and (ii) the fair value of the look-back feature determined by using the Black-Scholes model.  We recognized approximately $0.1 million of compensation expense associated with the plan for each of the three month periods ended June 30, 2012 and, 2011, and approximately $0.2 million of compensation expense associated with the six month periods ended June 30, 2012 and 2011.

XML

Segment Information

6 Months Ended

Jun. 30, 2012

Segment Information

Note 10 – Segment Information

Our reporting structure is comprised of the following operating segments: High Performance Foams, Printed Circuit Materials, Curamik Electronics Solutions and Power Distribution Systems and the Other reportable segment.

Segment Structure
Core Strategic
	High Performance Foams
	Printed Circuit Materials
	Power Electronics Solutions
		Curamik Electronics Solutions
		Power Distribution Systems
Other

The “Power Electronics Solutions” core strategic category is comprised of  two operating segments – Curamik Electronics Solutions and Power Distribution Systems.

The following table sets forth the information about our reportable segments for the periods indicated:

(Dollars in thousands)	Three Months Ended						Six Months Ended
	June 30, 2012			June 30, 2011			June 30, 2012			June 30, 2011
Net sales
Core Strategic
High Performance Foams	$	43,329		$	44,021		$	83,763		$	83,156
Printed Circuit Materials		40,533			43,375			79,914			86,228
Power Electronics Solutions
Curamik Electronics Solutions		23,908			34,613			48,200			67,510
Power Distribution Systems		11,573			13,978			22,089			26,413
Other		7,328			7,514			14,078			16,122
Net sales		126,671			143,501			248,044			279,429
Operating income (loss)
Core Strategic
High Performance Foams		5,708			6,658			7,153			11,293
Printed Circuit Materials		3,123			4,405			2,777			9,234
Power Electronics Solutions
Curamik Electronics Solutions		(1,205	)		2,855			(2,978	)		3,157
Power Distribution Systems		135			1,644			(515	)		3,909
Other		1,315			945			1,953			2,146
Operating income (loss)		9,076			16,507			8,390			29,739
Equity income in unconsolidated joint ventures		1,305			1,323			1,962			2,751
Other income (expense), net		261			280			122			1,629
Net realized investment gain (loss)		-			29			(3,245	)		32
Interest income (expense), net		(1,072	)		(1,265	)		(2,262	)		(2,843	)
Income (loss) before income tax expense (benefit)	$	9,570		$	16,874		$	4,967		$	31,308

Inter-segment sales have been eliminated from the sales data in the preceding table.

XML

Summarized Information for Joint Ventures (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Schedule of Equity Method Investments [Line Items]
Net sales	$ 15,880	$ 16,783	$ 28,685	$ 34,863
Gross profit (loss)	2,608	3,211	4,433	7,535
Net income (loss)	$ 2,610	$ 2,646	$ 3,924	$ 5,502

XML

Aggregate Payments (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2012
Debt Instrument [Line Items]
2011	$ 2.5
2012	7.5
2013	12.5
2014	17.5
2015	35.0
2016	$ 25.0

XML

Joint Ventures Accounted for Under Equity Method of Accounting (Detail)	6 Months Ended
	Jun. 30, 2012
Schedule of Equity Method Investments [Line Items]
Fiscal Year-End	--12-31
Rogers INOAC Corporation | JAPAN | High Performance Foams
Schedule of Equity Method Investments [Line Items]
Fiscal Year-End	--10-31
Rogers INOAC Suzhou Corporation | CHINA | High Performance Foams
Schedule of Equity Method Investments [Line Items]
Fiscal Year-End	--12-31

XML

Joint Ventures (Tables)

6 Months Ended

Jun. 30, 2012

Joint Ventures Accounted for Under Equity Method of Accounting

As of June 30, 2012, we had two joint ventures, each 50% owned, which are accounted for under the equity method of accounting.

Joint Venture	Location	Reportable Segment	Fiscal Year-End
Rogers INOAC Corporation (RIC)	Japan	High Performance Foams	October 31
Rogers INOAC Suzhou Corporation (RIS)	China	High Performance Foams	December 31

Summarized Information for Joint Ventures

The summarized financial information for the joint ventures for the periods indicated is as follows:

(Dollars in thousands)	Three Months Ended				Six Months Ended
	June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net sales	$	15,880	$	16,783	$	28,685	$	34,863
Gross profit (loss)		2,608		3,211		4,433		7,535
Net income (loss)		2,610		2,646		3,924		5,502

XML

Anti dilutive shares and Potential Ordinary Shares That Were Not Otherwise Antidilutive excluded from Calculation of Diluted Weighted Average Shares Outstanding (Detail)	3 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Earnings Per Share Disclosure [Line Items]
Anti-dilutive shares excluded	932,104	722,903

XML

Income Taxes

6 Months Ended

Jun. 30, 2012

Income Taxes

Note 15 – Income Taxes

Our effective tax rate was 32.5% in the second quarter of 2012 as compared to 20.4% in the second quarter of 2011. On a year to date basis, the effective tax rate was 4.3% in the first six months of 2012 as compared to 21.8% in the first half of 2011. In the second quarter of 2012, our tax rate was higher than in the second quarter of 2011 due primarily to a shift of income generated in those periods to higher taxing jurisdictions in the second quarter of 2012. In the first half of 2012, our tax rate benefited from certain discrete items, including a $1.5M benefit related to the reversal of the valuation allowance related to the sale of the auction rate securities portfolio, as compared to the first half of 2011 which drove the lower effective tax rate in the first half of 2012 as compared to the first half of 2011. In both the first half of 2012 and 2011, our tax rate benefited from favorable tax rates on certain foreign business activity as compared to our statutory rate of 35%. We project the effective tax rate will be 26% for the balance of 2012, with some quarter to quarter volatility.

In 2009, we established a valuation allowance against substantially all of our U.S. deferred tax asset based upon the consideration of all available evidence, both positive and negative, using a “more likely than not” standard.  A valuation allowance for deferred tax assets is recorded to the extent we cannot determine if it is more likely than not that we will ultimately realize our deferred tax assets. In determining the need for a valuation allowance, we assess the available positive and negative evidence as well as consider available tax planning strategies. As of June 30, 2012, we have concluded, based on this standard, that a valuation allowance is still appropriate against a significant portion of our U.S. deferred tax assets.

We may in appropriate circumstances undertake tax planning strategies that provide a basis for the realization of a portion of our U.S. deferred tax assets.  Such a strategy to utilize these assets would be based primarily upon our ability to make a tax election to capitalize certain expenses that will result in generating taxable income and utilizing our foreign tax credits before they expire.  We would undertake such a strategy to realize such tax benefits prior to expiration only if we determined it was reasonable, prudent, and feasible. Accordingly, because we believe it is reasonably likely this strategy will be available, along with other positive evidence, we recognized our foreign tax credit and deferred tax assets at June 30, 2012 and June 30, 2011, respectively.

The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and the deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the entity’s financial statements.  We are subject to income taxes in the United States and in numerous foreign jurisdictions.  No provision is made for U.S. income taxes on the undistributed earnings of substantially all of our wholly-owned foreign subsidiaries because such earnings are indefinitely reinvested in those companies. If circumstances change and it becomes apparent that some or all of the undistributed earnings of our wholly-owned foreign subsidiaries will not be indefinitely reinvested, a provision for the tax consequences, if any, will be recorded in the period in which the circumstances change.

Our accounting policy is to account for interest expense and penalties related to uncertain tax positions as income tax expense.  As of June 30, 2012, we have approximately $1.8 million of accrued interest related to uncertain tax positions included in the $18.6 million of unrecognized tax benefits, $11.3 million of which, if recognized, would impact the effective tax rate.

We are subject to numerous tax filings including U.S. Federal, various state and certain foreign jurisdictions.  Currently, the following tax years remain open to the possibility of audit, by jurisdiction - U.S. Federal: 2008 – 2011; various states: 2007 – 2011; and foreign: 2007 – 2011.

XML

Hedging Transactions and Derivative Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Notional Amounts of Outstanding Derivative Positions

Notional Value of Copper Derivatives
Copper	70 metric tons per month

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

(Dollars in thousands)	The Effect of Current Derivative Instruments on the Financial Statements for the six-month period ended June 30, 2012				Fair Values of Derivative Instruments as of June 30, 2012
Foreign Exchange Option Contracts	Location of gain (loss)	Amount of gain (loss)			Other Assets (Liabilities)
Contracts not designated as hedging instruments	Other income, net	$	81		$	-
Copper Derivative Instruments
Contracts designated as hedging instruments	Other comprehensive income (loss)		(82	)		(82	)

XML

Components of Accumulated Other Comprehensive Income or Loss (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency translation adjustments	$ 989	$ 5,875
Funded status of pension plans and other postretirement benefits, net of tax	(67,239)	(67,239)
Unrealized gain (loss) on derivative instruments, net of tax	(58)	(270)
Unrealized gain (loss) on marketable securities, net of tax		(1,168)
Accumulated other comprehensive income (loss)	$ (66,308)	$ (62,802)

XML

Rollforward of Credit Losses Recognized in Earnings (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2011
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]
Beginning Balance	$ 917
Credit losses recorded	39
Reduction in credit losses due to redemptions	(71)
Ending Balance	$ 885

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (USD $) In Thousands, unless otherwise specified	Total	Capital Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2011	$ 338,256	$ 16,221	$ 52,738	$ 332,099	$ (62,802)
Comprehensive income (loss):
Net income (loss)	4,646			4,646
Other comprehensive income (loss):
Foreign currency translation, net of tax	(4,886)				(4,886)
Unrealized loss on marketable securities, net of tax	1,168				1,168
Unrealized loss on derivative instruments, net of tax	212				212
Total comprehensive income (loss)	1,140			4,646	(3,506)
Stock options exercised	3,427	115	3,312
Stock issued to directors		15	(15)
Shares issued for employees stock purchase plan	413	15	398
Shares issued for restricted stock	(571)	30	(601)
Stock-based compensation expense	2,678		2,678
Ending Balance at Jun. 30, 2012	$ 345,343	$ 16,396	$ 58,510	$ 336,745	$ (66,308)

XML

Acquisition of Business

6 Months Ended

Jun. 30, 2012

Acquisition of Business

Note 4 – Acquisition of Business

Curamik Electronics GmbH

On January 4, 2011, we acquired Curamik Electronics GmbH (Curamik), a manufacturer of power electronic substrate products headquartered in Eschenbach, Germany.  The aggregate purchase price was $151.1 million, which reflects post-closing adjustments.

Curamik, founded in 1983, is the worldwide leader for the development and production of direct bonded copper ceramic substrate products which are used primarily in the design of intelligent power management devices, such as IGBT (insulated gate bipolar transistor) modules, that enable a wide range of products, including high efficiency industrial motor drives, wind and solar energy converters and electrical systems in automobiles.  Most of Curamik’s products are manufactured using state of the art automated processes in its facility located in Eschenbach.

The acquisition has been accounted for in accordance with applicable purchase accounting guidance.  The following table represents the fair market value assigned to the acquired assets and liabilities in the transaction.

(Dollars in thousands)
Assets:
Cash	$	11,256
Accounts receivable		11,876
Other current assets		1,386
Inventory		12,259
Property, plant & equipment		32,312
Other non-current assets		2,276
Intangible assets		52,354
Goodwill		79,837
Total assets		203,556
Liabilities
Accounts payable		6,053
Other current liabilities		20,427
Deferred tax liability		9,329
Other long-term liabilities		16,666
Total liabilities		52,475
Fair value of net assets acquired	$	151,081

Total costs incurred related to the acquisition were approximately $3.4 million, of which $1.3 million were incurred in the first quarter of 2011 and $2.1 million in the fourth quarter of 2010.  They are included in “Selling and administrative expenses” on our condensed consolidated statements of comprehensive income (loss).

XML

Components of Net Periodic Benefit Cost (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2012	Mar. 31, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1,108		$ 1,060	$ 2,297	$ 2,120
Interest cost	2,124		2,116	4,242	4,232
Expected return on plan assets	(2,495)		(2,591)	(4,903)	(5,182)
Amortization of prior service cost	116		150	232	300
Amortization of net loss	1,442		553	2,791	1,106
Net periodic benefit cost	2,295		1,288	4,659	2,576
Retirement Health and Life Insurance Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	149		176	331	352
Interest cost	92		97	180	194
Amortization of prior service cost	(113)		(157)	(226)	(314)
Amortization of net loss	66		81	181	162
Special termination benefit		1,600		2,300
Adjustment to termination benefit	(707)			(707)
Net periodic benefit cost	$ (513)		$ 197	$ 2,059	$ 394

XML

Goodwill and Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012 Curamik Electronics GmbH	Jan. 04, 2011 Curamik Electronics GmbH	Jan. 04, 2011 Curamik Electronics GmbH Unclassified Indefinite-lived Intangible Assets
Goodwill and Intangible Assets Disclosure [Line Items]
Amortization expense	$ 1,000,000	$ 1,400,000	$ 2,200,000	$ 2,900,000
Anticipated future amortization expense for remainder of 2012	2,200,000		2,200,000
Anticipated future amortization expense for 2013	5,700,000		5,700,000
Anticipated future amortization expense for 2014	5,700,000		5,700,000
Anticipated future amortization expense for 2015	5,500,000		5,500,000
Anticipated future amortization expense for 2016	5,100,000		5,100,000
Intangible assets					52,354,000	52,400,000	5,300,000
Goodwill					$ 79,837,000	$ 79,800,000

XML

Acquisition of Business (Tables) (SK Utis Co., Ltd.)

6 Months Ended

Jun. 30, 2012

SK Utis Co., Ltd.

Fair Values of Assets Acquired and Liabilities Assumed

The following table represents the fair market value assigned to the acquired assets and liabilities in the transaction.

(Dollars in thousands)
Assets:
Cash	$	11,256
Accounts receivable		11,876
Other current assets		1,386
Inventory		12,259
Property, plant & equipment		32,312
Other non-current assets		2,276
Intangible assets		52,354
Goodwill		79,837
Total assets		203,556
Liabilities
Accounts payable		6,053
Other current liabilities		20,427
Deferred tax liability		9,329
Other long-term liabilities		16,666
Total liabilities		52,475
Fair value of net assets acquired	$	151,081

XML

Restructuring Impairment Charges - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended							3 Months Ended	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012 High Performance Foams	Jun. 30, 2012 High Performance Foams Contract Termination [Member]	Jun. 30, 2012 High Performance Foams Employee Severance	Jun. 30, 2012 High Performance Foams Asset impairments [Member]	Jun. 30, 2012 High Performance Foams Facility Closing [Member]	Jun. 30, 2012 Other Non-woven composite materials products	Dec. 31, 2011 Other Non-woven composite materials products
Restructuring Cost and Reserve [Line Items]
Expenses and charges related to the termination of the operations					$ 3,100,000	$ 900,000	$ 800,000	$ 1,100,000	$ 300,000
Restructuring and related costs					1,500,000
Net sales	$ 126,671,000	$ 143,501,000	$ 248,044,000	$ 279,429,000						$ 1,400,000	$ 4,800,000

XML

Various Instruments That Require Fair Value Measurement (Detail) (Fair value on a recurring basis, USD $) In Thousands, unless otherwise specified	Jun. 30, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency option contracts
Copper derivative contracts	(82)
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency option contracts
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency option contracts
Copper derivative contracts	(82)
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency option contracts

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2012

Commitments and Contingencies

Note 14 – Commitments and Contingencies

We are currently engaged in the following environmental and legal proceedings:

Superfund Sites

We are currently involved as a potentially responsible party (PRP) in one active case involving a waste disposal site.

Chatham Superfund Site - Currently, this proceeding is at a stage where it is not possible to estimate the ultimate cost of remediation, or the timing and extent of remedial action that may be required by governmental authorities.  It is also not possible to estimate the amount of our liability, if any, alone or in relation to that of any other PRPs.  The costs incurred since inception for this claim have been immaterial and have been primarily covered by insurance policies, for both legal and remediation costs.  In this matter we have been assessed a cost sharing percentage of approximately 2% in relation to the range for estimated total cleanup costs of $17.0 million to $24.0 million.  We believe we have sufficient insurance coverage to fully cover this liability and have recorded a liability and related insurance receivable of approximately $0.3 million as of June 30, 2012, which approximates our share of the low end of the range.  We believe we are a de minimis participant and, as such, have been allocated an insignificant percentage of the total PRP cost sharing responsibility.  Based on facts presently known to us, we believe that the potential for the final results of this case having a material adverse effect on our results of operations, financial position or cash flows is remote.  This case has been ongoing for many years and we believe that it will continue on for the indefinite future.  No time frame for completion can be estimated at the present time.

Omega Chemical Superfund Site - In the fourth quarter of 2011, the United States Environmental Protection Agency (EPA) notified us that we were a PRP for the cleanup of the Omega Chemical Corporation Superfund Site in Los Angeles County, California.  In the first quarter of 2012, we were notified that we are no longer a PRP related to this superfund site.

PCB Contamination

We have been working with the Connecticut Department of Energy and Environmental Protection (CT DEEP) and the EPA, Region I, in connection with certain polychlorinated biphenyl (PCB) contamination in the soil beneath a section of cement flooring at our Woodstock, Connecticut facility.  In 2000, the majority of the clean-up efforts were completed, and a small amount of residual soil contamination remained.  In 2011, after several discussions and proposals with the CT DEEP, we agreed to install a pump and treat system to alleviate further contamination of the ground water.  Since inception, we have spent approximately $2.5 million in remediation and monitoring costs related to the PCB soil contamination at this site.  We anticipate future costs related to the ground water contamination issue to be de minimis and related to the continued use and maintenance of the pump and treat system now in place at the site.

In addition, during the first quarter of 2010, we discovered PCB contamination in the building at our Woodstock, Connecticut facility, due to it having contained the equipment that was the source of the original PCB soil contamination.  Remediation of the contamination within the facility is currently projected to cost between $1.0 million and $2.6 million; therefore, we recorded a liability of $1.0 million related to the building contamination, which represents the low end of the estimated range, as no other amount in the range was more probable at that time.  To date, we have incurred $0.3 million in remediation costs at the site and the reserve at June 30, 2012 is $0.7 million which we believe is adequate to cover the remaining remediation work.

We believe that these situations will continue for several more years and no time frame for completion can be estimated at the present time.

Asbestos Litigation

A significant number of asbestos-related product liability claims have been brought against numerous United States industrial companies where the third-party plaintiffs allege personal injury from exposure to asbestos-containing products. We have been named, along with hundreds of other companies, as a defendant in some of these claims. In virtually all of these claims filed against us, the plaintiffs are seeking unspecified damages, or, if an amount is specified, such amount merely represents a jurisdictional amount.  However, occasionally specific damages are alleged and in such situations, plaintiffs’ lawyers often sue dozens of defendants, frequently without factual basis or support.  As a result, even when a specific amount of damages is alleged, such action can be arbitrary, both as to the amount being sought and the defendant being charged with such damages.

We did not mine, mill, manufacture or market asbestos; rather we made a limited number of products which contained encapsulated asbestos.  Such products were provided to industrial users.  We stopped manufacturing these products in the late 1980s.

● Claims

We have been named in asbestos litigation primarily in Illinois, Pennsylvania and Mississippi.  As of June 30, 2012, there were 298 pending claims compared to 242 pending claims at December 31, 2011.  The number of open claims at a particular time can fluctuate significantly from period to period depending on how successful we have been in getting these cases dismissed or settled.  Some jurisdictions prohibit specifying alleged damages in personal injury tort cases such as these, other than a minimum jurisdictional amount which may be required for such reasons as allowing the case to be litigated in a jury trial (which the plaintiffs believe will be more favorable to them than if heard only before a judge) or allowing the case to be litigated in federal court.  This is in contrast to commercial litigation, in which specific alleged damage claims are often permitted.  The prohibition on specifying alleged damages sometimes applies not only to the suit when filed but also during the trial – in some jurisdictions the plaintiff is not actually permitted to specify to the jury during the course of the trial the amount of alleged damages the plaintiff is claiming.  Further, in those jurisdictions in which plaintiffs are permitted to claim specific alleged damages, many plaintiffs nonetheless still choose not to do so. In those cases in which plaintiffs are permitted to and choose to assert specific dollar amounts in their complaints, we believe the amounts claimed are typically not meaningful as an indicator of a company’s potential liability. This is because (1) the amounts claimed may bear no relation to the level of the plaintiff’s injury and are often used as part of the plaintiff’s litigation strategy, (2) the complaints typically assert claims against numerous defendants, and often the alleged damages are not allocated against specific defendants, but rather the broad claim is made against all of the defendants as a group, making it impossible for a particular defendant to quantify the alleged damages that are being specifically claimed against it and therefore its potential liability, and (3) many cases are brought on behalf of plaintiffs who have not suffered any medical injury, and ultimately are resolved without any payment or payment of a small fraction of the damages initially claimed.  Of the 298 claims pending as of  June 30, 2012,  71 claims do not specify the amount of damages sought,  224 claims cite jurisdictional amounts, and only three (3) claims (approximately 1.0% of the total pending claims) specify the amount of damages sought not based on jurisdictional requirements. Of these three (3) claims, one (1) claim alleges compensatory and punitive damages of $20 million each; one (1) claim alleges compensatory damages of $65 million and punitive damages of $60 million and one (1) claim alleges compensatory and punitive damages of $1 million each.  These three (3) claims name between ten (10) and 109 defendants.  However, for the reasons cited above, we do not believe that this data allows for an accurate assessment of the relation that the amount of alleged damages claimed might bear to the ultimate disposition of these cases.

We believe the rate at which plaintiffs filed asbestos-related suits against us increased in 2001, 2002, 2003 and 2004 because of increased activity on the part of plaintiffs to identify those companies that sold asbestos-containing products, but which did not directly mine, mill or market asbestos.  A significant increase in the volume of asbestos-related bodily injury cases arose in Mississippi in 2002.  This increase in the volume of claims in Mississippi was apparently due to the passage of tort reform legislation (applicable to asbestos-related injuries), which became effective on September 1, 2003 and which resulted in a higher than average number of claims being filed in Mississippi by plaintiffs seeking to ensure their claims would be governed by the law in effect prior to the passage of tort reform.  The number of asbestos related suits filed against us decreased slightly in 2005 and 2006, but increased slightly in 2007, declined in 2008 and increased again in 2009 and 2010.  The number of lawsuits filed against us in 2011 was significantly higher than in 2010.  However, it is still too early to be able to determine if this is a meaningful trend even though more such lawsuits were filed against us in the first two quarters of 2012 compared to the comparable period in 2011. Regardless, these new claims, and all previously filed claims, may take a significant period of time to resolve.

● Defenses

In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of exposure to our asbestos-containing products.  We continue to believe that a majority of the claimants in pending cases will not be able to demonstrate exposure or loss.  This belief is based in large part on two factors: the limited number of asbestos-related products manufactured and sold by us and the fact that the asbestos was encapsulated in such products.  In addition, even at sites where the presence of an alleged injured party can be verified during the same period those products were used, our liability cannot be presumed because even if an individual contracted an asbestos-related disease, not everyone who was employed at a site was exposed to the asbestos containing products that we manufactured.  Based on these and other factors, we have and will continue to vigorously defend ourselves in asbestos-related matters.

● Dismissals and Settlements

Cases involving us typically name 50-300 defendants, although some cases have had as few as one (1) and as many as 833 defendants.  We have obtained dismissals of many of these claims.  For the six months ended June 30, 2012, we were able to have 44 claims dismissed and settled nine (9) claims.  For the year ended December 31, 2011, 120 claims were dismissed and eight (8) were settled.  The majority of costs have been paid by our insurance carriers, including the costs associated with the small number of cases that have been settled.  Such settlements totaled approximately $3.1 million for the six months ended June 30, 2012, compared to $8.1 million for the year ended 2011.   Although these figures provide some insight into our experience with asbestos litigation, no guarantee can be made as to the dismissal and settlement rates that we will experience in the future.

Settlements are made without any admission of liability.  Settlement amounts may vary depending upon a number of factors, including the jurisdiction where the action was brought, the nature and extent of the disease alleged and the associated medical evidence, the age and occupation of the claimant, the existence or absence of other possible causes of the alleged illness of the alleged injured party and the availability of legal defenses, as well as whether the action is brought alone or as part of a group of claimants.  To date, we have been successful in obtaining dismissals for many of the claims and have settled only a limited number.  The majority of settled claims were settled for immaterial amounts, and the majority of such costs have been paid by our insurance carriers.  In addition, to date, we have not been required to pay any punitive damage awards.

● Potential Liability

National Economic Research Associates, Inc. (NERA), a consulting firm with expertise in the field of evaluating mass tort litigation asbestos bodily-injury claims, has historically been engaged to assist us in projecting our future asbestos-related liabilities and defense costs with regard to pending claims and future unasserted claims.  Projecting future asbestos costs is subject to numerous variables that are extremely difficult to predict, including the number of claims that might be received, the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, dismissal rates, costs of medical treatment, the financial resources of other companies that are co-defendants in claims, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case and the impact of potential changes in legislative or judicial standards, including potential tort reform.  Furthermore, any predictions with respect to these variables are subject to even greater uncertainty as the projection period lengthens.  In light of these inherent uncertainties, the  variability of our claims history and consultations with NERA, we currently believe that five years is the most reasonable period for recognizing a reserve for future costs, and that costs that might be incurred after that period are not reasonably estimable at this time.  As a result, we also believe that our ultimate asbestos-related contingent liability (i.e., our indemnity or other claim disposition costs plus related legal fees) cannot be estimated with certainty.

● Insurance Coverage

Our applicable insurance policies generally provide coverage for asbestos liability costs, including coverage for both resolution and defense costs.  Following the initiation of asbestos litigation, an effort was made to identify all of our primary and excess level insurance carriers that provided applicable coverage beginning in the 1950s through the mid-1980s.  Where appropriate, carriers were put on notice of the litigation.  Marsh USA, Inc., a consulting firm with expertise in the field of evaluating insurance coverage and the likelihood of recovery for asbestos-related claims, has historically been engaged to work with us to project our insurance coverage for asbestos-related claims. Marsh’s conclusions are based primarily on a review of our coverage history, application of reasonable assumptions on the allocation of coverage consistent with certain industry practices, an assessment of the creditworthiness of the insurance carriers, analysis of applicable deductibles, retentions and policy limits, the experience of NERA and a review of NERA’s reports.

● Cost Sharing Agreement

To date, our insurance carriers have paid for substantially all of the settlement and defense costs associated with our asbestos-related claims.  The current cost sharing agreement between us and such insurance carriers is primarily designed to facilitate the ongoing administration and payment of such claims by the carriers until the applicable insurance coverage is exhausted.  This four year agreement expires on January 25, 2015 and replaced an older agreement that had expired.

● Impact on Financial Statements

Given the inherent uncertainty in making future projections, we have had the projections of current and future asbestos claims periodically re-examined, and we will have them further updated if needed based on our experience, changes in the underlying assumptions that formed the basis for NERA’s and Marsh’s models, and other relevant factors, such as changes in the tort system and our success in resolving claims. As of December 31, 2011, the estimated liability and estimated insurance recovery, for the five-year period through 2016, was $28.8 million and $28.4 million respectively.  During the first quarter of 2012, NERA and Marsh provided revised projections for the asbestos liability and related insurance receivable, which resulted in revised projections for the five-year period through 2016 of $27.9 million and $27.7 million for the estimated liability and insurance receivable, respectively.

The amounts recorded for the asbestos-related liability and the related insurance receivables described above were based on facts known at the time and a number of assumptions.  However, projecting future events, such as the number of new claims to be filed each year, the average cost of disposing of such claims, the length of time it takes to dispose of such claims, coverage issues among insurers and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States could cause the actual liability and insurance recoveries for us to be higher or lower than those projected or recorded.

There can be no assurance that our accrued asbestos liabilities will approximate our actual asbestos-related settlement and defense costs, or that our accrued insurance recoveries will be realized.  We believe that it is reasonably possible that we will incur additional charges for our asbestos liabilities and defense costs in the future, which could exceed existing reserves, but such excess amount cannot be reasonably estimated at this time.  We will continue to vigorously defend ourselves and believe we have substantial unutilized insurance coverage to mitigate future costs related to this matter.

Other Environmental and General Litigation

● In the second quarter of 2010, the CT DEEP contacted us to discuss a disposal site in Killingly, Connecticut.  We are currently in the very early stages of evaluating this matter and have initiated internal due diligence work related to the site to better understand the issue and our alleged involvement.  Currently, we do not know the nature and extent of any alleged contamination at the site, how many parties could be potentially involved in any remediation, if necessary, or the extent to which we could be deemed a potentially responsible party.  CT DEEP has not made any assessment of the nature of any potential remediation work that may be done, nor have they made any indication of any potential costs associated with such remediation.  Therefore, based on the facts and circumstances known to us at the present time, we are not able to estimate the probability of incurring a contingent liability related to this site, nor or we able to reasonably estimate any potential range of exposure at this time.  As such, no reserve has been established for this matter at this time. We continually monitor this situation and are in correspondence with the CT DEEP as appropriate.  When and if facts and circumstances related to this mater change, we will review our position and our ability to estimate the probability of any potential loss contingencies, as well as the range of any such potential exposure.

● The Rogers Corporate Headquarters located in Rogers, Connecticut is part of the Connecticut Voluntary Corrective Action Program (VCAP).  As part of this program, we have recently started conversations with the CT DEEP to begin to determine if any corrective actions need to be taken at the site related to any potential contamination issues. We are currently in the very early stages of this evaluating this matter and have initiated internal due diligence work related to the site to better understand any potential issues. However, at this time, it is currently unknown what the nature and extent of any potential contamination is at the site, nor what any potential remediation or associated costs would be if any such issues were found.  Therefore, based on the facts and circumstances known to us at the present time, we are unable to estimate the probability of incurring a contingent liability related to this site, nor or we able to reasonably estimate any potential range of exposure at this time.  As such, no reserve has been established for this matter at this time.

In addition to the above issues, the nature and scope of our business brings us in regular contact with the general public and a variety of businesses and government agencies.  Such activities inherently subject us to the possibility of litigation, including environmental and product liability matters that are defended and handled in the ordinary course of business.  We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation, after taking into account insurance coverage and the aforementioned accruals, will have a material adverse impact on our results of operations, financial position, or cash flows.